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Hydrogen sulfide (H2S) is an endogenous gasotransmitter that regulates vascular function 
and blood pressure, and also protects the heart from injury associated with myocardial 
infarction (MI). The mitochondrial enzyme thiosulfate sulfurtransferase (TST) has a putative 
role in the breakdown of H2S but its role in the cardiovascular system is unknown. I 
hypothesised that TST reduces cardiovascular H2S availability and that inhibiting TST 
activity may therefore ameliorate cardiovascular pathology. 
 
In the heart, TST was expressed by cardiomyocytes and vascular smooth muscle cells. Tst-/- 
mice all survived to adulthood and had normal cardiac structure and function. Cardiac and 
hepatic H2S breakdown rates were reduced and H2S levels were higher in the blood of Tst
-/- 
mice. However, in heart tissue, protein levels for the H2S-activated Nrf2 downstream targets, 
thioredoxin (Trx1) and heme oxygenase-1 (HO-1) were comparable. In contrast, protein 
levels for the cardiac specific H2S-synthetic enzyme, cystathionine gamma lyase (CSE) was 
reduced, suggesting a homeostatic negative feedback mechanism to maintain H2S at non-
toxic levels. Respiration, measured using an oxygen-sensing electrode was normal in 
isolated mitochondria from whole Tst-/- compared to control C57BL6 hearts. Endothelial 
nitric oxide synthase (eNOS) protein expression was lower in Tst-/- hearts, highlighting 
potential cross talk between H2S and nitric oxide (NO) signalling. 
 
TST was expressed in whole aorta homogenates and in isolated endothelial cells from aorta 
and small intramuscular vessels of the hindlimb from C57BL/6N control mice. Myography 
and western blotting revealed a greater influence of NO in aorta from Tst-/- mice that was 
associated with increased phosphorylation of the activating serine1177 residue of eNOS (P-
eNOSSer1177). NO plays a lesser role in resistance arteries, but in comparison to control 
vessels, small mesenteric vessels from Tst-/- mice was more reliant on small and intermediate 
calcium activated potassium channels for relaxation.  
 
Tst-/- mice were normotensive, despite this alteration in the regulation of vascular tone. 
However, metabolic cage experiments identified that Tst-/- mice presented with diuresis, 
polydipsia, and increased urinary electrolyte excretion of sodium, potassium and chloride, 




To investigate the role of TST in regulating the response to pathological challenge, MI was 
induced by coronary artery ligation (CAL). In control mice, gene expression of CSE was 
downregulated by 2 days after CAL, but TST expression was 12-fold increased, suggesting 
regulation of H2S bioavailability during the acute MI-healing phase. Tst-/- male mice had a 
40% greater incidence of cardiac rupture during infarct healing and surviving Tst-/- mice had 
greater left ventricular dilatation and impaired function compared to controls. Ex vivo, 
isolated perfused hearts from Tst-/- mice were more susceptible to ischaemia/ reperfusion 
injury, suggesting an additional role of TST in determining cardiomyocyte susceptibility to 
injury.  
 
In conclusion, these data indicate that cardiovascular H2S bioavailability is regulated through 
degradation by TST. The data presented here provide evidence for significant tissue specific 
crosstalk between H2S synthetic and degradative mechanisms and between H2S and other 
local regulatory mechanisms, including ion channels and NOS. We infer TST has a 
physiological role in the kidney where its loss leads to changes in renal electrolyte and water 
handling, although other compensatory mechanisms prevent a change in blood pressure. 
Under conditions of pathological challenge following MI, loss of TST is detrimental, 
illustrating its key role in removal of H2S. The data refute the original hypothesis that TST 
inhibition would be protective against cardiovascular pathology.  Further studies in mice 
with tissue specific deletion of TST are now required to more fully reveal the cardiovascular 
role of TST. 
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1.1 Hydrogen sulfide   
Hydrogen sulfide (H2S) is a gaseous signalling molecule and the latest member to join the 
gasotransmitter family alongside nitric oxide (NO) and carbon monoxide (CO). Historically, 
H2S was characterised as a toxic gas, capable of fatally inhibiting mitochondrial respiration 
via cytochrome c (Szabó, 2007). However, H2S has since been shown to be biologically 
relevant molecule, endogenously produced and capable of modulating a variety of biological 
functions including neuromodulation in the brain (Abe et al., 1995), vascular function and 
blood pressure management (Elsey et al., 2010; Geng et al., 2004; Ishigami et al., 2009; 
Mikami et al., 2011; Zhao et al., 2001) and stimulation of angiogenesis (Papapetropoulos et 
al., 2009). Numerous pharmacological studies have shown the therapeutic potential of H2S-
donors in a variety of disease models such as hypertension, inflammatory disorders and most 
notably, ischaemic injury in the heart (Elrod et al., 2007; Johansen et al., 2006), which will 
be discussed in detail later (section 1.1.6.2).  
In water, H2S dissociates to HS- (hydrosulfide anion) and S2- (sulfide anion) 
(Whiteman et al., 2011). Under physiological pH and temperatures, ≈80% of total sulfide 
exists as HS-, ≈20% as free H2S gas and only negligible amounts as S2-, making it unlikely 
that S2- plays any significant role in H2S’ effects (Kevil, 2012). The term hydrogen sulfide 
refers to the sum of these sulfide species with free H2S considered the most biologically 
relevant species (Whiteman et al., 2011).  
 
1.1.1 Enzymatic H2S production 
Hydrogen sulfide is not only a therapeutic molecule but is endogenously synthesised within 
most major tissues by cytosolic and mitochondrial bound enzymes. The sulfur-containing 
amino acid methionine is initially converted to homocysteine by methionine 
adenosyltransferase (MAT) and glycine N-methyltransferase (GNMT) (Figure 1-1). 
Homocysteine is broken down to L-cysteine and used as substrate by the cytosolic 
pyridoxal-5-phosphate dependent enzymes, cystathionine-β-synthase (CBS) and 
cystathionine-γ-lyase (CSE) to produce H2S (Figure 1-1) (Elsey et al., 2010). Cysteine 
aminotransferase (CAT) converts L-cysteine to 3-mercaptopyruvate (3-MP), which is used 
as substrate by the cytosolic and mitochondrial bound enzyme, 3-mercaptopyruvate 
sulfurtransferase (3MST) to produce H2S in the presence of thioredoxin (Figure 1-1) 
(Mikami et al., 2011). Administration of L-cysteine or 3-MP dose dependently increases H2S 
production in brain homogenates (Ishigami et al., 2009) and isolated rat liver mitochondria 
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respectively (Modis et al., 2013b). CBS, CSE and 3MST are expressed in a variety of tissues 
within the body but exhibit a tissue specific expression pattern.  
 
CBS is highly expressed in the brain, liver and kidneys (Szabó, 2007) where it is involved in 
the transsulfuration pathway, converting homocysteine to cystathionine and L-cysteine to 
H2S (Figure 1-1). CBS expression and its contribution to H2S production within the 
cardiovascular system remains controversial (Elsey et al., 2010; Sen et al., 2008). However, 
human umbilical vein endothelial cells (HUVEC) express CBS and knockdown of CBS with 
lentiviral shRNA reduces cell proliferation and induces premature senescence that is 
exacerbated by homocysteine (Albertini, 2012). In humans, genetic deficiency of CBS 
causes hyperhomocysteinemia, which increases the risk of hypertension and cardiovascular 
events (Maron & Loscalzo, 2009). These data identify a role for CBS in endothelial function 
and cardiovascular health but it remains unclear if these outcomes are H2S related or 
secondary effects of homocysteine-induced damage.  
 
CSE is considered the chief H2S synthetic enzyme within the cardiovascular system with 
high expression observed in the heart, vascular endothelium and smooth muscle (Fu et al., 
2012b; Zhao et al., 2001). CSE converts cystathionine to L-cysteine and L-cysteine to H2S 
(Figure 1-1). It has been reported that CSE activity is regulated by calcium-calmodulin but 
these conclusions remain controversial. In vitro studies have shown that administration of 
calcium and calmodulin to recombinant CSE increases CSE activity (Yang et al., 2008). 
Furthermore, administration of the calcium ionophore, A23187 or the muscarinic receptor 
agonist, methacholine to HUVECs or bovine aortic endothelial cells (BAECs) increases H2S 
production (Yang et al., 2008). H2S production can be attenuated by the calcium chelators, 
EGTA, the calmodulin antagonist W7 or by silencing of CSE with siRNA (Yang et al., 
2008). However, high concentrations of calcium were used in these studies (1-2mM), 
relative to intracellular calcium concentrations achieved under steady state conditions 
(100nM) or following cell stimulation (3μM) (Kimura, 2014). Mikami and colleagues 2013 
showed that H2S production in purified rat liver CSE is stimulated at low concentrations of 
calcium (<100nM) but that H2S production is inhibited when calcium concentrations exceed 
300nM. Furthermore, calmodulin had no effect on H2S production in purified rat liver CSE 
in the presence of calcium (Mikami et al., 2013). Improved understanding of the 
mechanisms that regulate CSE-activation holds great therapeutic potential given the positive 
role that CSE plays in cardioprotection and blood pressure regulation.  
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Figure 1-1 Enzymatic H2S 
production pathway in tissues 
CBS is involved in the 
transsulfuration pathway 
converting homocysteine to 
cystathionine. CSE catalyses a β-
disulfide elimination reaction of 
cystathionine forming L-cysteine 
which is used as a substrate by 
cytosolic enzymes, CBS and CSE 
to produce H2S. L-cysteine is 
converted to mercaptopyruvate by 
cysteine aminotransferase (CAT), 
which is used as a substrate by 
mercaptopyruvate 
sulfurtransferase (MPST) to 
produce H2S in the presence of 
thioredoxin (Trx). Diagram 
adapted from (Szabo et al., 2014) 
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3MST is highly expressed in the brain, liver and kidney tissues and has been localised to 
aortic endothelial cells (Nagahara et al., 1998; Shibuya et al., 2009). The sulfur from L-
cysteine (Figure 1-1) is transferred to α-ketoglutarate by cysteine aminotransferase (CAT), 
forming 3-mercaptopyruvate (3-MP). 3-MP is used as substrate by 3-mercaptopyruvate 
sulfurtransferase (3MST) to form a persulfide thiol (RSSH), which releases H2S in the 
presence of an endogenous or exogenous reducing agent such as thioredoxin (Trx) or 
dithiothreitol (DTT) respectively (Mikami et al., 2011). There is evidence that 3MST is 
redox sensitive as H2S production in the presence of 3MP is enhanced or reduced by Trx1 
(Mikami et al., 2011) or hydrogen peroxide (Modis et al., 2013) respectively. Cysteine 
aminotransferase (CAT) and 3MST are present in the cytosol and in mitochondrial fractions, 
where cysteine concentrations are high (Fu et al., 2012). Inhibition of CAT with aspartate in 
isolated rat liver mitochondria inhibits H2S production stimulated by L-cysteine and α-
ketoglutarate (Szabó et al., 2014).  
Although characterised as an H2S synthesising enzyme, 3MST is evolutionarily 
comparable to the mitochondrial H2S and cyanide breakdown enzyme, thiosulfate 
sulfurtransferase (TST). 3MST is located immediately adjacent to TST on chromosome 15 
and both enzymes share considerable structural and sequence homology (Spallarossa 2004, 
Cipollone et al., 2007). However, 3MST and TST differ in their active site loop residues and 
their substrates, 3-MP and sulfite respectively (Cipollone et al., 2007; Hildebrandt & 
Grieshaber, 2008; Spallarossa et al., 2004). The similarities between these two enzymes 
suggest that 3MST may also have a role in H2S removal under certain conditions.  
 
1.1.2 H2S Breakdown 
Endogenous levels of H2S are likely regulated not only by its synthesis but also by its 
breakdown. Given the ability of H2S to inhibit mitochondrial respiration, H2S bioavailability 
is tightly regulated to avoid such harmful effects. The mitochondrial H2S breakdown 
enzymes have a high affinity for H2S and it is believed that free H2S is rapidly removed 
(within seconds-minutes) under basal conditions. H2S is rapidly oxidised within the 
mitochondria by the sulfide quinone oxidoreductase (SQR), persulfide dioxygenase 
(ETHE1), thiosulfate sulfurtransferase (TST) and sulfide oxidase to form persulfide, sulfite, 
thiosulfate and sulfate respectively (Figure 1-2) (Kabil et al., 2014). The mitochondrial H2S 
breakdown enzymes are believed to be ubiquitously expressed in most tissues, with high 
expression observed in liver (Modis et al., 2013a; Modis et al., 2013b). However, it remains 
unclear if the breakdown enzymes are co-expressed in the same cell types as the H2S 




The SQR, situated in the inner mitochondrial membrane, initiates oxidation of H2S and 
converts it to two persulfide groups (SSH), resulting in a 2-electron donation to coenzyme Q 
in the respiratory chain via ubiquinone, which are used to generate ATP (Kabil et al., 2014). 
According to the widely accepted H2S breakdown pathway mechanism described by 
Hildebrandt and Grieshaber (Hildebrandt et al., 2008), SQR-produced persulfides are 
transferred to a mobile acceptor, which is yet to be fully identified. The sulfur dioxygenase 
ETHE1 oxidises one of the persulfide groups, forming sulfite (SO32-), consuming oxygen 
and water in the process. TST utilises the second persulfide group, transferring sulfur to 
sulfite, forming thiosulfate (S2O32-), a stable non-harmful metabolite that can be excreted in 
urine (Hildebrandt et al., 2008). Alternatively, SO in the mitochondrial intermembrane space 
transfers an atom of oxygen from water to sulfite, forming sulfate (SO42-), which is excreted 
in urine.  
 
Currently, no selective inhibitors are available to inhibit any of the enzymes in the H2S 
breakdown pathway and as a result, research into their functional roles in mammalian tissues 
has been relatively scant. Silencing of SQR with siRNA in murine Hepa1c1c7 hepatoma 
cells reduces SQR protein expression and impairs basal respiration (Modis et al., 2013b). 
SQR siRNA significantly attenuates stimulation of mitochondrial respiration by 3MST in the 
presence of 3-MP (Modis et al., 2013b). Together these observations suggest that impaired 
H2S breakdown leads to H2S accumulation and consequently to inhibition of mitochondrial 
respiration. ETHE1 deficient mice also have markedly elevated tissue H2S levels and 
mitochondrial dysfunction associated with retarded growth and they die from sulfide toxicity 


































Figure 1-2 Mitochondrial H2S breakdown pathway 
(1) Two H2S molecules are converted to persulfide groups (SSH) by the SQR, donating 2 electrons to quinone oxidoreductase and used by complex 
III and IV in the electron transport chain to form ATP. (2) One SQR-persulfide is converted to sulfite (SO32-) by ETHE1 in an oxygen and water 
dependent reaction. (3) TST uses the second SQR persulfide group to convert sulfite (SO32-) to thiosulfate (S2O32-), which can be excreted in urine. 
(4) Alternatively, sulfite oxidase converts sulfite (SO32-) to sulfate (SO42-), in an oxygen dependent reaction, which can be excreted in urine. (5) 




1.1.2.1 TST and its involvement in H2S breakdown 
TST, previously referred to as rhodanese, is a mitochondrial bound enzyme that has been 
highly conserved throughout evolution and is widely expressed in prokaryotes and 
eukaryotes (Billaut-Laden et al., 2012; Nagahara et al., 1998). In mice, TST is highly 
expressed in the liver, kidney and lung tissues, specifically in hepatocytes in close proximity 
to hepatic blood supply within the renal proximal tubule and in epithelial cells surrounding 
the lungs bronchioles (Cipollone et al., 2007; Nagahara et al., 1998). The mitochondrial 
bovine TST, commonly known as Rhobov, is the most well characterised TST and it is 
regularly used as a reference structure for other species (Cipollone et al., 2007). The TST 
sequence varies between species but its 3D structure is highly conserved, for example TST 
in Pseudomonas aeruginosa shows only 22% sequence identity with Rhobov but their 3D 
structures are remarkably similar (Cipollone et al., 2007). TST is commonly thought to 
utilise thiosulfate as a natural substrate for its reaction. Indeed, patients suffering from 
cyanide poisoning receive sodium thiosulfate as treatment. TST transfers sulfur from 
thiosulfate to cyanide, forming the stable thiocyanate, which can then be excreted in urine 
(Figure 1-3) (Hildebrandt et al., 2008). However, purified TST from rat and lugworm show 
low substrate affinity for thiosulfate and the Km (mM range) is low compared to that of 
sulfite and persulfides (μM range), supporting the view that these may preferentially act as 
natural substrates in vivo (Hildebrandt et al., 2008).  
 
TST has also been implicated in sulfide clearance, especially in the colon where bacterial 
flora produce large amounts of H2S. TST is highly expressed in the colon where it may 
modulate local H2S bioavailability. Sulfate reducing bacteria in the colon produce large 
amounts of H2S and are widely believed to be involved in the aetiology of ulcerative colitis 
(Rowan et al., 2009; Taniguchi et al., 2009). Reduced TST expression has been reported in 
mice following experimentally induced ulcerative colitis using dextran sulfate sodium (DSS) 
in drinking water (Taniguchi et al., 2009), supporting a role for TST in H2S removal. At days 
3-6 of DSS treatment, TST activity and protein content were reduced in colonic tissues 
corresponding with time dependent features of ulcerative colitis such as diarrhoea and 
hematochezia (Taniguchi et al., 2009). Currently, no selective inhibitors for TST are 
available and no transgenic models have yet been published on this enzyme to help elucidate 














Figure 1-3 Cyanide detoxification reaction catalysed by TST 
Mitochondrial TST transfers sulfur from sodium thiosulfate (NaS2O32-) to cyanide (CN-), 




1.1.3 Intracellular H2S stores 
Sulfide can be stored in the cell in either acid-labile sulfide stores or as bound sulfane sulfur 
and released as H2S in response to acidic and reducing conditions respectively (Ogasawara et 
al., 1994; Shen et al., 2012). It is becoming clear that these pools are important in regulating 
bioavailable sulfur and may serve as emergency sources of H2S under pathophysiological 
conditions. Acid-labile sulfur stores consist of sulfur atoms present in iron-sulfur cluster 
proteins found in a variety of mitochondrial proteins such as aconitase and succinate 
dehydrogenase (Shen et al., 2012). Rat hearts contain markedly higher acid-labile sulfur 
stores compared to liver, kidney and brain tissues (Ogasawara et al., 1994) and release H2S 
in acidic conditions (Ishigami et al., 2009). As pH is tightly regulated under steady state 
conditions, acid-labile sulfur stores may only release H2S under pathophysiological 
conditions such as ischemia, perhaps when lactic acid accumulation promotes an 
intracellular acidic environment (Kimura, 2010). 
Bound sulfane sulfur exists when sulfur covalently binds to another sulfur atom, 
such as thiosulfate (S2O32-), persulfides (R-S-S-H) or polysulfides (R-Sn-R) (Shen 2012). 
Bound sulfane sulfur releases H2S under reducing conditions and can be liberated with 
exogenous or endogenous reducing agents such as dithiothreitol (DTT) or dihydrolipoic acid 
(DHLA) respectively (Ishigami et al., 2009; Olson et al., 2013). The kidney, liver and brain 
contain high bound sulfane sulfur stores whilst heart shows relatively low levels (Ogasawara 
et al., 1994). By 30 minutes after administration of the H2S-donor Na2S, H2S is absorbed into 
bound sulfane sulfur stores in brain homogenates (Ishigami et al., 2009). Administration of 




pre-treated homogenates supporting the concept that intracellular sulfide storage regulates 
free H2S bioavailability (Ishigami et al.,2009). 
However, the action of release and the precise endogenous conditions in which these 
stores liberate H2S are poorly understood, requiring further investigation (Kolluru et al., 
2013). Currently, no data supports that stored sulfane sulfur is used instead of free H2S for 
signalling within the cell (Kabil et al., 2014).  
 
 
1.1.4 Cellular mechanisms of H2S 
Given its ability to diffuse through cell and organelle membranes, H2S exerts effects in 
multiple cell types and within intracellular organelles, namely the mitochondria. H2S has 
been reported to act upon several molecular targets including; ion channels (section 1.1.5.5), 
protein modification by S-sulfhydration (section 1.1.5.5) and upregulation of the antioxidant 
and anti-apoptotic signalling (section 1.1.6.3). H2S-mediated signalling and cytoprotection 
will be discussed in relation to its contribution to cardiovascular function under health and 
pathophysiological states in the following sections. 
 
1.1.4.1 The mitochondria are an important target of H2S under stress 
conditions 
High concentrations of H2S are toxic, capable of inhibiting cytochrome c in the 
mitochondrial respiratory chain, which can be fatal (Tiranti et al., 2009). In recent years it 
has become clear that H2S donor compounds exert a biphasic effect with low doses (<1μM) 
shown to stimulate mitochondrial respiration and ATP production whilst higher doses 
(>10μM) inhibit these effects (Elrod et al., 2007; Modis et al., 2013b). Administration of 
low doses of the H2S donor, Na2S (50μg/kg body weight) to mouse hearts at the time of 
reperfusion preserves mitochondrial function at 24 hours after ischaemia reperfusion injury 
(IRI) (Elrod et al., 2007). H2S-donors are believed to mediate these protective effects, in part 
by acting as an emergency mitochondrial energy source during low oxygen conditions by 
donating electrons to the mitochondrial respiratory chain via the sulfide quinone 
oxidoreductase (SQR) enzyme at Complex II, to help generate ATP (Szabo et al., 2014). 
 
Recent evidence now shows that the endogenous H2S synthetic enzymes can also contribute 
to mitochondrial respiration and ATP production under certain conditions. In isolated rat 
liver mitochondria, administration of the H2S-synthetic enzyme substrates, L-cysteine or 3-




dependent fashion, but these substrates become inhibitory at higher concentrations (Modis et 
al., 2013b; Szabo et al., 2014). Furthermore, the cytosolic H2S synthetic enzymes can 
translocate to the mitochondria and produce H2S under stress conditions. Mitochondria 
contain high concentrations of cysteine, facilitating enzymatic H2S production (Fu et al., 
2012b). Following hepatic ischaemic injury in vivo, CBS translocates to the hepatic 
mitochondria in a time dependent manner, peaking at 60 minutes of ischaemia (Teng et al., 
2013). At this time mitochondrial H2S levels were increased compared to shams and this 
could be prevented by the CBS inhibitor aminooxyacetic acid (AOAA). CSE was not found 
to translocate to liver mitochondria during ischaemia. Interestingly, H2S production was not 
different in whole liver homogenates between sham and 60 minutes ischaemic liver tissues 
(Teng et al., 2013) indicating that CBS translocation does not increase whole tissue H2S 
production, but diverts its release to the mitochondria. Following hepatic ischaemia, 
reintroduction of oxygen rapidly degraded CBS enzyme, likely a mechanism to avoid 
sustained mitochondrial H2S delivery and induced cytotoxicity (Teng et al., 2013).  
Translocation of CSE has been reported in vascular smooth muscle cells following 
administration of the calcium ionophore A23187. Translocation occurs via the mitochondrial 
membrane transporter Tom-20 and results in H2S production and ATP generation (Fu et al., 
2012a). Silencing of Tom-20 with siRNA, or administration of calcium chelators, reduces 
CSE translocation, H2S production and ATP synthesis (Fu et al., 2012a). These data indicate 
that in conditions associated with ischaemia reperfusion injury (IRI) such as ischaemia and 
calcium overload, H2S enzymes have the potential to translocate and energise the 
mitochondrion, protecting it from injury. Moreover, under reducing conditions (such as 
ischaemia), thiosulfate can be converted to H2S by 3MST and endogenous reducing agents, 
such as Trx1 or DHLA (Mikami et al., 2011). Olson and colleagues propose that during 
hypoxia, when the mitochondrial matrix becomes reduced, thiosulfate is rapidly recycled and 
used as a readily available source of H2S to conserve thiols (Olson et al., 2013). Currently, it 
is unclear if H2S enzyme translocation occurs in cardiomyocytes following coronary artery 
ligation (CAL)-induced ischaemia to help generate ATP and this warrants further 
investigation.  
 
Currently, there is little data regarding the behaviour of mitochondrial H2S breakdown 
enzymes during ischaemia, although this is likely to have a significant impact on H2S 
bioavailability. ETHE1 and SO are oxygen dependent and therefore H2S breakdown is likely 





1.1.4.2 H2S-Nitric oxide crosstalk 
Nitric oxide (NO) is endogenously produced by neuronal, inducible and endothelial nitric 
oxide synthase (NOS1, NOS2, NOS3 respectively), which produce NO from L-arginine 
(Yuan et al., 2015). NO is produced in many tissues in the body and critical in mediating 
cardiac and vascular physiology as well as the response to injury ( Scherrer-Crosbie et al., 
2001; Elrod et al., 2006). NO activates cyclic guanosine monophosphate and protein kinase 
G (PKG), which have been shown to alter calcium handling by the sarcoplasmic reticulum, 
and thereby modulating vasodilatation in vascular smooth muscle cells and limiting injury 
following IRI (Elrod et al., 2006, King et al., 2014). PKG phosphorylates vasodilator-
stimulated phosphoprotein (Vasp) at the serine residue 239 (P-Vasp239) and so, P-Vasp239 can 
serve as a surrogate biomarker of NO bioavailability and PKG activation (Chen et al., 2004). 
In the heart, eNOS and nNOS are constitutively expressed in the coronary vascular 
endothelium and cardiomyocytes respectively (Danson et al., 2005), whilst iNOS is induced 
in leukocytes recruited to the heart following injury or infection (Yuan et al., 2015). 
Cardiomyocyte specific eNOS overexpressing mice subjected to myocardial IRI have 
reduced MI size and preserved cardiac function by 72 hours of reperfusion (Elrod et al., 
2006), supporting a role for NO in cardioprotection.  
 
It is becoming increasingly clear that H2S and NO interact to regulate biological effects in 
vivo. In isolated aortic rings, low doses of the NO donors, sodium nitroprusside (SNP, 
10nM) or morpholinosydnonimine (30nM) enhance the relaxant effect of NaHS (H2S donor, 
see Table 1-1) (Hosoki et al.,1997). Conversely, pre-treatment with the NO synthase 
inhibitor L-NAME reduces H2S-mediated vasorelaxation in isolated rat aorta rings (Zhao et 
al., 2001). While these outcomes suggest interaction at target level there is also evidence for 
crosstalk at the level of synthesis. Incubation of cultured aortic smooth muscle cells with the 
NO donor, S-nitroso-N-acetyl-D, L-penicillamine (SNAP) for 6 hours increases CSE 
transcription and administration of SNP increased H2S production in a dose dependent 
fashion (Zhao et al., 2001). 
 
Recently, H2S donors have been shown to increase NO availability via phosphorylation of 
the eNOS activation site at the serine1177 residue (P-eNOSSer1177) (Kondo et al., 2013). 
Daily administration of the H2S donor, SG1002 to mice for 6 weeks following transaortic 
constriction (TAC) surgery increased P-eNOSSer1177 and myocardial nitrite levels, but had no 
influence on myocardial iNOS or nNOS (Kondo et al., 2013). Furthermore, CSE deficient 




myocardial phosphorylation of the eNOS inhibitory site at threonine495 (P-eNOST495) (King 
et al., 2014). As a result Cse-/- mice have reduced levels of nitrite, nitrosothiols and other 
nitroso species in the heart, supporting the existence of gasotransmitter crosstalk occurs in 
vivo (King et al., 2014).  
 
Furthermore, it has been reported that H2S and NO can also react to form several potent 
intermediates including nitrosothiol (HSNO) or nitropersulfide (SSNO-). Feelisch and 
colleagues argue that the S-N bonds in nitrosothiol are too strong and do not readily release 
NO (Cortese-Krott et al., 2014; Kimura, 2014). Conversely, nitropersulfide has been 
reported to be more stable than nitrosothiol but release NO and polysulfides more efficiently, 
resulting in activation of soluble guanylyl cyclase and relaxation of vascular smooth muscle 
(Kimura, 2014). However, the significance of these H2S-NO intermediate molecules in 
biological signalling and functional relevance is far from clear at this stage.  
 
Compound                   Action 
Sodium sulfide (Na2S) H2S donor - Fast release 
Sodium hydrosulfide (NaHS) H2S donor - Fast release 
SG1002 (garlic derived) H2S donor - Slow release  
GYY4137  H2S donor - Slow release  
AP39  H2S donor - Slow release  
Propargylglycine (PAG) CSE enzyme inhibitor  
β-cyano-l-alanine (BCA) CSE enzyme inhibitor 
L-aminoethoxyvinylglycine (AOAA) CBS enzyme inhibitor 
 







1.1.5 H2S and Cardiovascular Physiology 
1.1.5.1 Regulation of blood pressure  
Blood pressure is maintained within the body by renal electrolyte-fluid handling, vascular 
resistance and by endocrine pathways, such as the renin-angiotensin system. Kidney 
electrolyte fluid handling is the predominant regulator of long-term blood pressure 
maintenance (Guyton, 1987; Mullins et al., 2006). Increased peripheral resistance in small 
resistance arteries increases the resistance the heart must pump against with each beat, 
causing blood pressure to rise. Additionally, over-activation of the renin angiotensin 
aldosterone system (RAAS) increases sodium and water reabsorption and causes 
vasoconstriction, raising blood pressure. Hypertension is clinically diagnosed when systolic 
blood pressure is >140mmHg or diastolic pressure is >90mmHg. The majority of 
hypertensive patients suffer with primary or essential hypertension meaning no clear 
mechanism or secondary causes such as renal disease has been identified (Mullins et al., 
2006).  
 
Blood pressure is predominantly determined by extracellular fluid volume (ECFV) 
homeostasis, which is in turn determined by renal sodium handling (Mullins et al., 2006). 
The kidney maintains sodium balance and ECFV by matching sodium intake with urinary 
sodium excretion via a series of ion pumps and exchangers throughout the renal tubules. The 
kidney acutely modulates sodium excretion in response to changes in blood pressure, a 
critical mechanism named ‘pressure natriuresis’ (Guyton, 1987; Mullins et al., 2006). 
Paracrine signalling is involved in the pressure natriuresis response and contributes to 
modulation of tubular sodium transport. Impaired pressure natriuresis responsiveness and 
tubular function are therefore considered as initiating forces in the development of 
hypertension. All antihypertensive treatments influence renal sodium handling by direct 
inhibition of tubular sodium transport proteins or indirectly via modulation of endocrine 
pathways or cardiovascular function (Ivy et al., 2014). 
 
1.1.5.2 H2S, renal function and contribution to blood pressure control 
H2S has long been characterised for its abilities to reduce blood pressure, via relaxation of 
blood vessels (Yang et al., 2008; Zhao et al., 2001) and will be covered in detail in section 
1.1.5.5. Intravenous administration of NaHS to rats (Zhao et al., 2001) or mice (Yang et al., 
2008; Zhao et al., 2001) dose dependently reduces blood pressure but this effect is transitory, 
likely due to acute changes in neurohormonal pathways to maintain normotension via renal 




evidence suggests that H2S donors can modify salt handling transporters in the renal 
nephron, intensifying interest in its role in the kidney (Nagahara et al., 1998; Yamamoto et 
al., 2012). 
 
1.1.5.3 Salt handling in the kidney 
The human kidneys filter approximately 180L of water at the glomerulus daily, with over 
99% of the water reabsorbed with sodium and other electrolytes in the renal nephron 
(Castrop et al., 2014). Sodium and water homeostasis is tightly regulated by complex 
neurohormonal systems that keep sodium water balance neutral and maintain plasma 
osmolality. The filtrate concentrating ability of the nephron allows plasma osmolality to 
remain constant while tubular filtrate can become hypo-osmotic or hyperosmotic depending 
on water intake. Dehydration increases tubular sodium reabsorption and water retention to 
maintain plasma osmolality and ECFV, resulting in excretion of small volumes of highly 
concentrated urine (Mullins et al., 2006). Conversely, high water intake reduces sodium 
reabsorption and water retention along the nephron, resulting in large volumes of dilute 
urine, preventing dilution of plasma and volume expansion. The renal nephron is composed 
of different tubular segments (Figure 1-4), which are responsible for electrolyte and water 














Figure 1-4 The renal nephron reabsorbs electrolyte and water from the filtrate  







Filtrate from the glomerulus initially enters the proximal convoluted tubule (PCT) where the 
majority of sodium and potassium (≈67%), phosphate (≈80-90%) and calcium (≈60%) 
cations are reabsorbed (Amirlak et al., 2000), by sodium-coupled exchangers or by 
paracellular transport. In the PCT, large amounts of water (60-70%) are reabsorbed via 
aquaporin channels 1 and 7 in response to Na+ reabsorption to maintain plasma osmolality 
(Figure 1-5). Sodium is reabsorbed from the filtrate via several sodium-coupled exchangers 
such as the sodium- phosphate co-transporter but mainly by the apical sodium-hydrogen 
exchanger (NHE3) where sodium is reabsorbed in exchange for hydrogen (Amemiya et al., 
1995; Mullins et al., 2006). Other cations such as potassium and calcium are reabsorbed 
from filtrate in the PCT by passive paracellular reabsorption. The active movement of 
sodium and passive movement of other electrolytes into the cell is driven by the 
electrochemical gradient produced by the basolateral membrane bound Na+/ K+-ATPase 
pump (Figure 1-5) (Amirlak et al., 2000). The Na+/ K+-ATPase pump is present in the PCT, 
thick ascending limb of Henle (TALH) and the distal convoluted tubule (DCT) (Wang et al., 
2009). At the basolateral membrane, the Na+/ K+-ATPase uses ATP generated by nearby 
mitochondria to actively pump intracellular sodium out of the cell and into the interstitium 

















Figure 1-5 Electrolyte and water transport in a proximal tubular cell 
NHE3; sodium hydrogen exchanger isoform 3, Na/ Pi; sodium phosphate co-transporter, 




TST and the H2S synthetic enzymes are highly expressed in the kidney have been localised 
to the proximal convoluted tubule (PCT) (Nagahara et al., 1998; Sylvester et al., 1990; 
Yamamoto et al., 2012), and may play a role in PCT sodium reabsorption.  
 
Following PCT reabsorption, the thick ascending limb of Henle (TALH) is responsible for 
20-25% of tubular NaCl and 20% of potassium reabsorption from the filtrate (Mullins et al., 
2006). Water is not reabsorbed in the TALH. Within the TALH, sodium, potassium and 
chloride reabsorption is mediated by the apical membrane bound Na-K-2Cl cotransporter 
(NKCC2) and renal outer medulla potassium (ROMK) channel and by the basolateral 
membrane bound chloride (ClC-Kb) channel (Figure 1-6). The apical ROMK channels 
recycle intracellular potassium back into the lumen and enable the NKCC2 to passively co-
transport luminal sodium, potassium and chloride into the cell (Bhat, et al., 2012; Castrop et 
al., 2014). The NKCC2 plays a critical role in the handling of sodium, potassium and 
chloride within the TALH and is driven by the electrochemical gradient produced by the 
basolateral membrane bound Na+/ K+-ATPase pump (Amirlak et al., 2000). Large amounts 
of calcium and magnesium are passively reabsorbed in the TALH, which are coupled with 

















Figure 1-6 Electrolyte transport in the thick ascending limb of Henle 
NKCC2; sodium-potassium-chloride co-transporter, ROMK; renal outer medulla potassium 
channel, Na/ K ATP-ase; sodium potassium ATPase pump, ClCKb; basolateral chloride 




1.1.5.4 H2S donor effects on kidney function 
Relatively few studies have investigated H2S’ effect on renal sodium handling. 
Administration of NaHS to the renal artery of rats increases urinary flow rate and excretion 
of sodium, highlighting a potential role of endogenous H2S in electrolyte-fluid homeostasis 
(Xia et al., 2009). In vitro studies performed on isolated renal basolateral membranes from 
rats showed that NaHS dose dependently reduced Na+/ K+-ATPase activity caused by 
internalisation of the Na+/ K+-ATPase pump from the basolateral membrane to the cytosol 
(Ge et al., 2014; Xia et al., 2009). As renal basolateral membranes were isolated from whole 
kidneys in this study rather than from individual regions of the nephron, it remains unclear 
where H2S acts along the nephron. However, as the Na+/ K+-ATPase pump is present in the 
PCT, TALH and DCT and significant sodium and water losses are observed following NaHS 
infusion, it seems plausible that H2S inhibits Na+/ K+-ATPase activity at each of these 
regions. CSE, CBS, 3MST and TST are all expressed in the PCT and may play a role in 
tubular sodium handling via inhibition of the Na+/ K+-ATPase pump. NaHS has also been 
reported to reduce Na+/ K+-ATPase currents and sodium absorption in the human bronchiolar 
epithelial cell line H441 and in tracheal tissues of pigs and mice (Althaus et al., 2012). 
Patients with chronic exposure to H2S gas have pulmonary oedema, potentially because of 
impaired transepithelial sodium reabsorption. 
 
1.1.5.5 Regulation of vascular function by H2S  
Several rodent studies have shown that the H2S-donors, NaHS and Na2S dose dependently 
relax blood vessels and reduce blood pressure (Hosoki et al., 1997; Mustafa et al., 2011; 
Yang et al., 2008; Zhao et al., 2001). Importantly, H2S is endogenously produced in the 
vasculature, predominantly by CSE, which is localised within murine endothelium and 
vascular smooth muscle (Fu et al., 2012a; King et al., 2011; Li et al., 2011; Zhao et al., 
2001). CSE deficient (Cse-/-) mice produce less H2S and suffer from endothelial dysfunction 
in mesenteric arteries and associated age-dependent hypertension, confirming that H2S acts 
as an endogenous vasodilator and blood pressure regulator (Mustafa et al., 2011; Paul et al., 
2012; Yang et al., 2008). Vasorelaxation within the rat aorta is largely NO and 
cyclooxygenase dependent, with H2S mediating <25% of total relaxation (Hosoki et al., 
1997; Mustafa et al., 2011). Conversely, vasorelaxation within the small resistance arteries is 
largely H2S dependent with NO playing a relatively minor role (Mustafa et al., 2011). 
 
In mesenteric arteries, cholinergic stimulation with acetylcholine (ACh) releases calcium 




CSE, producing H2S (Paul et al., 2012; Shibuya et al., 2009). Endothelial generated H2S 
activates small and intermediate calcium activated potassium (SKCa and IKCa) channels in the 
endothelium and via diffusion, activates KATP channels in smooth muscle cells (Figure 1-7). 
Activation of SKCa and IKCa channels causes endothelial hyperpolarisation via potassium 
extrusion, which is then transmitted to the smooth muscle through open KATP channels to 
cause whole vessel relaxation (Figure 1-7) (Albertini, 2012; Paul et al., 2012). SKCa and IKCa 
channels only mediate part of the vasodilator capacity of H2S (10-20% of total). The 
majority of its effects are exerted by activation of ATP-sensitive potassium (KATP) channels 
in the vascular smooth muscle. Inhibition of KATP channels with glibenclamide or 5-
hydroxydecanoate (5-HD) abolishes H2S-donor mediated vasorelaxation in aortic and 
mesenteric arteries and attenuates H2S-mediated blood pressure reduction (Maron et al., 
2009; Mustafa et al., 2011; Ovechkin et al., 2006; Zhao et al., 2001).  
 
H2S activates KATP channels by causing post-translational modification of one of its subunits 
in a process termed S-sulfhydration. S-sulfhydration adds a sulfur to thiols groups of 
cysteine residues, producing a hydropersulfide (-SSH) moiety (King et al., 2011; Li et al., 
2011; Sutton et al., 2000) with increased biological activity. Under basal conditions, the 
KATP channels found in vascular smooth muscle cells are bound to ATP, and remain closed 
(Figure 1-7). Following cholinergic stimulation, CSE-derived H2S diffuses to smooth muscle 
from the endothelium, and sulfhydrates the KATP channels Kir6.1 subunit at the cysteine 43 
(Cys43) residue. This promotes Kir6.1 binding to phosphatidylinositol-4, 5-biphosphate 
(PIP2) and reduces the binding affinity of ATP, leading to KATP channel opening, potassium 
influx and vasodilatation (Figure 1-7) (Mustafa et al., 2011; Paul et al., 2012; Sutton et al., 
2000). Administration of the KATP channel blocker glibenclamide or mutation of the Kir6.1-
Cys43 residue in HEK293 cells attenuates NaHS- mediated hyperpolarisation via reduced 
Kir6.1-Cys43 sulfhydration, reduced PIP2 binding and enhanced ATP-binding, keeping the 
channel closed (Hausenloy et al., 2013; Mustafa et al., 2011). Cse-/- mice produce less H2S 
and have reduced sulfhydration of Cys43 at Kir6.1, accounting for vascular dysfunction and 
hypertension in this model (Mustafa et al., 2011).  
3MST is expressed in aortic endothelium and smooth muscle (Koivumaki et al., 
2009; Shibuya et al., 2009; Yellon et al., 2007) but as no selective 3MST inhibitors are 
currently available, 3MST’s influence on vascular function remains unclear. CBS has also 
been localised to the aortic endothelium but its expression is considered to be low and its 
contribution to vascular H2S synthesis has been largely dismissed. As mentioned previously, 






















Figure 1-7 Mechanisms of H2S-mediated vasodilatation  
Diagram from Paul et al. 2012. Abbreviations; CaM; calmodulin, Cys43; Cysteine43, IP3R; 
inositol triphosphate receptors, PtdIns(4,5)P2 / PIP2; phosphatidylinositol-4, 5-biphosphate.  
 
proliferation and induces premature senescence, which is enhanced by homocysteine 
administration (Albertini, 2012; Hausenloy et al., 2013). CBS deficient (Cbs-/-) mice suffer 
from hyperhomocysteinemia, endothelial dysfunction and hypertension, mimicking the 
human disorder, but the levels of H2S in Cbs
-/- mice are currently unknown making it 
difficult to interpret if their dysfunction is due to reduced H2S availability or a secondary 
effect of high homocysteine concentrations (Maron et al., 2009; Ovechkin et al., 2006; 
Yellon et al., 2007). Therefore, it is clear that CBS plays a vital role in endothelial health and 
function, likely via homocysteine breakdown. It remains unclear if TST is present in the 









1.1.6 Cardiovascular pathophysiology and H2S mediated cardioprotection 
 
1.1.6.1 Myocardial Infarction & reperfusion Injury 
Cardiovascular disease is responsible for 160,000 deaths each year in the United Kingdom 
(British Heart Foundation 2015). Cardiovascular disease encompasses a host of morbidities 
such as myocardial infarction, stroke, coronary heart disease and angina.  
 
Myocardial infarction (MI) occurs when a coronary vessel is occluded by thrombus 
formation on a ruptured atherosclerotic plaque. Tissue downstream of the occlusion is 
deprived of oxygen, preventing aerobic respiration and causing cardiomyocyte cell death 
through necrosis and apoptosis. As the heart is unable to regenerate, the damaged tissue is 
replaced by scar tissue. The remaining myocardium undergoes structural and functional 
remodelling in an attempt to maintain cardiac output (Sutton et al., 2000; van der Horst et 
al., 2007). Over time, reduced pumping efficiency of the heart reduces blood supply to 
organs and tissues and increases and risk of developing chronic heart failure (Sutton et al., 
2000). With increasing rates of intervention now clinically performed to restore blood supply 
to the heart after MI, the number of individuals surviving MI, but subsequently going on to 
develop heart failure is increasing.  
 
Infarct size is a key determinant of long-term outcome post MI. Experimental and clinical 
studies have shown that this can be reduced by early reperfusion. However, reperfusion still 
results in irreversible ‘reperfusion injury’ to the myocardium (Hausenloy et al., 2013). 
Reperfusion injury itself can generate large amounts of reactive oxygen species (ROS) and 
cause calcium overload, which can irreversibly damage the cells mitochondria, propagating 
cardiomyocyte death (Hausenloy et al., 2013). Oxidative stress causes dysfunction of the 
sarcoplasmic reticulum, releasing high concentrations of calcium into the cytosol causing 
further mitochondrial damage, cardiomyocyte hypercontracture and cell death (Koivumaki et 
al., 2009; Yellon et al., 2007). Therefore, therapies aimed at reducing reperfusion injury are 
key in reducing the likelihood of developing of heart failure (Hausenloy et al., 2013). Brief 
periods of ischaemia administered either immediately before (pre-conditioning) or 
immediately after (post-conditioning) reperfusion reduces reperfusion injury and patient 
outcome (Yellon et al., 2007). β-blockers, ACE inhibitors and diuretics are currently used to 
reduce the likelihood of cardiac remodelling and the development of heart failure following 
injury (van der Horst et al., 2007). H2S has shown great promise in animal studies by 




reperfusion (Polhemus et al., 2014). However the H2S-donor compounds release H2S quickly 
in an uncontrolled manner, which may not be a safe approach given the toxic capabilities of 
H2S at high concentrations.  
 
1.1.6.2 H2S mediated cardioprotection in acute models of myocardial 
infarction 
Several in vivo studies have shown the therapeutic potential of administering H2S donors 
before, during or after IRI (Calvert et al., 2010; Elrod et al., 2007; Sodha et al., 2009; Zhu et 
al., 2006). Ex vivo IRI studies show that administration of the H2S donor NaHS prior to and 
during ischaemia until shortly after reperfusion, dose dependently reduces MI size in isolated 
perfused rat hearts (Johansen et al., 2006). Johansen and colleagues showed that 0.1μM - 
1μM of NaHS dose dependently reduced MI size but at 10μM NaHS, these effects were lost 
showing a narrow therapeutic window of action (Johansen et al., 2006). The biphasic 
concentration dependent effect of H2S on MI size was confirmed in in vivo IRI studies with 
protection being lost at higher concentrations (Elrod et al., 2007). Administration of low 
doses of Na2S (<50μg/kg body weight) directly into the left ventricular lumen of mice at the 
time of reperfusion significantly reduced 24 hour serum cardiac troponin-I, MI size, left 
ventricular dilatation and preserved ventricular contractility compared to vehicle treated 
controls (Elrod et al., 2007). Higher concentrations of Na2S (100μg/kg body weight) were 
less effective at reducing MI size whilst maximal concentrations of Na2S (500μg/kg body 
weight) had no effect on MI size whatsoever. 
 
Conversely, pharmacological CSE inhibitor studies and transgenic mouse models of altered 
CSE expression have shown how important endogenous H2S production is in the hearts 
response to MI. Administration of the CSE inhibitor propargylglycine (PAG) to rats for 7 
days prior to permanent coronary artery ligation (CAL) increases infarct size and mortality 
compared to vehicle treated controls (Zhu et al., 2006). Furthermore, Cse-/- mice have 
reduced levels of L-cysteine and H2S and are more susceptible to IRI (King et al., 2014; 
Yang et al., 2008). Conversely, cardiac specific CSE over-expressing (αMHC-CGL-Tg) 
mice have increased CSE expression and myocardial H2S availability and are protected from 
IRI (Elrod et al., 2007), highlighting the therapeutic potential of increasing myocardial CSE 
expression following IRI. Given the low expression of CBS in the heart, it is not currently a 
major area of interest. 3MST is highly expressed in the heart and due to the recent generation 
of the 3MST knockout mouse (Nagahara et al., 2013), there is much anticipation within the 




1.1.6.3 H2S mediated mechanisms of cardioprotection 
Hydrogen sulfide exerts its cardiovascular protection via several mechanisms including 
mitochondrial protection (section 1.1.4.1), H2S-NO crosstalk (section 1.1.4.2), upregulation 
of antioxidant genes, anti-apoptotic cell signalling and ion channel activation.  
 
As discussed in section 1.1.4.1, exogenous H2S has been shown to preserve cardiac 
mitochondrial function in in vitro and in vivo IRI studies (Elrod et al., 2007). The H2S 
synthetic enzymes have been reported to translocate to the mitochondria in liver and smooth 
muscle cells under ischaemic and high calcium conditions to produce H2S and stimulate 
mitochondrial respiration and ATP formation (section 1.1.4.1) (Fu et al., 2012a; Teng et al., 
2013). These data indicate that the heart may also possess this ability under conditions 
associated with IRI and may underlie H2S ability to limit cardiac injury, but this remains to 
be confirmed. 
 
As discussed in section 1.1.4.2, H2S-NO crosstalk plays a major role in mediating H2S-
related cellular mechanisms. Cse-/- mice produce less H2S and have reduced eNOS activity 
and NO availability in the heart (King et al., 2014). Resultantly, Cse-/- mice have an 
increased susceptibility to myocardial IRI (King et al., 2014). Administration of Na2S to Cse
-
/- mice increases myocardial P-eNOSSer1177, normalises myocardial P-eNOST495 and increases 
cardiac nitrite and RXNO levels resulting in reduced infarct size at 24 hours following IRI 
(King et al., 2014). However, Na2S failed to reduce infarct size in eNOS knockout mice or in 
mice with mutated eNOSSer1177 indicating that H2S-mediated cytoprotection is eNOS and NO 
dependent. This is the most compelling in vivo data thus far showing that H2S-NO crosstalk 
is vital in mediating cardioprotection. However it is currently unclear how H2S 
phosphorylates eNOSSer1177 and dephosphorylates eNOSThr495, warranting further 
investigation.  
 
Several groups have reported the ability of H2S to act as an antioxidant and reduce apoptosis. 
Administration of Na2S to mice at 24 hours before myocardial IRI reduces injury induced-
oxidative stress and apoptosis (Calvert et al., 2009). Na2S pre-treatment maintains 
myocardial redox potential (reduced glutathione oxidation) and reduces lipid hydroperoxide 
levels following 45minutes of ischaemia and 1 hour, 4 hours or 24 hours reperfusion injury 
(Calvert et al., 2009). Following 4 hours reperfusion, Na2S pre-treated mice had reduced 
myocardial expression of cleaved caspase 3, reduced cytochrome c release and reduced 




oxidative stress is mediated via the upregulation of antioxidant enzymes. H2S initiates 
translocation of the antioxidant transcription factor, nuclear factor E2 related factor (Nrf2) to 
the nucleus where it is involved in transcription of several anti-oxidant enzymes such as 
thioredoxin (Trx1) and hemeoxygenase 1 (HO-1). Hearts isolated from uninjured mice at 30 
or 120 minutes following intravenous Na2S treatment show that Nrf2 time dependently 
translocates from the cytosol to the nucleus (Calvert et al., 2009) and by 24 hours, protein 
expression of Trx1 and HO-1 are significantly increased in the heart (Calvert et al., 2009). In 
Nrf2 deficient (Nrf2-/-) mice treated with Na2S, upregulation of Trx1 is significantly stunted 
whilst HO-1 protein expression is unchanged after 24 hours (Calvert et al., 2009). 
Furthermore, Nrf2-/- mice have increased susceptibility to myocardial IRI and cannot be 
rescued with Na2S (Calvert et al., 2009). Moreover, αMHC-CGL-Tg mice, which produce 
more H2S in the heart and are protected from IRI 6, have increased myocardial Nrf2, Trx1 
and HO-1 under basal conditions (Calvert et al., 2009). These data support that 1) H2S exerts 
its cardioprotective effects via Nrf2 antioxidant signalling and 2) Trx1 and HO-1 are largely 
regulated by the H2S-sensitive Nrf2.  
 
H2S reduces apoptosis via phosphorylation of the anti-apoptotic pathways, extracellular 
signal-regulated kinase (ERK1/2) and phosphatidylinositol 3-kinase PI3K/Akt (Hu et al., 
2007). Inhibition of CSE with PAG or β-cyano-l-alanine (BCA) attenuated H2S-mediated 
phosphorylation of ERK ½ in rat cardiomyocytes (Hu et al., 2007). Moreover, 
pharmacological inhibition of ERK1/2 with PD98059 and PI3K/Akt with LY-294002 and 
Akt III attenuated H2S mediated protection of rat cardiomyocytes undergoing in vitro IRI 
(Hu et al., 2007) supporting that anti-apoptotic signalling plays a role in H2S-mediated 
cardioprotection. Furthermore, administration of Na2S to mice increases expression of the 
anti-apoptogens Bcl-2 and Bcl-xL in the heart by 24 hours, corresponding to reduced 
TUNEL staining (Calvert et al., 2009). 
 
H2S-induced activation of ion channels has also been shown to play a role in 
cardioprotection (Bian, 2005; Johansen et al., 2006; Sivarajah et al., 2006; Sun et al., 2008). 
As detailed previously, H2S activates KATP channels via sulfhydration of the KATP channels 
Kir6.1 subunit at the cysteine 43 (Cys43) causing vasorelaxation (Mustafa et al., 2011). Ex 
vivo isolated perfused hearts exposed to NaHS show a dose dependent reduction of MI size, 
which was attenuated with the KATP channel inhibitors, glibenclamide or 5-
hydroxydecanoate (5HD) (Johansen et al., 2006). Coronary flow rate was not significantly 




IRI protocol indicating that H2S does not protect hearts via increased tissue perfusion 
(Johansen et al., 2006). Sarcolemmal and putative mitochondrial KATP channels play a role in 
protection from IRI (Garlid et al., 2012). However, due to a lack of selective subcellular 
KATP channel inhibitors, it remains unclear which of these channels is acted upon by H2S, 
requiring further investigation with a more selective approach. Additionally, H2S dose 
dependently inhibits opening of cardiac L-type calcium channels in isolated rat 
cardiomyocytes (Dewald et al., 2005; Sun et al., 2008; Zhang et al., 2012), which may also 
help to prevent Ca2+ overload upon reperfusion injury. 
 
1.1.6.4 Infarct healing 
Ischaemia and cell death initiates a strong inflammatory response, facilitated by activation of 
toll-like receptors and the complement cascade, which upregulate chemoattractant and cell-
adhesion molecules, directing neutrophils and monocytes towards the necrotic site 
(Frangogiannis et al., 2002; Ghigo et al., 2014). Enhanced neutrophil infiltration can 
exacerbate cardiomyocyte death by vascular plugging, degradative enzyme release and 
reactive oxygen species (ROS) production (Carden et al., 2000; Gao et al., 2005; Yellon et 
al., 2007).  
 
Although leukocyte infiltration is considered harmful in IRI, it is critical for effective infarct 
healing and scar formation in models of permanent coronary artery ligation (CAL). In CAL, 
post-infarct healing is orchestrated by infiltrating inflammatory cells, which remove dead 
cardiomyocytes and stimulate collagen deposition by myofibroblasts, forming a scar in place 
of damaged myocardium and stabilising the structural integrity of the heart (Frangogiannis, 
2012; McSweeney et al., 2010). In mouse models of permanent ligation, the stages of 
leukocyte infiltration are well defined (Frangogiannis et al., 2002). Neutrophils and 
monocytes infiltrate the infarcted myocardium facilitated by chemoattractant and adhesion 
molecules in the hours- days after MI. The neutrophil content of the heart peaks at 1-2 days 
after injury. Thereafter, monocyte subsets and the macrophages derived from them dominate 
and accumulate in a biphasic pattern, responding to different chemokine signals released 
from the injured myocardium during the early and late healing phases (Elrod et al., 2007; 
Nahrendorf et al., 2010; Sodha et al., 2009; Zhang et al., 2014). Pro-inflammatory Ly6Chigh 
monocytes and macrophages predominate until 3-4 days after injury, attracted by the potent 
chemoattractant MCP-1. These release pro-inflammatory cytokines and their primary 
function is to ensure the removal of apoptotic and necrotic tissue. Impaired or excessive 




cardiac rupture (Gao et al., 2005; Sodha et al., 2009). By 24 hours post-MI, MCP-1 deficient 
mice have reduced macrophage recruitment and by day 3 post-MI, the removal of necrotic 
myocardium and replacement with granulation tissue is delayed compared to wild type 
controls (Dewald et al., 2005; Zanardo et al., 2006). 
 
From day 3-4 post-MI the monocytes/macrophages population becomes a more 
predominantly anti-inflammatory, pro-repair phenotype (Ly6Clow), under the influence of 
cytokines e.g. IL-4 and IL-13, generated in the healing myocardium by other cells, including 
fibroblasts and T cells. These release growth factors including TGF-β, which stimulate 
angiogenesis and fibroblast to myofibroblast differentiation, necessary for collagen synthesis 
and deposition for scar formation (Frangogiannis et al., 2002; Zanardo et al., 2006). Poor 
infarct healing and impaired resolution of inflammation limits removal of dead cells and 
delayed scar formation with a reduced tensile strength resulting in increased dilatation of the 
left ventricle and an increased risk of cardiac rupture (Gao et al., 2005; Zhang et al., 2008). 
Administration of clodronate-loaded liposomes to mice immediately following CAL or at 
day 3 post CAL depletes Ly6Chigh and Ly6Clow monocytes respectively resulting in reduced 
scavenging of necrotic tissue, impaired collagen deposition and reduced microvessel 
formation (Nahrendorf 2007). Conversely, promotion of pro-repair macrophages leads to 
increased angiogenesis reduced infarct expansion and improved retention of cardiac function 
(McSweeney et al., 2010; Zhang et al., 2014). 
 
1.1.6.5 H2S and post-infarct inflammation, wound healing and development 
of heart failure     
The anti-inflammatory actions of H2S have been reported in various models of inflammation 
and injury, including CAL and IRI models of MI (Elrod et al., 2007; Sheng et al., 2013; 
Sodha et al., 2009; Zhang et al., 2014). Yorkshire pigs pre-treated with Na2S prior to IRI 
have markedly reduced leukocyte infiltration and IL-6, IL-8 and TNF-α cytokine levels (Cai 
et al., 2007; Sodha et al., 2009), but it is unclear if this effect is mediated by reduced MI 
size. Intravital microscopy experiments show that H2S dose-dependently inhibits aspirin-
induced leukocyte adherence in mesenteric arteries of rats and that was attenuated with the 
KATP channel inhibitor glibenclamide (Papapetropoulos et al., 2009; Zanardo et al., 2006). 
Furthermore, in models of carrageenan induced air pouch inflammation, H2S treatment 
reduces leukocyte infiltration, which is abrogated in rats pre-treated with the CSE or KATP 
channel inhibitors, BCA and glibenclamide respectively (Papapetropoulos et al., 2009; 




CSE prevents acute leukocyte attachment via activation of KATP channels. Conversely, high 
concentrations of H2S can evoke a pro-inflammatory response, again highlighting the 
important relationship between H2S concentration and outcome. Zhang and colleagues 
showed that in mice subjected to cecal ligation and puncture-induced sepsis, NaHS increases 
TNF-α, IL-1β IL-6 and MCP-1 expression but that could be rescued with the CSE inhibitor 
PAG (Polhemus et al., 2014; Zhang et al., 2008). However, as this study administered high 
concentrations of Na2S (10mg/ kg), it is likely that H2S caused a toxic effect, propagating 
inflammation.  
 
Following permanent ligation, neutrophil recruitment to the heart at 24 hours post CAL is 
abrogated by NaHS treatment (Calvert et al., 2010; Zhang et al., 2014). As described 
previously (section 1.1.8), a timely inflammatory response is required in permanent ligation 
models to replace dead cardiomyocytes with collagen rich scar tissue to preserve the 
structural integrity of the heart. Inhibition of inflammation by H2S would potentially impair 
this process. Whilst the Zhang 2014 study shows a similar H2S-mediated inflammatory 
suppression response as seen in other studies, it did not assess the effects of H2S on scar 
formation or cardiac function at later timepoints. In vitro studies have shown that H2S can 
inhibit the differentiation of fibroblasts to myofibroblasts, which would limit scar formation 
and increase the risk of cardiac rupture in permanent coronary artery ligation models 
(Calvert et al., 2010; Sheng et al., 2013). Although the anti-inflammatory effects of H2S are 
protective in models of IRI, it is currently unclear what effect increased H2S availability has 
on early infarct healing in models of permanent ligation.  
 
H2S treatment is also beneficial following injury by promoting angiogenesis. Cai and 
colleagues showed that low doses of NaHS increased cell migration in scratch wound assays 
and increased tube-like structure formation in matrigel experiments performed on RF/6A 
endothelial cells (Cai et al., 2007; Kondo et al., 2013). In in vivo Matrigel plug assay in 
mice, 7-day NaHS treatment significantly increased cellular infiltration, neovascularisation 
and haemoglobin content, compared to vehicle treated mice. Paradoxically, higher 
concentrations (200μM) of H2S do not produce any pro-angiogenic effects (Cai 2007) 
highlighting the importance of dose in determining the effects of H2S. H2S promotes 
angiogenic branching and complexity of vascular networks in chicken chorioallantoic 
membranes, which are attenuated by CSE inhibitors, PAG and BCA (Papapetropoulos et al., 
2009). In vitro aortic ring angiogenesis assays show that aortas from Cse-/- mice have 




(Papapetropoulos et al., 2009), confirming that endogenous H2S production mitigates the 
angiogenic response.  
 
1.1.6.6 H2S and heart failure 
Heart failure patients have markedly reduced levels of circulating H2S compared to age 
matched controls (Polhemus et al., 2014). Calvert and colleagues show that daily H2S-
treatment for the first 7 days following IRI prevented left ventricular end systolic dilatation 
and preserved ejection fraction by 4 weeks after IRI (Calvert et al., 2010). Interestingly this 
was not reproduced by single dose Na2S treatment immediately following IRI, suggesting 
the improved outcomes are not accounted for simply by reduction of infarct size (Calvert et 
al., 2010). Furthermore, αMHC-CGL-Tg mice, which produce more H2S, have markedly 
reduced cardiac dilatation and preserved cardiac function compared to wild type controls at 4 
weeks post IRI suggesting that chronic elevation of H2S may have long-term benefits in 
preventing the development of heart failure.  
 
In a model of pressure overload-induced heart failure, mice subjected to transaortic 
constriction (TAC) surgery had reduced H2S levels in the heart and blood by 6 weeks 
(Kondo et al., 2013). Mice placed on the garlic derived H2S-donor SG1002-containing chow 
1 week before TAC and then continuously for 6 weeks after TAC had increased circulating 
and tissue H2S levels. This was associated with reduced left ventricular dilatation, cardiac 
fibrosis and lung weight and preserved ejection fraction compared to vehicle treated 
controls. αMHC-CGL-Tg mice also had reduced left ventricular end systolic diameters and 
preserved ejection fraction by 12 weeks following TAC compared to wild type controls. 
Conversely, Cse-/- mice had greater left ventricular dilatation, heavier hearts and lungs and 
reduced ejection fraction by 12 weeks post TAC, which could be rescued when Cse-/- mice 
were maintained on SG1002-containing chow. These two separate models of heart failure 
show that elevated H2S is capable of preventing heart failure when administered chronically.  
 
Although SG1002 increases H2S levels, it also increases NO availability as discussed 
previously (1.1.4.2) and this may have contributed to improved outcomes. Following 6 week 
of TAC, eNOS-/- mice develop heart failure but cannot be rescued with SG1002-containing 
chow highlighting the key importance of H2S-NO crosstalk in the beneficial effects of H2S in 
heart failure. Previously found to be non-toxic to humans, SG1002 is currently in the phase 1 






The distribution of the H2S synthetic enzymes in the cardiovascular system is well defined. 
However, it is unclear if TST is localised in the same tissues and cell types and may be 
responsible for regulating local H2S availability and cardiovascular function.  
 
The first hypothesis of this thesis is that TST is present in the heart and vasculature where it 
regulates local H2S availability by efficient breakdown.  
 
The second hypothesis of this thesis is that lack of TST would lead to increased H2S 
availability resulting in  
(i) reduced blood pressure associated with increased vasodilation 
(ii) protection of the heart from injury associated with myocardial ischaemia  
 
 
1.2.1 The specific aims were to:  
 Establish the expression and localisation of TST and the H2S synthetic enzymes in 
the healthy heart and vasculature  
 
 Quantify the expression profile of the H2S synthetic and breakdown enzymes in the 
heart during the early and late phases of infarct healing following coronary artery 
ligation 
 Using the novel TST knockout mouse, investigate if TST deletion impacts upon; 
i. Whole body H2S availability, H2S-NO crosstalk, and the regulation of the 
H2S synthetic enzymes in the heart  
ii. Cardiac function and mitochondrial respiration under basal conditions  
iii. Blood pressure and sodium-fluid homeostasis in the kidney  
iv. Vascular function in isolated large and small conductance arteries 
v. Mortality, infarct healing, leukocyte recruitment and cardiac function 
following in vivo coronary artery ligation  
vi. MI size in isolated perfused hearts following ex vivo IRI and mitochondrial 







2 Materials and Methods 
 
2.1 Animals 
All experimental protocols were approved by the University of Edinburgh Preclinical Ethical 
Review Committee and by the UK Home Office (GA Gray, PPL 60/4247). Mice were fed 
standard chow, had free access to food and water and maintained on a 12hour light: dark 
cycle. 
 
A global Tst -deficient (Tst-/-) mouse was generated by Velocigene (Regeneron 
Pharmaceuticals, USA) using KOMP technology to ablate the entire TST gene to achieve a 
definitive null allele. A LacZ neomycin resistant gene cassette with homology arms that 
flank the 5 3 regions of the entire Tst gene was inserted into blastocyst cells by homologous 
recombination. Cells incorporating the gene cassette were positively selected following 
neomycin treatment, expanded and microinjected into blastocysts and placed back into a 
pseudopregnant surrogate mother on a C57BL/6N background. The Tst knockout allele went 
germline and Tst heterozygous sperm from male offspring was sent to Edinburgh and used 
for in vitro fertilization onto a C57BL/6N background, performed in-house by a local 
transgenic facility (GIST; Dr Matthew Sharp). F1 progeny that were heterozygous for Tst 
deficiency mice were identified by genotyping (Transnetyx, USA). The initial colony was 
maintained through het x het breeding with 1:4 mice in the progeny obtained as Tst knockout 
(Tst -/-). From generation 4 of backcross to C57BL/6N, Tst-/- and littermate C57BL/6N mice 
were bred as separate colonies. Age matched C57BL/6N wild type littermates were bred as 
controls. Male mice aged 11-20 weeks were used for experiments.  
 
Professor Nik Morton acquired the Tst-/- sperm from Velocigene and subsequently set up 





2.2 In vivo work 
2.2.1 Intra-carotid blood pressure  
Blood pressure was measured using a pressure transducer tipped Millar catheter (1.4F 
cannula, Millar). Prior to blood pressure measurement, the Millar catheter was equilibrated 
in warmed 0.9% saline for 20 minutes. The Millar catheter was connected to a PCU-2000 
Pressure Control unit (Millar), which was connected to AD Instruments Powerlab 8/30 for 
real time data acquisition and signal was recorded using LabChart 7 software (AD 
Instruments). The catheter was calibrated using the PCU-2000 unit and LabChart7 software 
to set the range of voltages that corresponded to 0, 25, 100 and 125 mmHg. 
 
Mice were anaesthetised with ketamine (50mg/kg)/ medatomidine (0.5mg/kg) administered 
intraperitoneally. Depth of anaesthesia was established by a lack of the pedal pain 
withdrawal reflex. Mice were shaved from the lower jaw to rib cage and placed on a heat 
mat. A 1.5cm incision was made from the lower jaw and the salivary gland manoeuvred to 
allow visualisation of the right carotid artery. Ligatures were tied distally to stop blood flow 
to the head and the tie clamped to stretch the carotid. The right carotid was clamped 
proximately and an incision was made into the carotid artery. The Millar catheter was 
inserted into the carotid artery, tied into place around the artery and the proximal clamp 
removed to return blood flow. Blood pressure was recorded in real time using LabChart 7. 
Blood pressure was allowed to equilibrate for 30 minutes before basal blood pressure was 
measured. Blood pressure traces that did not remain steady throughout 30 minutes of 











Figure 2-1 Typical steady blood pressure trace recorded from the carotid artery of 
anaesthetised mice  
The waveform displays arterial pressure in mmHg. Peak pressure corresponds to systolic 
















2.2.2  Echocardiography  
Echocardiography scanning was performed by Adrian Thomson. Tst -/- mice and wild-type 
controls underwent high frequency ultrasound (Visualsonics Vevo 770) and trans-mitral 
doppler ultrasound at 6 & 10 weeks of age and at 7days following coronary artery ligation 
surgery (section 1.2.3). Mice were lightly anaesthetised with isofluorane (1%) delivered via 
a nose cone. Hair was removed from the thoracic scanning area to improve image 
acquisition. Anaesthetised mice were laid supine on a platform and their legs secured to 
electrocardiogram electrodes to measure heart rate. Body temperature was maintained at 37-
380C using a heat pad and lamp and continuously monitored with a rectal thermometer. Gel 
was applied to the chest and a 15-45MHz real time micro visualization scanhead transducer 
was placed in contact with the gel to acquire a real time cardiac image. The platform the 
mice were attached to was manoeuvred to obtain a long axis view of the left ventricle (LV) 
as well as a short axis view of the whole heart. The M-mode short axis view provided 
information on tissue motion during systole and diastole, which was used to calculate 
fractional shortening. The B-mode long axis view allowed collection of ventricular 
dimensions at end-systole and end-diastole for calculation of structural and functional 
parameters (Table 2-1). Following echocardiograms, gel was cleaned from the chest and the 
mice were allowed to recover from anaesthesia. Naïve mice were placed back into allocated 
animal house rooms and 7 day post MI mice transferred to the ex vivo room for perfusion 
fixation as described below. Echocardiograms were analysed in a single blind manner using 
Vevo770-Image Analysis Software (Visualsonics) to measure cardiac size, function and 
performance parameters from the B-mode, M-mode and pulse waved Doppler ultrasound 








Table 2-1 Echocardiography parameters 






LV end systolic area (mm2) B-mode Area at end systole  
LV end diastolic area (mm2) B-mode Area at end diastole 
LV end systolic volume B-mode 
4/3 *(LV Major; s/ 2) 
* LV Area; s/ (LV Major; s/2)2 
LV end diastolic volume  B-mode 
4/3 *(LV Major; d/ 2) 
* LV Area; d/ (LV Major; d/2)2 
Ejection Fraction (%)  B-mode (SV/ LV Vol; d) * 100 
Stroke Volume (μL) B-mode LV vol; d – LV vol; s 
Cardiac Output (mL/ min) B-mode HR * SV 
Endocardial area change 
(mm2) 
B-mode 
Endocardial Area; d – Endocardial Area; 
s 
Fractional area change (%) B-mode 
(LV Area; d – LV Area; s/ LV Area; d) * 
100 
Fractional Shortening (%) M-mode 
(LV dimension; d – LV dimension;n s/  
LV dimension; d) * 100 
Myocardial Performance 
Index (MPI) 




2.2.3 Coronary artery ligation surgery 
Male Tst-/- and controls (10-12weeks old) underwent coronary artery ligation (performed by 
Dr. Katie Mylonas and Xiaofeng Zhao). Mice were anaesthetised with 3% isoflurane and 
maintained under anaesthesia with 1% isoflurane with oxygen for the duration of the 
surgery. Mice were intubated and their ventilation maintained mechanically (120 
strokes/min, 200ul stroke volume, HSE-Harvard MiniVent Ventilator). Mice were injected 
with analgesic subcutaneously (buprenorphine 0.05mg/kg) prior to surgery. An initial 
incision was made in the left upper thorax, the superficial pectoralis muscles were then 
blunt-dissected and chest opened at the fourth intercostal space. Rib retractors were inserted 
to maintain an open chest. The pericardium surrounding the heart was removed and a 6-0 
prolene suture (Ethicon) was placed around the left anterior descending (LAD) artery and 
tied. Ligation of the LAD was confirmed by apical cyanosis. Rib retractors were removed 
and the chest sewn shut using 5-0 mersilk suture (Ethicon), ensuring that no air remained in 
the chest cavity to avoid pneumothorax. The skin was stapled shut using 9mm autoclips 
(Harvard Apparatus) and 1.5ml 0.9% saline was administered subcutaneously to maintain 
hydration. Mice were placed in cages on top of 370C heat pad overnight and subsequently 
moved to a quiet room to limit noise-related stress to aid recovery. Mice were checked daily 
and any deaths following CAL were recorded and subsequently investigated by post-mortem 
analysis to determine the cause. Briefly, post-mortem analysis identified cardiac rupture as 
the cause of death when the chest cavity was filled with blood. Acute heart failure was 
identified as cause of death in the absence of blood within the chest cavity. Surviving mice 
were culled at 4hours, 2days or 7days following CAL surgery by perfusion (section 1.4.2) 
and hearts excised for western blotting (section 1.5.6), flow cytometry (section 1.5.8) or 
histology (section 1.4.5).  
 
2.2.4 Tail blood venesection 
Blood was withdrawn from conscious mice at 24 and 48hours after CAL surgery via the tail 
vein to detect circulating leukocyte numbers by flow cytometry (as detailed below). Briefly, 
mice were lightly restrained, a small cut was made from the tip of the tail and using a 
milking action, blood (30μl) was withdrawn into an Eppendorff tube, containing 3.2mM 
sodium citrate solution (30μl) to avoid coagulation. Blood samples were kept on ice at all 






2.2.5 Metabolic cages  
Metabolic cage sample collections were performed in collaboration with Matthew Gibbins. 
C57BL/6N wild type and Tst -/- mice aged 10-12weeks were acclimatised to single housed 
metabolic cages for 4-6days prior to data acquisition. Data was not recorded during the 
acclimatisation periods. Mice were fed a standard ground RM1 diet (0.25% salt content) and 
given free access to water. 12hr light: dark cycles were maintained in ambient 210C heated 
rooms to control for lack of bedding in single housing. Daily measurements of body weight, 
water & food intake (weighing water and food hoppers), urine & faecal output (weighing 
urine and faecal collecting containers) were taken at the same time of day for the duration of 
the study. Measurements were displayed as mean readings to reduce natural daily 
fluctuations of water and food intake and excretion. Electrolyte measurements were 
performed on urine samples as detailed below.  Electrolyte intake was calculated as food 
intake * (g) sodium/ potassium/ chloride in RM1 diet. Fluid and electrolyte balances (Intake 
– excretion) were displayed as cumulative values.  
 
2.2.6 Urinary & plasma electrolyte measurement 
Sodium and potassium levels in urine samples from metabolic cage studies (as described in 
chapter 2.2.5) and plasma from naïve Tst-/- and C57BL6 mice were measured using the 
Roche 9180 Electrolyte analyser. Prior to measurements, quality control samples were 
measured to confirm that the Na, K and Cl electrodes were all operating within the correct 
parameters. Urine samples were spun at 13,000rpm for 5 minutes to pellet food particulates 
and the debris-free urine used for sampling. Urine samples were diluted 1:5 and 1:50 with 
120mM NaCl for sodium and potassium readings respectively. Plasma samples were diluted 
1:5 in distilled water (MilliQ) for potassium measurements. Urinary electrolyte values were 
multiplied by total urinary weight in a 24hr period to calculate total electrolyte excretion and 
then corrected to body weight. 
 
Urinary calcium and phosphate measurements were performed by Forbes Howie in the 
Clinical Analysis Core Services at the University of Edinburgh using commercially available 








2.3 Ex vivo work 
2.3.1 Langendorff model of ischaemia reperfusion injury 
Ex vivo myocardial infarction was performed on isolated perfused hearts using the 
Langendorff technique (performed by Emma Batchen). Mice were injected with heparin 
(1000U/mL) i.p. 10 minutes prior to tissue extraction to avoid thrombus formation within the 
coronary vasculature. Mice were anaesthetised with 2% isoflurane and the hearts rapidly 
dissected and immediately placed in ice cold Krebs-Henseleit buffer containing (mM; NaCl 
118, NaHCO3 25, Glucose 11, KCl 4.7, MgS04 1.22, KH2PO4 1.21, CaCl2 1.84) for 
preservation. In a petri dish filled with cold Krebs buffer, the ascending aorta was tied onto 
the Langendorff cannula (AD Instruments), which was primed with Krebs buffer to avoid 
bubbles entering the heart. The cannula was held under the flowing Langendorff for a few 
seconds to remove air bubbles before placing onto the apparatus (Figure 2-2) and perfusing 
the heart at a rate of 3ml/min with 95% O2/ 5%CO2 aerated Krebs-Henseleit buffer, at 370C 
for the duration of the experiment. The heated (370C) water-jacketed organ chamber was 
placed around the heart to provide a warm atmosphere. All hearts were cannulated and 
perfused by approximately 3-4 minutes from the time the chest was opened. Coronary 
perfusion pressure was measured with a pressure transducer connected to AD Instruments 
Powerlab 8/30 and signal was recorded in real time using LabChart 5 software (AD 
Instruments). The pressure transducer used to detect coronary perfusion pressure was 
calibrated daily using a manual sphygmomanometer and LabChart5 software to relate 
pressure (mmHg) to voltage change. Coronary perfusion pressure of 80-110mmHg was 
considered acceptable whilst pressures above or below these parameters were omitted from 
the study. Hearts were allowed to stabilize for 15 minutes before ischaemia was induced. 
Ischaemia was performed by passing a 5-0 suture (11mm round bodied, Interfocus Ltd, 
England) around the left anterior descending artery (LAD), threading it through a plastic 
tube and clamping it against the heart with an alligator clip forming a snare and occluding 
the artery. Following 30 minutes of ischaemia, the clip was removed, loosening the snare 
allowing reperfusion for 2hours. At the end of the 2hours reperfusion, the suture was re-tied 
and Evans blue (1% w/v in phosphate buffered saline (PBS), Sigma) was injected into the 
aortic cannula to differentiate between ischaemic (area at risk; AAR, red) and perfused non-
ischaemic heart tissue (blue). The heart was rapidly rinsed in PBS, the myocardium above 














































Figure 2-2 Schematic diagram of the Langendorff apparatus 
Hearts are attached to the Langendorff apparatus via the cannula and perfused with warmed 
Krebs solution at a constant rate by the peristaltic pump. Bubble traps at 2 points along the 
system prevent bubbles from entering the heart. Coronary perfusion pressure is monitored 
from a side port in the junction block above the heart. Figure adapted from (Reichelt, 






2.3.2 Infarct size assessment – 2, 3, 5 triphenyltetrozolium Chloride (TTC) 
staining 
Infarct tissue was visualised using 2, 3, 5 triphenyltetrozolium chloride (TTC) staining 
(Jeanes, Tabor, Black, Ederveen, & Gray, 2008). TTC staining allows further definition of 
the AAR (identified as Evans blue negatively stained myocardium) into viable (ischaemic 
but viable tissue) and infarcted (non-viable ischaemic tissue) myocardium (Figure 2-3). 
Frozen infarcted hearts were cut transversely into 1mm slices using a blade and tissue slicer 
matrix (Alto), the right ventricle was discarded and the remaining myocardium was 
immersed in 1% w/v TTC in 0.9% saline and incubated at 370C for 30 minutes. TTC is 
enzymatically reduced to triphenylformazan in the presence of various dehydrogenases 
present in viable tissues forming a brick red colour. Infarcted necrotic myocardium remains 
white as the tissues dehydrogenases are denatured or degraded. Photographs were taken of 
each heart slice (Leica MZFLIII microscope) and analysed using Image J software. Areas of 
the left ventricle (LV) and blue, red and white zones were analysed on Image J. The AAR 
(red and white zones) was expressed as percentage of LV and the infarct size (white zone) 





















Figure 2-3 Representative TTC stained heart section following ex vivo MI 
Representative image of a murine heart section following Evans blue and TTC staining. 
Tissue stained by Evans blue represents perfused non-ischaemic tissue. Red tissue and 
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2.3.3 Cardiomyocyte Isolation 
Cardiomyocytes were isolated from whole mouse hearts using collagenase digestion mixture 
perfused through the heart using the Langendorff apparatus and then placed into lysis buffer 
for protein extraction. Mice were injected with heparin (1000U/mL) i.p. 10 minutes prior to 
tissue extraction to avoid thrombus formation within the coronary vasculature. Mice were 
killed by cervical dislocation and the heart rapidly removed and arrested in ice-cold calcium 
free solution containing (mM; NaCl 134, Glucose 11, KCl 4, MgSO4 1.2, Na2H2PO4 1.2, 
HEPES 10, pH 7.34). In a petri dish filled with cold calcium free solution, the ascending 
aorta was pulled and tied onto the Langendorff cannula, which was primed with buffer to 
avoid bubbles entering the heart. The cannula was held under the flowing Langendorff for a 
few seconds to remove air bubbles before placing onto the apparatus and perfusing the heart 
at a rate of 5ml/min with calcium free buffer at 370C for 5 minutes. The heart was then 
perfused for 8 minutes with 0.075mg/ml protease (Sigma, Type XIV, 3.5U/ mg) and 
0.6mg/ml collagenase type 2 (Worthington, 320U/ mg) dissolved in calcium free solution at 
370C. Hearts were then perfused for 8 minutes with a taurine (Sigma) containing low 
calcium buffer containing (mM; NaCl 108, Glucose 11, KCl 4, MgSO4 1.2, Na2H2PO4 1.2, 
HEPES 10, Taurine 50, CaCl2 50nM, pH 7.34) to wash off enzymes and preserve 
cardiomyocyte survival. Heart digests were considered effective when the heart turned pale 
during the collagenase/ protease step. Hearts were cut below the atria, the ventricles 
transferred to a 7ml bijout with warmed taurine containing solution and minced with a 
scissors. The tissue was allowed to sediment in the bottom of the bijout before the solution 
was tipped out and replaced with fresh warmed taurine solution before the mincing process 
was repeated. This process was repeated 5 times before the myocardial tissue was transferred 
to a sterile eppendorff containing protein lysis buffer (as detailed in section 1.5.4) and 
homogenised. Protein content was quantified using Bradford assays (sections 1.5.5) and 
Western blots performed as detailed in sections 1.5.6.  
 
2.3.4 Endothelial cell isolation 
Isolated CD31+ endothelial cells from thoracic aorta and intramuscular vessels of the 
hindlimb of C57BL/6J mice, were kindly donated by Dr. Andrea Caporali and Lorraine 
Rose. Endothelial cell (EC) isolation from thoracic aorta was performed by Lorraine Rose. 
The thoracic aorta from C57BL/6J mice were isolated and then flushed with heparinised 
endothelial growth basal medium (EBM2) media (20U/ ml heparin) containing 1mM 
aurintricarboxylic acid. Following this, the lumen of the aorta was flushed with collagenase 




in 0.5ml of collagenase solution for 30 minutes at 370C with agitation. EBM2 media 
containing 1mM aurintricarboxylic acid was added to the aorta to block collagenase activity 
and then the endothelium was carefully removed by slowly flushing PBS through the lumen 
and collected in a 15ml corning tube. Cells were centrifuged for 10 minutes x 300g, 
immunomagnetically labelled with commercially available CD31 microbeads (Miltneyi), 
isolated using MACS columns in magnetic fields and sorted as per kit instructions (CD31 
micobead kit, Miltneyi). The CD31 antibody reacts with the cell surface protein CD31, 
which is present on mature endothelial cells (Woodfin, Voisin, & Nourshargh, 2007). The 
cell population was verified using flow cytometry. Single cell suspensions were incubated 
with CD31-PE fluorophores, the respective isotype control as a negative control and 
unstained controls to define positivity. Isolated cells showed high expression of CD31 (Flow 
cytometry data owned by Dr. Caporali and has not been shown).  
 
Endothelial cell (EC) isolation from the hindlimb of C57BL/6J mice was performed by Dr. 
Andrea Caporali as described previously (Caporali et al., 2011). Briefly, adductor muscles of 
mice were harvested, enzymatically digested immunomagnetically sorted using the same 
commercially available kit as detailed above (Miltneyl).  
 
Isolated CD31+ cells from thoracic aorta and intramuscular vessels of the hindlimb adductor 
muscle were then processed for RNA extraction and cDNA synthesis by Lorraine Rose as 
described in section 2.5.1 and 2.5.2. qRT-PCR (as described in section 2.5.3) was performed 
on CD31+ cells by Christina Intrator.  
 
2.3.5 Mitochondrial Isolation 
Cardiac mitochondria were isolated from two pooled hearts by differential centrifugation as 
previously described(Frezza, Cipolat, & Scorrano, 2007). All glassware and buffers were 
cooled to 40C to avoid mitochondrial damage. In brief, two hearts (with atria removed) from 
14-16week old naïve wild type and two hearts from Tst -/- mouse littermates were extracted 
on the same morning from mice following cervical dislocation. Hearts were washed briefly 
in ice-cold isolation buffer (IB) (mM; Sucrose 67, Tris/ HCl 50, KCl 50, EDTA 10, BSA 
10%, pH 7.4) and immersed in a small glass flask containing fresh ice-cold isolation buffer. 
Hearts were minced with scissors on ice, washed with isolation buffer 3 times and 
homogenised in 5ml of IB with a potter Elvehjem homogeniser (using only 10 full strokes) 
to maintain mitochondrial integrity. Tissue homogenates were transferred to 50ml Falcon 




cooled ultracentrifuge glass tubes (Beckmann) before being spun at 7700 x g for 10min 
using an ultracentrifuge to pellet the mitochondria. Following ultracentrifugation, the 
supernatants were carefully discarded, the pellet washed in respiration buffer containing 
(KCl 130mM, KH2PO4 5mM, 4-Morpholinepropanesulfonic acid (MOPS) 20mM, Na4P2O7 
1μM, CaCl2 5μM, BSA 0.1%, pH 7.2) and spun again at 7700 x g for 10min. Following the 
second centrifugation step, the supernatant was carefully discarded and the remaining buffer 
in the tube (approximately 100μl) used to re-suspend the pure mitochondrial fraction by 
gentle pipetting. Mitochondria were kept on the ice and used within 4hours for respiration 
studies.  
 
2.3.6 Mitochondrial respiration studies 
Isolated cardiac mitochondrial respiration studies were carried out in an Oroboros Oxygraph 
2K (Oroboros Instruments) two-chambered high resolution respirometer using DataLab 
software (Oroboros). Respiration buffer (as detailed above) was placed in both chambers of 
the Oroboros Oxygraph and equilibrated to ambient oxygen concentration for one hour 
before the chambers were closed. Both chambers had previously been calibrated for 
differences in sensor sensitivity by performing a zero oxygen (addition of excess dithionite) 
measurement followed by and air calibration using respiration buffer (as detailed above). 
Equal volumes of isolated cardiac mitochondria from naïve wild type or Tst -/- mice were 
injected directly into either left or right chambers using a Hamilton syringe and magnetically 
stirred and maintained at 370C. In the purposes of time, mitochondrial protein content was 
measured later the same day using a Bradford assay as detailed in section 2.2.5. 
Mitochondria from each genotype were alternated between left and right chambers on a daily 
basis to control for any potential remaining sensor differences in O2 partial pressure 
detection. Respiratory substrates (malate, 2.5mM, glutamate, 5mM, succinate, 5mM, 
adenosine diphosphate, 2mM) and inhibitors (oligomycin, 2.5μM, FCCP, 100nM) were 
administered via the injection port throughout the experiment. Basal respiratory rate was 
calculated as the rate of O2 consumption observed during a linear phase and corrected for 
protein. 
 IRI can cause considerable damage to mitochondria, which can lead to the opening 
of the mitochondrial permeability transition pore and cause apoptosis and necrosis (Yellon & 
Hausenloy, 2007). In vitro cardiac mitochondrial ischaemia-reperfusion experiments were 
performed as detailed previously (Ljubkovic et al., 2006). Briefly, isolated naive cardiac 
mitochondria were permitted to consume all O2 within the chamber until anoxia was 




was opened to ambient air, permitting reperfusion. Upon stabilisation of the O2 signal to 
ambient O2 concentrations, the chamber was closed again and O2 consumption again 
measured. Post-ischaemic respiratory rate was expressed as a percentage of pre ischaemic 
respiratory rate and corrected for protein.  
 
Vessel Myography 
Vascular function experiments were performed using the Mulvany-Halpern myograph 
(Multi-myograph 610M, Danish Myotech, Denmark). C57BL/6N and Tst -/- mice were killed 
by cervical dislocation and the thoracic aorta dissected and quickly placed in ice-cold PSS 
buffer containing (mM; NaCl2 119, NaHCO3 25, D-Glucose 5.5, KCl 4.7, MgSO4 (2H2O) 
1.17, KH2PO4 1.18, CaCl2 (2H2O) 2.5, EDTA 27μM), for preservation before pinning to 1% 
agarose coated petri dish containing ice cold PSS. The mesenteric bed and attached intestinal 
tissue were exteriorised, dissected together and placed in PSS for preservation as described 
above. The first order mesenteric artery and aorta was cleaned of surrounding fat tissue in 
preparation for mounting and cut into transverse rings approximately 2.5 - 3.0mm in length. 
Briefly, one tungsten wire was held between the jaws of the myograph and secured at one 
end to one of the two myograph jaws. The arterial ring was carefully placed onto the wire 
and the wire stretched and secured at the opposing end of the same myograph jaw. A second 
wire was carefully inserted through the lumen of the vessel to avoid damage to the 
endothelium and secured at both ends of the opposing myograph jaw. Myograph baths were 
filled with fresh PSS buffer bubbled with 95% O2/ 5% CO2 and maintained at 370C at all 
times. Each arterial ring was stretched to its appropriate optimal resting tension for 45 
minutes (Table 2-2). The optimal resting tension values were determined by previous 







Table 2-2 Optimal resting tension (mN) for aortic and mesenteric vessels 
 
Following the stretched equilibration period, aortic rings were exposed to high potassium 
concentrations with KPSS buffer containing, (mM; NaCl2 4.7, NaHCO3 25, D-Glucose 5.5, 
KCl 119, MgSO4 (2H2O) 1.17, KH2PO4 1.18, CaCl2 (2H2O) 2.5, EDTA 27μM), and 
Vessel Resting Tension 
Thoracic aorta 7.36mN 




noradrenaline to evaluate their contractile responsiveness. Aortic vessels were exposed to 
three periods of KPSS incubation and washed with PSS several times between treatments. 
Mesenteric arteries were exposed to varying KPSS and adrenergic receptor agonist 
noradrenaline (NA, 1*10-6 M) treatments as follows; KPSS*2, NA alone *1, KPSS alone *1, 
KPSS + NA *1 with several PSS washes between treatments. Following the normalisation 
protocol, vascular reactivity to pharmacological agents constrictors and dilators were 
administered to confirm the endothelium was intact and responsive. Vessels were pre-
constricted with phenylephrine (Sigma, 1*10-7M) to partially constrict the vessel and then 
subsequently administered with 1*10-5M acetylcholine (Sigma), an endothelium dependent 
vasodilator (Figure 2-4). If aortic and mesenteric vessels did not relax by 70% of pre-
constriction values, they were omitted from further experiments. Vessels were rested in PSS 
for 30 minutes following KPSS & NA administration to avoid desensitisation before 










Figure 2-4 Diagram illustrating test for vascular endothelium 
Vessel pre-constricted with 1*10-7M PE (left arrowhead) to a submaximal constriction before 
ACh (1*10-5M) was added to bath (right arrowhead) to relax vessel. The vessel relaxed by 
78% indicating the endothelium was intact and the vessel then used for experimentation. 
 
Protocol 
Phenylephrine (PE) and acetylcholine were added to PSS filled myography baths in 
increasing doses of half-log increments (1x 10-9M – 3x 10-5M) to achieve cumulative drug 
dose response curves. Each dose was administered once the previous dose-dependent 
constriction (PE) or relaxation (ACh) had plateaued. Initially, dose response curves were 
obtained for PE, an α1-adrenergic receptor agonist, washed several times with PSS and 
vessels rested for 30 minutes. For ACh dose response curves, vessels were pre-constricted to 
80% of PE-induced maximal vasoconstriction before ACh was administered. To determine if 
differences in channel activation were present in the Tst -/- vessels compared to controls, 
inhibitors against a variety of channels were incubated in the myograph bath for 20 minutes 




prior to PE pre-constriction, before ACh dose curves were repeated (please see Table 2-3 for 
inhibitor details and bath concentrations). Channel inhibitors were present in myograph baths 
for the duration of dose response curves with ACh or SNP. Aortic samples were incubated 
with L-nitroarginine methyl ester (L-NAME, dissolved in PSS buffer, Alexis Biochemicals) 
and indomethacin (dissolved in PSS buffer, Sigma) to inhibit nitric oxide and 
cyclooxygenase respectively. Mesenteric samples were incubated with apamin (US 
Biologicals) and charybdotoxin (US Biologicals) to inhibit small and intermediate calcium 













Table 2-3 Inhibitor details and concentrations used in myography protocols 
Inhibitors were added to the organ bath 20 minutes before vessels were pre-constricted to 
80% of their maximal constriction with phenylephrine. 
 
 
Vascular tension (mN) data during all protocols was collected using AD Instruments 
transducers (Powerlab 8/30, MacLab 4/e) using LabChart 7 Pro software. Maximal vascular 
tensions were recorded corresponding to each dose of either PE or ACh. Functional 
responses to PE were normalised to the maximal response to KPSS or NA and ACh 






L-NAME Nitric oxide synthase 100μM 
indomethacin cyclooxygenase 10μM 
apamin 




intermediate calcium activated 






2.4.1 Tissue collection 
10-12week old wild type and Tst -/- mice were culled by cervical dislocation and the heart, 
liver, right kidney and thoracic aorta dissected. Atria were removed from heart tissue and all 
tissues either snap frozen on dry ice for protein and RNA extraction or fixed in 10% formalin 
for 24hours before being placed in 70% ethanol and wax embedded for histological analysis. 
For aortic western blotting experiments, the thoracic aorta was cleared of fat in vivo, 
cannulated with a 24G catheter (Terumo) and flushed with ice-cold PBS before being snap 
frozen in liquid nitrogen and stored at -800C.  
 
2.4.2 Perfusion studies 
At 4hours, 2days or 7days following CAL surgery, wild type and Tst -/- mice were perfused 
to remove the blood from the tissues. Perfusion was performed by Kieran McGregor, Katie 
Mylonas and Xiaofeng Zhao. Briefly, mice were weighed and anaesthetised with ketamine 
(50mg/kg)/ medatomidine (0.5mg/kg) administered intraperitoneally. Depth of anaesthesia 
was established by a lack of the pedal pain withdrawal reflex. An incision was made in the 
abdomen and the descending aorta was cannulated with a 24G catheter (Terumo). Blood was 
extracted from the descending aorta and placed in sodium citrate coated Eppendorff tubes. 
Blood samples were later spun at 6,000 x g for 6 minutes and the plasma isolated and frozen 
at -800C for further studies. Following blood withdrawal, ice-cold heparinised saline (10U/ 
mL in 0.9% saline) was perfused through the animal using a peristaltic pump at a 
physiological perfusion pressure of 100mmHg. The carotid artery was cut to allow full 
removal of the blood. For 7day post CAL gene expression assays, left ventricular infarct and 
border zones were snap frozen on dry ice for RNA extraction. For 4hour and 48hr post CAL 
hearts, the infarct zone was not clearly defined from surrounding border zone tissue and so 
left ventricular free wall tissue below the ligature was dissected and weighed. Ventricular 
tissue was cut in half; one half snap frozen on dry ice for protein extraction and the other half 
snap frozen on dry ice for RNA extraction for western blotting and real-time PCR 
experiments respectively. Alternatively, all left ventricular free wall tissue below the ligature 
was dissected and placed in ice-cold Hanks buffered saline solution without calcium and 
magnesium (HBSS[--]) for flow cytometry as discussed in section 1.5.8. Tissue extraction 
was always conducted by the same person to avoid inconsistencies when cutting tissues.  
For histological experiments, the animal was perfused with 10% formalin (diluted in 




right kidney and spleen were then removed and placed in 10% formalin for 24hours before 
being placed in 70% ethanol and wax embedded.  
 
2.4.3 Immunohistochemistry for localisation of H2S metabolic enzyme 
expression 
Tissues were isolated as detailed in section 2.4.1. Tissues were specifically wax embedded to 
achieve a cross-axis view when cut. Paraffin wax blocks were cut using a microtome to 
achieve 5µm thickness, placed on glass slides and dried at room temperature overnight to 
allow firm adhesion to the slide. Slides were de-waxed with xylene (2*5mins), rehydrated 
through a series of graded ethanol concentrations (100%*2, 90%, 80%, 70% for 30seconds 
each) and washed in tap water.  
Tissue fixation can cause protein cross-linking, which can mask protein antigens and 
prevent binding of primary antibodies. Cross-linked antigens were unmasked with a heat 
mediated antigen retrieval approach. Sections were placed in a sealed plastic container, 
submerged in 0.01M sodium citrate buffer (pH 6), and placed in a microwave on high power 
for 12 minutes until the buffer was boiling. The buffer was allowed to cool before slides 
were quenched in 3% H202 for 5mins at RT to block endogenous peroxidases. Slides were 
washed in PBS and incubated with 10% goat blocking serum for 1hr at RT to block non-
specific binding of secondary goat anti-rabbit antibodies. Following PBS washes (3*3min), 
avidin & biotin (Vector) were applied as per kit instructions to reduce non-specific binding 
of biotinylated antibodies. Following avidin & biotin application, sections were washed with 
PBS (3*3min), and incubated with rabbit raised-polyclonal antibodies overnight at 40C. 
Optimisation of primary antibody concentration (in dilutions ranging from 1:100 - 1:3000) 
was performed for each antibody in each tissue to achieve a strong signal with little to no 
background staining. Antibodies against CBS, CSE, MPST, TST and CD31 were raised in 
rabbit and sourced from Abcam. After several PBS washes (3*3min), biotinylated goat anti-
rabbit secondary antibodies (1:500, Vector) were incubated for 1hr at RT before being 
washed off with PBS. Streptavadin horseradish peroxidase (Vector ABC reagent kit) was 
subsequently incubated (30mins at RT) which binds to the biotinylated secondary antibody 
and amplifies antigen signal by binding to multiple antigen sites. After several PBS washes, 
sections were incubated with the chromagen, 3-3’-diaminobenzidine (DAB, Vector) for the 
appropriate time. DAB reacts with peroxidase activity resulting in the development of a 
brown colour at antigen target sites. Sections were counterstained with Harris’ Haematoxylin 
for 4 minutes to stain nuclei, rinsed in Scotts tap water and dehydrated through a series of 




(5mins*2) before being mounted with DPX and coverslipped. Positive control tissues (where 
protein is notably most abundant) and negative control sections (omitting primary antibody 
incubation step) were used for all staining protocols. Sections were acquired using an 
Olypmus light microscope with Image Capture Pro 7 software. 
 
2.4.4 Immunofluorescence staining for TST expression 
Immunofluorescent co-localisation staining of CSE and TST staining with α-smooth muscle 
actin (α-SMA) was performed on heart tissue sections from 12wk old male C57BL/6 mice. 
CSE localisation within smooth muscle cells was used as a positive control for H2S enzyme 
smooth muscle staining as described previously (Yang et al., 2008). Paraffin embedded heart 
samples, 5µm thick were de-waxed, heat treated for antigen retrieval and blocked with goat 
serum, avidin & biotin as described above. Fluorescently conjugated α-SMA-Cy3 (Sigma) 
was co-incubated with primary antibodies for TST (Abcam) and CSE (Abcam) in the dark 
overnight at 40C. All further steps and washes were performed in the dark. Sections were 
washed in PBS and incubated with goat anti-rabbit secondary antibodies (Vector) for 1hr at 
RT.  Following several PBS washes, fluorescently labelled strepavadin Alexa 488 (Life 
Technologies) was incubated for 1hr at RT in the dark and then washed with PBS. DAPI 
(Life Technologies) was incubated for 4 minutes at RT to stain for nuclei before mounting 
with Floromount G and coverslipped. Sections were imaged using a Zeiss Axiovert 200 
fluorescent microscope with AxioVision Rel 4.8 software (Zeiss).  
 
2.4.5 Haematoxylin and Eosin (H & E) staining  
Haemotoxylin & Eosin staining was used to investigate morphological differences between 
wild type and Tst-/- mice in heart, liver and kidney tissues. Haematoxylin stains nuclei purple 
and Eosin stains cytoplasm pink. Tissue sections were deparrafinised with xylene, 
rehydrated with a series of graded ethanol concentrations and washed in tap water as 
described above. Slides were then immersed in Harris’ Haemotoxylin solution (Sigma) for 4 
minutes, washed in tap water and then placed in Scotts tap water (H20 with ammonia) for 
30seconds and washed again in tap water. Scotts tap water is a mild blueing reagent that 
causes Haematoxylin stained nuclei to turn blue and also enhances tissue adhesion to the 
slide which can otherwise be partially lost during graded ethanol and xylene dehydration 
steps. Slides were then immersed in Eosin for 10seconds until sufficient cytoplasmic staining 
was obtained and then washed in tap water. Slides were dehydrated by phased ethanol and 




2.4.6 Masson’s Trichrome staining  
Massons Trichrome staining was performed by Deborah Mauchline (Histology service, 
QMRI) on hearts from 7day post-CAL surgery mice for quantification of infarct size. 
Massons Trichrome (TCS Biosciences) stains collagen fibres blue, nuclei black and the 
cytoplasm red. Wild type and Tst-/- mice were perfusion fixed and the hearts extracted (as 
described above) and wax embedded. Slides were deparaffinised and rehydrated with xylene 
and ethanol as previously described above. Slides were placed in Weigert’s haemotoxylin for 
10min at RT, rinsed with dH20 and incubated with phosphomolybdic-phosphotungstic acid 
solution for 15min until collagen lost its red appearance. Slides were subsequently incubated 
in aniline blue solution for 10min at RT, washed in dH20 and further incubated in 1% acetic 
acid for 5 minutes. Slides were dehydrated by phased ethanol and xylene steps and mounted 
with DPX and coverslipped as described in chapter 2.4.3. 
 
2.4.7 Picrosirius Red staining  
Picrosirius Red (PSR) staining was performed on hearts from 7day post-CAL surgery mice 
for quantification of fibrosis. With PSR staining, collagen appears red and the background 
appears green in colour. Sections were stained by Deborah Mauchline (Histology service, 
QMRI). Slides were deparaffinised and rehydrated with xylene and ethanol as previously 
described and placed in PSR solution (0.1% Direct red, 0.1% Fast green and diluted 1:9 in 
Picric acid solution, Sigma) for 2hours at RT and then washed in tap water. Slides were 
dehydrated by phased ethanol and xylene steps and mounted with DPX and coverslipped as 
described previously. 
 
2.4.8 Quantification  
Sections were tiled at 4x magnification to generate whole heart images on Sterologer 3 and 
quantified using CapturePro5. Collagen (Picosirrius Red), scar area (Massons Trichome) and 
macrophage staining (Mac2) were calculated as percentage staining of left ventricle (LV). 
Scar thickness was calculated as average thickness from three points along the scar. First and 
last points were marked at the infarct border areas where 50% of viable tissue and 50% scar 
tissue were found. The third point was placed between the first two and average thickness 
along the scar calculated using ImagePro software. Infarct length was calculated as infarct 





2.5 Biochemical and Molecular Techniques  
2.5.1 RNA extraction 
Mice were culled by cervical dislocation, the tissues excised and then snap frozen on dry ice 
for RNA extraction. Hearts were dissected, the atria removed and the ventricles snap frozen, 
as was the right kidney and a portion of the liver. For CAL hearts, left ventricular myocardial 
tissue below the ligature incorporating the infarct and border zones were dissected and snap 
frozen. RNA was extracted from frozen tissues using a Trizol RNA extraction method. 
Samples were homogenised in RNase-free Eppendorff tubes with 1ml of ice-cold Trizol 
(Invitrogen) using autoclaved and RNA-Zap treated steel homogenised beads and 
homogenised for 1minute at a frequency of 30rpm/ second using the Retsch Vibration Mill. 
Samples were incubated at RT for 5 minutes before 0.2ml of chloroform (Fisher Scientific) 
was added and vigorously mixed for 15seconds and allowed to incubate for 10min at room 
temperature. Following the incubation period, samples were centrifuged for 15min at 12,000 
x g at 40C to achieve a phase separation. Samples were separated into three distinct layers; a 
lower red-phenol phase, an interphase containing protein and a colourless upper phase 
containing RNA. The upper phase was transferred to an RNase-free eppendorff and the RNA 
precipitated with 0.5ml of ice-cold isopropyl alcohol (Fisher Scientific). Samples were 
centrifuged at 12,000 x g at 40C for 10 minutes and the supernatant discarded. The RNA 
pellet was washed with 1ml of ice-cold 70% ethanol (diluted in nuclease-free water, Qiagen) 
and centrifuged again at 12,000 x g at 40C for 5 minutes. Following washing step, the 
ethanol supernatant was discarded and the RNA pellet air-dried for 5min on wet ice before 
the RNA was eluted in 30μl of nuclease free water. RNA concentration was measured using 
a NanoDrop spectrophotometer (NanoDrop ND-1000, Thermo Fisher Scientific) at a 
wavelength of 230-280nm. RNA purity was identified by the A260/ A280 ratio where values of 
1.8 – 2.1 were deemed highly pure and were used for further analysis. Samples with A260/ 
A280 ratio values outwith the appropriate range were not used for further analysis. Neat RNA 






2.5.2 cDNA synthesis 
Synthesis of cDNA was carried out in a two-step process. Firstly, 1μg of RNA was mixed 
with 1μl of 10mM dNTP mix (Applied Biosystems), 1μl random hexamers (Applied 
Biosystems) and 3μl of nuclease-free water and loaded into a Reverse Transcription system 
(Peltier Thermal Cycler 200, UK) at the following conditions; 650C *5mins, 00C *1min and 
held at 10C. Samples were then removed from the thermal cycler and supplemented with 4μl 
of 10x RT buffer (Applied Biosystems), 8.8μl of 25μM magnesium chloride (Applied 
Biosystems), 0.8μl RNase inhibitors (Applied Biosystems), 1μl multiscribe reverse 
transcriptase (Applied Biosystems), and 15.4μl of nuclease free water before returning to the 
Reverse Transcription system (Peltier Thermal Cycler 200, UK) at the following conditions; 
250C *2mins, 420C *50mins, 700C *15mins and held at 40C. Samples were then diluted 1:2 
with nuclease-free water and stored at -200C until needed. A control RNA sample was run in 
parallel with all samples and supplemented with all reagents except for reverse transcriptase 
and used as a negative control for all RT-PCR reactions.  
 
2.5.3 Quantitative real-time PCR  
The Applied Biosystems 7900HT fast real-time PCR system and applied biosystems taqman 
gene expression probes were used to measure the relative mRNA expression between tissues 
or the fold change differences in the same tissue of different genotypes using the 2ΔΔCt 
method. The reaction mixture contained 10μl fast advanced mastermix (Applied 
Biosystems), 7μl RNase-free water, 1μl Taqman gene expression probes (Applied 
Biosystems, see table x for full details of probes used). The reaction mixture was added to 
96well plates in duplicate and supplemented with 2μl of cDNA. Nuclease free water and 
reverse transcriptase-free RNA (as described above) served as two separate negative controls 
to determine if reagent contamination or genomic DNA amplification occurred during the 
PCR reaction respectively. Negative controls were plated in duplicate for all probes on each 
PCR plate. The 96well plate was centrifuged at 1000rpm *20seconds and placed in the ABI 
7900HT PCR machine. The PCR reaction was performed at the following conditions; 950C 
*1:20min followed by 40cycles alternating between 950C *0:01min and 600C *0:20min). 
The data was used if the amplification curves were exponential before 35 cycles followed by 
a flat plateau. Taqman probes were obtained from Applied Biosystems. Probe sequences are 






Quantification of relative expression was analysed using the ΔCt method to assess the 
presence of each gene in various tissues and using positive control tissue as reference (I.e. 
Liver used as a positive control tissue for Tst). Quantification of fold change was analysed 
using the 2ΔΔCt method to compare upregulation/ downregulation of mRNA levels in the 
same tissue of different genotypes (WT vs. Tst-/-). qRT-PCR was prepared and run as above 
(cDNA made using comparable concentrations of RNA) for both ΔCt and 2ΔΔCt 
quantification approaches. TATA-binding protein (Tbp) was used as a housekeeping gene 
for all experiments involving enzymes of cytosolic origin (Cbs, Cth, Mpst, Nos1, Nos2, 
Nos3, Ccl2, Ccr2, Icam1, Vcam). Cytochrome oxidase IV (Cox4i1), a component of the 
mitochondrial respiratory chain was used as the housekeeping gene for experiments 
involving mitochondrial bound enzymes (Tst, Sqrdl, Ethe1, Suox) to normalise for 
differences in mitochondrial density between tissues. Neither Tbp nor Cox4i1 expression was 
significantly changed by CAL treatment (Figure 2-5). Gapdh was used as an internal control 
gene when assessing Tst expression in endothelial cells only as Gapdh is the commonly used 
housekeeping gene for this cell type.  
































Figure 2-5 Internal control gene expression is unaltered in hearts following myocardial 
infarction  
A) TBP and B) COX4 internal control gene expression expressed as cycle threshold (Ct) 
values in naïve hearts and at 1, 2 and 7 days following myocardial ischaemia. Values ± 
SEM, analysed by repeated measures ANOVA.  
 
 
2.5.4 Protein extraction 
Western blotting was performed on heart, liver, kidney and aortic tissues from naïve animals 
or on hearts from CAL operated mice from both Tst-/- and control groups. Frozen liver, heart 
and kidney tissues (20-100mg) were placed in a sterile Eppendorff tube containing ice-cold 
1x RIPA buffer (Millipore), protease inhibitor cocktail (Sigma, 1:100) and phosphatase 
inhibitors cocktails 2 & 3 (Sigma, 1:100) to preserve protein quality. From CAL hearts, 
myocardium was isolated from the infarct and border zones below the ligature. Sterile steel 
homogenisation beads were added to the Eppendorff tube and the samples homogenised for 
1minute at a frequency of 30rpm/ second using the Retsch Vibration Mill. Samples were 
centrifuged at 13,000rpm at 40C to pellet tissue debris and clear homogenate transferred to 
clean eppendorffs. Myocardial and aortic homogenates used for western blots investigating 
eNOS and Vasp protein expression were prepared by Alessandra Borgognone at the 
University of Birmingham. Frozen hearts and thoracic aortas were crushed under liquid 
nitrogen conditions and 10% (wt/vol) solution of tissues homogenate was prepared in 
homogenisation buffer containing ice-cold 100 mM Tris·HCL (pH 7.4), protease complete C 
tablet (Roche) per 50 ml, 2 mM sodium orthovanadate, and 5 mM sodium fluoride.  
 
2.5.5 Bradford protein assay 
Albumin protein standards (0, 25, 125, 250, 500, 750, 1000, 1500, 2000μg/ mL, Thermo 
Scientific) diluted in homogenisation buffer were plated in duplicate in a 96well flat-
Naive
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bottomed plate alongside diluted sample homogenates. Samples were supplemented with kit 
reagents to initiate colour change and incubated at 370C for 30 minutes as per kit 
instructions. Samples were read at 562nm on a Spectrophotometer and sample protein levels 
quantified using the standard curve method using Excel. Aliquots of neat protein samples 
were diluted in homogenisation buffer to obtain equal protein concentrations (2-10μg 
protein/ μl) and frozen at -200C until required.  
 
2.5.6 Western Blotting 
Equal concentrations of heart, kidney & liver protein samples were run on 10-12% sodium 
dodecyl sulphate (SDS) gels SDS. 5% separating gel (30% acrylamide, 0.5M Tris buffer, 
10% SDS, 10% Ammonium persulfide, dH20 and TEMED) were set on top of 12% resolving 
gel (containing 30% acrylamide, 1.5M Tris buffer, 10% SDS, 10% Ammonium persulfide, 
dH20 and TEMED). Protein samples (10-30µg protein) incubated with 6X sample buffer 
(0.35M Tris-Hcl, 0.35M SDS, 30% v/v glycerol, 0.6M DTT, 0.175mM bromophenol blue) 
and protein markers (Colorplus Prestained Protein Marker Broad Range, 7-175kDa, New 
England Biolabs) were boiled at 950C for 5min and centrifuged at 13,000rpm for 1min 
before loading into the gel. Electrophoresis was performed at 80V for 15min, then 120V for 
1hr in running buffer containing (mM; Glycine 39, Tris 50 and SDS 2).  
Following electrophoresis, the gel was placed in transfer buffer (mM; Tris 48, Glycine 40 
SDS 1.2, 1:5 methanol: dH20) and stacked with transfer buffer soaked extra-thick blot paper 
(Bio-Rad) and ECL nitrocellulose membranes (Amersham) on a Trans-Blot Semi Dry 
Transfer Cell (Bio-Rad). Protein transfer was ran for 90min using an appropriate milli-
amplitude (mA) calculated from the following equation:   
 
mA = Gel surface area (cm2) x 0.8 
 
Membranes were then blocked with 5% dried milk dissolved in Tris-Buffered Saline Tween 
(TBST; 1000mL 1X TBS, 1ml Tween 20) for 1hr at RT to eliminate non-specific binding of 
the antibodies. Following blocking, membranes were incubated with internal control 
antibodies Beta-actin (Abcam) or cytochrome oxidase IV (COX IV, Abcam) for 1hr at room 
temperature (RT), washed in TBST (3*15mins) and further incubated for 1hr at RT in the 
dark with Alexa-780 fluorescent secondary antibodies (Li-Cor) at 1:10,000 dilutions. The 
mitochondrial respiratory enzyme, cytochrome oxidase IV (COX IV) was used as an internal 




After further washes (3*15mins), membranes were developed on the fluorescent 
detection Licor Odyssey developer where signal intensity was quantified using the Odyssey 
software package. Membranes were again blocked with 5% milk for 1hour at RT, briefly 
washed in TBST and then incubated with the primary antibodies for proteins of interest 
overnight at 40C with agitation. Antibody optimization was performed in dilutions ranging 
from 1:500 - 1:5000 in 5% BSA to determine working dilutions that resulted in good signal 
but little non-specific binding. Antibodies against CBS, CSE, MPST, TST, HO-1 and Trx1 
were raised in rabbit and sourced from Abcam. Following washing (3*15mins), membranes 
were incubated for 1hr at RT in the dark with Alexa-780 fluorescent secondary antibodies 
(Li-Cor) at 1:10,000 dilutions. The membrane was again developed on the Licor Odyssey 
developer and internal control and protein of interest identified based on protein size using 
the protein ladder. Densitometric analysis was performed using the Odyssey software 
package, which quantified the relative intensity of the protein of interest and normalized it its 
own internal control to account for differences in sample loading and the efficiency of the 
protein transfer. Western blots were performed in duplicate and average normalised protein 
expression calculated. The relative intensity of each sample were then normalised to the 
mean of the control group (wild type naïve mice or wild type post-CAL mice).  
For eNOS and Vasp phosphorylation studies performed by Alessandra Borgognone 
in the University of Birmingham, total eNOS (BD transduction laboratories), eNOSSer1177 
(Cell signalling), total Vasp (Cell signalling), Vasp239 (Cell signalling) and GAPDH 
(Abcam) blots were performed on 10% SDS gels and transferred onto PVDF membranes 
(Hybond P, Amersham). Following primary antibody incubation, membranes were washed 
with TBST and incubated with horseradish peroxidase (HRP)- conjugated anti-species 
secondary antibodies (GE healthcare) for 1 hr at room temperature and then exposed to 
enhanced chemiluminescence (ECL) detection reagent (Amersham) and exposed to ECL 
Hyperfilm (Amersham). The hyperfilm was then scanned and densitometric analysis 
performed using Adobe Photoshop. eNOSSer1177 was normalised to total eNOS and VaspSer239 
was normalised to total Vasp. Total eNOS and total Vasp blots were normalised to GAPDH.  
 
2.5.7 TST enzyme activity assay 
Tissue TST enzyme activity as measured by the formation of thiocyanate from potassium 
cyanide and thiosulfate as described previously (Hildebrandt & Grieshaber, 2008a) with 
modifications, in collaboration with Roderick Carter. Liver tissue was used for TST enzyme 
activity assays as TST is most abundant in liver tissue. Equal amounts of liver protein 




phosphate (500mM, Sigma) and distilled water. Thiocyanate formation is catalysed by 
addition of potassium cyanide (50mM, Sigma) and incubated at room temperature for 10 
minutes. The reaction is halted with 38% paraformaldehyde (Sigma) before 0.25M iron 
nitrate (Sigma) and 25% nitric acid (Sigma) are added to initiate colour change. Thiocyanate 
levels were measured spectrophotometrically at 460nm. Thiocyanate levels were corrected 
for background signal by subtracting the absorbance read in blank samples. Heat-treated 
wild type protein (950C for 5 minutes) was used a negative control in all experiments. Low 
enzyme activity observed in Tst-/- mice was deemed as artefact as wild type heat-treated 
tissue (950C *5mins) had similar spectrophotometric signal. TST enzyme activity assays 
were performed on liver tissue from Tst-/- and C57BL/6N mice in each experimental study as 
a means of genotyping.  
 
2.5.8 Flow Cytometry 
2.5.8.1 Circulating leukocytes 
Circulating monocytes and neutrophils were measured in whole blood (30μl blood: 30μl 
3.2% citrate) withdrawn from the tail vein in conscious mice at 2days post MI. Whole blood 
was placed in 5ml round bottomed FACS tubes, incubated with fluorescent antibodies 
against CD11b-AF700, Ly6C-PerCP5.5 and Ly6G-PacificBlue (BioLegend) for 30mins in 
the dark and washed with PBS[--] (without calcium and magnesium). Red blood cells were 
lysed with 1ml of Lysis buffer (1:10 in dH20, BD FACS), washed with PBS[--] and 
centrifuged at 300 x g for 5 minutes and resuspended in 1ml PBS[--]. Auto florescent 
counting beads (50,000beads) were added to flow tubes immediately prior to sample 
readings on the LSR flow cytometer and used as reference values to quantify the total 
numbers of neutrophils, Ly6Chigh and Ly6Clow monocytes per mL of blood. Sample 
measurement was stopped when the number of counting beads reached 5000 events. 
Neutrophils were identified as CD11bhigh/ Ly6Ghigh/ Ly6Cintermediate. Monocytes subsets were 
identified as CD11bhigh/ Ly6Glow/ Ly6Chigh or CD11bhigh/ Ly6Glow/ Ly6Clow. Cells were gated 
upon as described in Figure 2-6. 
 
2.5.8.2 Infiltrated leukocytes 
All left ventricular free wall cardiac tissue below the ligature was harvested from mice 2days 
after MI as described above. Tissues were chopped with scissors and placed into warmed 
(370C) MACS tubes containing a cocktail of Collagenase D (1.25mg/ml, Roche), DNase 1 
(60U/ml, Roche) in HBSS and homogenised on a MACS dissociator (Macs Biotinyl 




for 30 minutes before being homogenised a second time on a MACS disrupter to increase the 
yield. Cells were filtered through a 70μm nylon mesh (Fisher brand), and centrifuged at 300 
x g for 5 minutes at 40C and live counted using a Nucleocounter (Chemometec 
Nucleocassette).  
 
Cells were washed with PBS[--], blocked with 10% mouse serum and incubated with 
fluorescent antibodies against CD45-PeCy7, CD11b-AF700, Ly6C-PerCP5.5 and Ly6G-PB 
(BioLegend), for 30mins in the dark and washed with PBS[--]. Cells were incubated with 
DAPI (1μg/ ml, Invitrogen) immediately prior to sample testing to identify dead cells 
(DAPI+) when disrupted cell membranes were permeable to DAPI. Cells were incubated 
with counting beads and 30,000 bead events counted on the LSR, which approximately 
accounted for the entire sample. Live neutrophils were identified as DAPI low/ CD45high/ 
CD11bhigh/ Ly6Ghigh/ Ly6Cintermediate. Monocytes subsets were identified as either DAPIlow/ 
CD45high/ CD11bhigh/ Ly6Glow/ Ly6Chigh or DAPIlow/ CD45high/ CD11bhigh/ Ly6Glow/ Ly6Clow. 
Neutrophil or monocyte subset numbers were calculated as total live cells multiplied by 
percentage of live neutrophils or live Ly6Chigh or Ly6Clow monocytes within identified gates. 
Cells were gated upon as described in Figure 2-7. Unstained and isotype controls for CD45, 
CD11b, Ly6G and Ly6C were ran in parallel to all samples as negative controls to ensure the 



























Figure 2-6 Flow cytometry gating strategy of blood from mice at 2days post CAL 
Gating strategy for flow cytometry in blood from infarcted wild type C57BL/6N mouse heart at 2days post CAL with anti-CD11b, Ly6G and Ly6C 
(reading left to right). Cells were gated for granularity and size (by Side scatter-SSC and Forward Scatter-FSC) and singlet cells gated using FSC-H/ 
FSC-A (height/ area) to exclude cell clumps. Cells expressing CD11b were gated against Ly6G and used to identify monocytes (M) and neutrophil 
(N) cell populations. CD11bhigh and Ly6G high cells were gated on to select for neutrophils. CD11bhigh and Ly6Glow cells were gated on to select for 
monocytes (M). The monocyte population was separated into CD11bhigh/ Ly6Glow/ Ly6Chigh and CD11bhigh/ Ly6Glow/ Ly6Clow populations. Neutrophils 
were further identified as CD11bhigh/ Ly6Ghigh/ Ly6Cintermediate. Abbreviations; FSC; forward scatter, Leuk; leukocyte, M; monocytes, N; neutrophils, 































Figure 2-7 Flow cytometry gating strategy in digested hearts of mice at 2days post CAL 
Gating strategy for flow cytometry from individual digested heart preparations from infarcted wild type C57BL/6N mouse heart at 2days post CAL 
stained with anti-CD45, CD11b, Ly6G, Ly6C and DAPI (reading top row left-right, then bottom row left-right). Cells were gated for granularity and 
size (by Side scatter-SSC and Forward Scatter-FSC) and singlet cells gated using FSC-H/ FSC-A (height/ area) to exclude cell clumps. Live cells 
were selected with a DAPI negative gate (Live cells were DAPIlow). Cells expressing high levels of the leukocyte marker CD45 were gated upon 
(Side Scatter-SSC/CD45+). Cells expressing CD11b were gated against Ly6G and used to identify monocytes (M) and neutrophil (N) cell 
populations. CD11bhigh and Ly6Ghigh cells were gated on to select for neutrophils. The monocyte population was separated into CD11bhigh/ Ly6Glow/ 
Ly6Chigh and CD11bhigh/ Ly6Glow/ Ly6Clow populations. Neutrophils were further identified as CD11bhigh/ Ly6Ghigh/ Ly6Cintermediate. Abbreviations; FSC; 




2.5.9 H2S Measurement - Bromophenol blue assay 
Initial experiments to measure tissue H2S production rates were performed with the 
bromophenol blue method as described previously (Geng et al., 2004a). Fresh left 
ventricular myocardium and liver tissue from naïve C57BL6 mice were isolated and 
homogenized in ice-cold 50mM potassium phosphate buffer (pH 6.8) and then added to the 
reaction mixture of 100mM potassium phosphate (pH 7.4), 10mM L-cysteine (Sigma), 2mM 
pyridoxal 5’-phosphate (Sigma) and 10% (w/v) tissue homogenate. Cryovial test tubes (2ml; 
Simport Plastics, Belocil, Que) were used as the centre wells containing a 2cm X 1.5cm 
piece of Whatmann filter paper soaked in 0.5ml 1% zinc acetate as a trapping solution for 
H2S. The centre wells of the reagent containing cyrovials were flushed with a slow stream of 
nitrogen gas, sealed with a layer of Parafilm and then capped. By transferring the flasks from 
ice to a 370C shaking water bath, the reaction was initiated. After incubation in the water 
bath for 90mins, 0.5ml of 50% trichloroacetic acid (Sigma) was added to stop the reaction. 
Flasks were flushed with nitrogen gas, sealed once more and placed in a water bath at 370C 
for another 60mins to ensure complete trapping of evolved H2S by the zinc acetate solution 
as zinc sulfide. The centre tubes contents were transferred to test tubes, each of which 
contained 3.5ml of water after which 0.5ml of 20mM N, N-dimethyl-p-phenylenediamine 
sulphate in 7.2M HCl and 0.5ml of 30mM FeCl3 (Sigma) in 1.2M HCl were added directly to 
the zinc acetate soaked Whatmann paper to initiate a colour change. The flasks were allowed 
stand for 20mins at room temperature and the absorbance of the resulting solution was 
measured at 670nm with a spectrophotometer (Molecular Devices, Sunnyvale, California, 
USA). A calibration curve of absorbance versus sulfide concentration was determined by 
using standards of the H2S donor, Na2S (as outlined in Figure 2-8). Bromophenol blue assays 
were deemed too insensitive to measure H2S as concentrations below 1mM Na2S were not 
linear (Figure 2-8). Tissue H2S measurements with a specific H2S electrode (discussed in 
further detail in chapter 2.5.10) were later adopted as a more sensitive method (lower 
detection limit within nM range) that could detect the rate of H2S production and breakdown 



































Figure 2-8 Bromophenol Blue method of H2S detection  


















2.5.10 H2S electrode 
The Hydrogen sulfide electrode was constructed during a lab visit to our collaborators, 
Professor Kenneth Olson and Eric DeLeon in the University of Notre Dame, Indiana, USA. 
The H2S electrode is capable of measuring H2S in the nM range compared to mM range as 
observed with the bromophenol blue assay. The electrode is based on the Doeller  H2S 
electrode design (Doeller et al., 2005), with modifications.  
A 0.6mm, 99.95% pure platinum wire (Alfa Aesar), which acted as the anode, was covered 
with a 2cm borosilicate capillary tube at its tip and heat-sealed to the platinum with a blow 
torch. The tip of the glass tube was then ground until the platinum is exposed on all sides and 
polished using ultrafine sandpaper under approximately 5ml of water to reduce vibration and 
avoid shattering the borosilicate glass. The platinum and glass were annealed overnight to 
strengthen the glass. Silastic tubing was heated in hot water and milked over the proximal 
end of the anode to provide electrical insulation from the cathode. Copper wiring was 
soldered onto the anode’s platinum, which was used to conduct the amperometric signal 
away from the tip of the anode (discussed in more detail below). A 32G platinum wire (Alfa 
Aesar), which acted as the cathode, was spun around the anode 10-15times. The copper from 
the anode and platinum cathode were soldered into a 2-prong lemo connector (Lemo UK; 
FGG 00.02.CLAD35). An outer glass tube 2mm in diameter was cut to match the length of 
the platinum wire and a groove cut 2mm from its tip (please see electrode schematic and 
picture of completed electrode in Figure 2-9). The tip of the glass was covered with a gas 
permeable silicone membrane, secured with an O-ring that fitted into the glass groove and 
filled with 50mM ferricyanide solution (World Precision Instruments). The anode and 
cathode assembly was then immersed in the ferricyanide containing outer glass tube and in 
conjunction with a threaded sleeve, screwed into a customised acrylic chamber with a 
stopper to limit H2S oxidation. The electrode was connected to a TBR4100 free radical 
analyser (World Precision Instruments) via the electrodes Lemo connector and equilibrated 
in 0.1M PBS overnight at 150mV polarising voltage. The TBR4100 was connected to an AD 
Instruments Powerlab 8/30 and signal was recorded in real time using LabChart 7 software 
(AD Instruments). 
Daily calibrations of the H2S sensor were carried out using standards of the H2S donor 
compound, Na2S (Sigma) to calculate tissue H2S concentration in terms of current change 
(1μM H2S/ nA). Na2S was added to a glass vial and sealed with a rubber stopper (Fisher 
USA) before nitrogenated dH20 was added with a syringe through the stopper to achieve a 
stock solution with a final concentration of 100mM Na2S. A second syringe was sealed with 




Na2S was added to achieve a final concentration of 2mM. The acrylic chamber was filled 
with 1mL of dH20 before Na2S standards (0.5μM, 1μM, 5μM, 10μM) were administered 
with a 0.25mL bevelled Hamilton syringe through the injection port within the chamber 
stopper. As H2S is added to the chamber, it permeates the sensor’s membrane and dissociates 
to HS-, which reduces ferricyanide to ferrocyanide (Figure 2-10). This chemical reduction 
donates electrons to the anode, creating a current potential that is proportional to H2S 
concentration (Figure 2-11). H2S standards were repeated 3 times before and after all tissue 
experiments. Baseline current is subtracted from the current produced by H2S standards and 
the current (nA) produced by 1μM Na2S is calculated to interpret tissue H2S experiments.  
 Heart and liver tissue was extracted from wild type and Tst-/- mice, quickly washed 
in ice-cold Krebs solution and immersed in Krebs solution containing protease inhibitors 
(1:100). Atria were removed from hearts and a portion of liver was dissected. All 
homogenisation apparatus and tubes were pre-chilled on ice to preserve mitochondrial 
integrity. Tissues were homogenised in a potter Elvehjem homogeniser, centrifuged at 
2,000rpm at 40C for 30seconds to pellet tissue particulate and kept on ice until used. All 
tissue was used within 6hours of collection. Tissue was placed into the closed H2S chamber 
with Krebs solution at a ratio of 1:10 and stirred with a micro magnetic rod driven by 
magnetic stirrer underneath. For H2S breakdown assays, 20μM Na2S was administered to 
tissues and H2S levels continuously monitored. The rate of H2S breakdown was calculated 
when a linear breakdown phase was observed. Tissue H2S breakdown was corrected for 
protein using a Bradford assay as described in chapter 2.5.5. Heat-treated (950C *5mins) 
wild type tissue and buffer alone were placed in the chamber and treated with 20μM Na2S to 
illustrate little breakdown in the absence of fresh tissue. For H2S production assays, tissue 
(1:10 with Krebs solution) was supplemented with H2S synthetic enzyme substrates, L-
cysteine (5mM) and pyridoxal-5-phosphate (1mM). The rate of H2S production was 
calculated when a linear production phase was observed and corrected for protein. However, 
spontaneous H2S generation with 5mM L-cysteine (but not pyridoxal 5’ phosphate) was 
observed in buffer alone led to lower L-cysteine being tested (0.2-1mM). Spontaneous 
decomposition of L-cysteine into H2S in aqueous solutions has been reported previously 
using gas chromatography techniques (Furne, Saeed, & Levitt, 2008). 1mM L-cysteine H2S 
was deemed satisfactory and tissue-free L-cysteine samples were to be used to correct for 
spontaneous decomposition in tissue-containing samples. The H2S polarographic electrode 
broke before the study was conducted and despite considerable efforts, could not be fixed 








































Figure 2-9 Schematic illustration of H2S electrode construction 
A) Diagram of prototype H2S sensor obtained from (Doeller et al., 2005). B) Picture of a 








Figure 2-10 H2S sensor redox chemistry 
H2S diffuses across the sensors membrane and reduces ferricyanide to ferrocyanide, which 
donates electrons to the anode creating a current proportional to H2S concentration. 





































Figure 2-11 H2S electrode responds to low concentrations of sulfide in real time 
A) Representative calibration trace of the H2S sensor using standards of a H2S donor (Na2S) 
administered to fresh normoxic dH20. Arrows from left to right illustrate H2S donor 
administration of 0.5μM, 1μM, 5μM and 10μM. B) H2S electrode displays a linear response 
to H2S donor concentrations illustrating its sensitivity.  

























2.5.11 Monobromobimane assay – H2S and thiosulfate measurements  
Monobromobimane assays measuring H2S and thiosulfate were performed by Dr. Martin 
Barrios-Llerena in the Morton group. Determination of H2S and thiosulfate concentration in 
whole blood samples were performed by derivatization with monobromobimane (MBB) 
followed by HPLC separation and detection with a fluorescence detector as described 
previously (Tiranti et al., 2009), with modifications. 
Briefly, 50µl blood samples were collected into an Eppendorff tube containing 10µl of 46 
mM MBB and incubated for 30 minutes in the dark. The MBB-sulfide was extracted with 
1ml of 160mM EPPS/16mM diethylenetriaminepentaacetic acid (DTPA) pH 8, dried under 
nitrogen, reconstituted 4-fold with buffer A (10 mM tetrabutylammonium phosphate 
aqueous, 10% methanol, 45 mM acetic acid adjusted to pH 3.4) and injected into an Ultimate 
3000 UHPLC+ focused system for identification and quantification. Separation was 
achieved by a gradient of buffer A to 100% Buffer B (10 mM tetrabutylammonium 
phosphate in methanol, 10% water, 45 mM acetic acid ) for 45 minutes at 1 ml/min flow 
rate.  
Separation was performed using an Ultimate 3000 UHPLC+ focused system, couple to a 4.0 
× 125 mm LiChroCART 125-4, (LiChrospher 60 RP-select B, 5 µm, Merck KGaA), 
analytical column fitted with a guard column LiChroCART 10-2, Superspher 60 RP-select B 
cartridge and using a fluorescence detector (excitation 380 nm, emission 480 nm). Na2S and 
sodium thiosulfate (Sigma) standards were performed in parallel with blood samples for 



















Figure 2-12 H2S standard curve using monobromobimane HPLC method of detection 
Linear response relationship between the fluorescence area of HPLC chromatograms as 
function of sulfide concentration, injecting 20 µL of standard sulfide solutions. Fluorescence 
trace was recorded at l_ex = 380 nm, l_em = 480 nm. 
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2.6 Statistical Analysis 
Statistical analysis was performed using Graphpad Prism software. All values presented are 
as mean ± SEM. Analysis of survival was performed using a Chi squared test. Analysis of 
non-parametric data for cumulative water and urinary electrolyte balance were performed 
using two-tailed Mann-Whitney U test. Other comparisons are by unpaired two-tailed 
Student t-test, 1-way ANOVA and 2way ANOVA followed by post-hoc analysis using 
Tukeys Multiple Comparison test or Bonferoni post-hoc tests respectively. For full details, 










3 TST is expressed in the murine cardiovascular system 
and regulates H2S synthesis and removal 
 
3.1 Introduction 
Hydrogen sulfide (H2S) is an endogenously produced gaseous signalling molecule with a 
diverse set of therapeutic capabilities across its physiological range. Pharmacological H2S 
donors limit myocardial infarction-(MI) induced injury (Szabo, 2007), reduce blood pressure 
via increased vasodilatation (Abe et al., 1995) and suppress inflammation (Zhang et al., 
2014). H2S donor compounds interact with endogenous nitric oxide (NO) to mediate these 
protective actions (Papapetropoulos et al., 2009). H2S is generated by the enzymes 
cystathionine beta synthase (CBS), cystathionine gamma lyase (CSE) and 3-
mercaptopyruvate sulfurtransferase (3MST), as described in detail in section 1.1.1. CSE is 
considered the primary H2S synthetic enzyme within the cardiovascular system and is highly 
expressed in the heart and vasculature. Cardiac specific CSE overexpressing (αMHC-CGL-
Tg) mice produce more H2S and are protected from myocardial ischaemia reperfusion injury 
(IRI) (Calvert et al., 2010; Elrod et al., 2007). αMHC-CGL-Tg mice have increased basal 
expression of the H2S-sensitive antioxidant transcription factor, nuclear receptor factor-E2-
related factor (Nrf2) and its downstream targets, hemeoxygenase 1 (HO-1) and thioredoxin 
(TRX1) in the heart, which help mediate their cardioprotective profile (Calvert et al., 2010).  
 
H2S bioavailability is likely to be determined not only by local synthesis, but also by local 
removal. As high concentrations of H2S can fatally inhibit mitochondrial respiration via 
cytochrome c (Modis et al., 2013b; Szabó, 2007), H2S bioavailability is tightly regulated to 
avoid such harmful effects by efficient breakdown within the mitochondria as described in 
detail in section 1.1.2. According to the Hildebrandt and Grieshaber H2S breakdown model 
(Hildebrandt et al., 2008b), thiosulfate sulfurtransferase (TST) is believed to utilise sulfite 
produced by a sulfur dioxygenase (ETHE1) in the mitochondria to form the stable metabolite 
thiosulfate, which is safely excreted in the urine. Ethe1 deficient mice have retarded growth 
and die from sulfide toxicity by 40 days of age (Tiranti et al.,2009), supporting a vital role 
for the sulfide detoxification pathway. TST is most abundantly expressed in the liver, 
kidneys and colon (Nagahara et al.,1998). Sulfate reducing bacteria in the colon produce 
large amounts of H2S and are widely believed to be involved in the aetiology of ulcerative 
colitis (Rowan et al., 2009; Taniguchi et al., 2009). Mice with ulcerative colitis have reduced 





Although TST has previously been shown to be present in whole heart homogenates 
(Nagahara et al., 1998), nothing is known of its cellular localisation within the heart and 
vasculature or its role in regulating H2S bioavailability. The work presented in this chapter 
aimed to address these issues by examining the expression and localisation of TST in the 
healthy murine heart and vasculature in comparison to the well-characterised H2S synthetic 
enzymes. Additionally, using a novel Tst deficient (Tst-/-) mouse, the current study aimed to 
investigate; (i) the extent to which TST plays a role in myocardial H2S breakdown, (ii) 
whether the Tst-/- mouse suffers a similar pathology as the Ethe1-/- mouse due to H2S over-
exposure, or if it represented a milder model of altered H2S breakdown (iii) if expression 
levels of the H2S synthetic and catabolic enzymes were altered in response to altered H2S 










3.2 Methods  
3.2.1 Mice 
Male 10-12 week old C57BL/6J mice, bred in-house, were used for all characterisation 
experiments to identify the basal expression and localisation of the H2S metabolising 
enzymes in the heart, liver and aorta. Male Tst knockout (Tst-/-) and wild type C57BL6/N 
littermates aged 10-12 weeks were used for basal characterisation studies, unless otherwise 
stated.  
Mice were culled by cervical dislocation and the heart, liver, right kidney and aorta 
removed and snap frozen on dry ice for either RNA or protein extraction. Alternatively, 
tissues were dissected and immersed into isolation buffer for mitochondrial isolation (see 
section 2.3.5) or immediately fixed in 10% formalin and processed for immunohistochemical 
and tissue morphological analysis as outlined in sections 2.4.3 and 2.4.5.  
 
3.2.2 Real time PCR  
Quantitative real time PCR was performed on heart, liver and kidney tissues of mice using 
Taqman probes as described in section 2.5.3. For full details of probes, please refer to Table 
2-4. Equal concentrations of RNA was reverse transcribed for cDNA synthesis and used for 
PCR reactions when comparing gene expression between tissues or cell types. For heart 
versus liver, 1μg RNA was reverse transcribed to make cDNA. For CD31+ cells in aorta, 
intramuscular vessels of the hindlimb and liver, 50ng RNA was reverse transcribed for 
cDNA synthesis. Relative expression was calculated using the Ct method to identify gene 
expression in tissues of C57BL/6J mice. Fold Change was calculated using Ct method 
when comparing gene expression in the same tissue of different genotypes (WT vs. Tst-/-). 
All PCR reactions were run in the same fashion. Christina Intrator conducted qRT-PCR of 
isolated endothelial cells. For full details, see section 2.5.3. 
 
3.2.3 Western blotting 
Western blotting was performed on heart, liver, kidney and aortic tissues of naïve mice using 
rabbit polyclonal antibodies as described in section 2.5.6.   
 
3.2.4 Immunohistochemistry 
Immunohistochemical staining for the localisation of the H2S metabolising enzymes in heart, 




as a positive control for vascular endothelial staining within aorta samples. For details of 
dilutions used and the full procedure, see section 2.4.3.  
3.2.5 Immunofluorescent co-localisation staining  
Immunofluorescent co-localisation staining of TST/ CSE and α-smooth muscle actin within 
myocardial vascular smooth muscle cells was performed on heart tissue sections from naive 
C57BL/6J mice as described in section 2.4.4.  
 
3.2.6 Survival rate & Body Weight 
Mice were checked regularly following birth until 20weeks of age to assess if TST loss 
impacted upon survival. A cohort of Tst-/- and wild type mice were weighed between 6-
12weeks following birth to examine if TST loss impacted growth rates.  
 
3.2.7 Echocardiography 
Cardiac size, function and performance were evaluated by Doppler ultrasound in naïve mice 
at 6 and 10weeks of age as described in Section 2.2.2, performed by Adrian Thomson. 
Cardiac dimensional, functional and performance measurements were analysed in a single 
blinded fashion.  
 
3.2.8 TST enzyme activity assay 
TST enzyme activity assays were performed on liver homogenates of naïve Tst-/- and wild 
type mice as described in section 2.5.7. Wild type heat-treated protein (950C x 5minutes) was 
used as a negative control for all experiments.  
 
3.2.9 Tissue H2S breakdown assay 
H2S breakdown assays were performed on fresh heart and liver homogenates from Tst
-/- and 
C57BL/6N wild type mice in a closed normoxic chamber using a H2S amperometric 
electrode as described in section 2.5.10. All tissue homogenates were kept on ice and used 
within 6hours of collection.  
 
3.2.10 H2S and thiosulfate measurements  
H2S and thiosulfate levels were measured in the blood of Tst
-/- and C57BL/6N wild type 








Tissue morphological analysis was assessed using haematoxylin and eosin (H&E) staining 
performed on heart sections of adult Tst-/- and C57BL/6N wild type mice, see section 2.4.5. 
H&E sections were assessed by a rodent pathologist (James Baily) who was blinded to 
genotype to examine if any gross structural abnormalities existed. 
 
3.2.12 Mitochondrial respiration  
Mitochondria were isolated from two pooled hearts of Tst-/- or wild type mice aged 14-16 
weeks as described in section 2.3.5. Mitochondria were placed into an Oroboros oxygraph in 
the presence of excess substrate (mM; Malate 2.5, Glutamate 5, Succinate 5, ADP 2) to 
stimulate state 3 respiration as detailed in section 2.3.6. Basal O2 respiratory rate during state 
3 respiration was calculated during the linear phase of O2 consumption and corrected for 
protein by BSA assays as detailed in section 2.3.6 and 2.5.5.  
 
3.2.13 Cardiomyocyte Isolation 
Cardiomyocytes were isolated from whole mouse hearts of C57BL/6J mice using 
collagenase digestion mixture perfused through the heart using the Langendorff apparatus as 
detailed in section 2.3.3 and then lysed for protein analysis using Western blotting. 
 
3.2.14 Endothelial cell Isolation  
CD31+ endothelial cells were isolated from thoracic aorta and intramuscular vessels of the 
hindlimb of C57BL/6J mice by Lorraine Rose and Dr. Andrea Caporali. RNA was extracted 
from endothelial cells, and kindly donated as cDNA by Lorraine Rose and Dr. Andrea 
Caporali (50ng RNA was reverse transcribed to make cDNA). For full details on endothelial 
isolations, see section 2.3.4.  
 
3.2.15 Statistical Analysis 
All values presented are as mean ± SEM. Unless otherwise stated, comparisons are by 







3.3.1 The H2S synthetic enzymes are expressed in the murine heart & liver 
Quantitative real-time PCR confirmed the presence of the H2S synthesising enzymes Cbs, 
Cth and Mpst in the hearts and livers of adult C57BL/6J mice. Cth gene expression was 
comparable in heart and liver tissues (Figure 3-1). Cbs gene expression was low in the heart 
in comparison to liver (Figure 3-1). Mpst gene expression was higher in the liver in 























Figure 3-1 The H2S synthetic enzymes are expressed in the murine heart and liver 
Quantitative real time PCR analysis measuring mRNA levels of the H2S synthetic enzymes 
Cbs, Cth (Cse) and Mpst in C57BL/6J hearts and livers. All data are normalised to the 
housekeeping gene β-actin (n=4/ tissue). Values are expressed as mean±SEM. *p < 0.05, 
**p < 0.01. Abbreviations; Cbs; cystathionine-β-synthase, Cth; cystathionine-γ-lyase, Mpst; 




























3.3.2 TST is expressed in the murine heart and vasculature 
Quantitative real-time PCR and western blots confirmed the presence of Tst mRNA and TST 
protein in whole hearts and livers of C57BL/6J mice (Figure 3-2). TST protein is 
significantly more abundant in the liver compared to heart tissue (Figure 3-2). Western blots 
performed on mitochondria and cardiomyocytes isolated from whole hearts confirmed that 




3.3.3 TST and CSE are expressed in aorta and are co-expressed in the 
coronary vasculature  
Immunofluorescent co-localisation staining localised CSE and TST with α-SMA within 
vascular smooth muscle cells within the myocardium (Figure 3-3). TST and CSE protein 
expression was observed in whole aorta homogenates (Figure 3-3).  
 
 
3.3.4 TST and H2S synthetic enzymes are differentially expressed in the 
vascular endothelium and smooth muscle of the aorta 
Immunohistochemical staining showed that CSE (Figure 3-4) was expressed in vascular 
smooth muscle of the aorta, but not in the endothelium (Figure 3-4). CBS and 3MST were 
both expressed in the endothelium with little staining observed within the smooth muscle 
(Figure 3-4). Quantitative real-time PCR confirmed the presence of Tst mRNA in CD31+ 
endothelial cells isolated from aorta and intramuscular vessels of the hindlimb of C57BL/6J 


















































Figure 3-2 TST is expressed in mitochondrial fraction of murine heart and in 
cardiomyocytes but to a lesser extent than in liver 
A) Quantitative real time PCR analysis measuring mRNA levels of the H2S breakdown 
enzyme Tst in naïve C57BL/6J hearts and livers when normalised to the housekeeping 
gene, β-actin (n=4/ tissue). (B) Representative immunoblot and densitometric analysis of 
TST protein levels in C57BL/6J whole heart and liver tissue (n=4/ tissue). Data presented as 
relative intensity of protein expression when normalised to the mitochondrial internal control, 
COX IV. C) Representative immunoblot showing TST and COX IV expression in 
mitochondria and ventricular cardiomyocytes isolated from three whole hearts of naïve 
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Figure 3-3 TST is localised with CSE in the coronary vasculature within smooth 
muscle and also in the aorta 
A) Representative immunofluorescent co-localisation staining images of CSE & TST 
(Alexa488; green) with smooth muscle cell marker, alpha smooth muscle actin (α-SMA Cy3; 
red). Nuclei stained with DAPI for all sections (blue), scale bar is 20μm. B) Representative 
immunoblot showing increasing protein concentration (20μg, 40μg protein) signal response 
for CSE and TST expression in whole aorta and liver homogenates (positive control tissue) 
of naïve C57BL/6J mice.   
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Figure 3-4 H2S synthetic enzymes are expressed in endothelial and smooth muscle 
cells within the aorta 
A) Immunohistochemical localisation staining of the H2S synthetic enzymes, CSE, CBS and 
3MST in the aorta of C57BL/6J mice. CD31 staining performed as positive endothelial cell 
control for comparative analysis. Sections photographed using an Olympus light microscope 
camera, 40x objective. Scale bar, 20μm. Abbreviations; E; endothelium, SMC; smooth 

























Figure 3-5 TST is expressed in the endothelium of aorta and small intramuscular 
vessels of mice 
Quantitative real time PCR analysis measuring mRNA levels of Tst in isolated CD31+ 
endothelial cells (EC) from aorta and intramuscular vessels of the hindlimb. Liver used as 
positive control tissue. All data are normalised to the housekeeping gene GAPDH (n=5/ 


























3.3.5 TST deficient mice are grossly normal up to 12 weeks  
3.3.5.1  TST is ablated in Tst-/- mice 
Quantitative real-time PCR and western blotting confirm the loss of Tst mRNA and protein 
in heart, liver and kidney tissues of Tst-/- mice (Figure 3-6). TST enzyme activity assays 
confirm that TST enzymatic activity is lost in Tst-/- livers (Figure 3-6).  
 
 
3.3.5.2 Tst-/- mice are grossly normal 
Tst-/- mice survive to adulthood with no observed differences in body weight up to 12weeks 
of age (Figure 3-7). Kidney and liver organ weights in adult mice are comparable between 













































Figure 3-6 Confirmation of TST loss in Tst-/- mice 
A) Quantitative real time PCR analysis measuring Tst mRNA levels in liver, heart and kidney 
tissues in Tst-/- and C57BL/6N wild type mice (n=4-5/ tissue/ group). Data normalised to the 
housekeeping gene Cox4i1 and then normalised to level of wild type controls.  
B) Representative western blot of TST protein expression in liver, heart and kidney tissues 
(10μg protein) in C57BL/6N wild type (+) and Tst-/- (-) mice. C) TST enzyme activity in fresh 
liver homogenates of Tst-/- and C57BL/6N control mice (WT; n=6, Tst-/-; n=5). Values are 
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Figure 3-7 Tst-/- mice survive to adulthood and grow normally 
A) Survival rates of Tst-/- mice. B) Body weight measurements in Tst-/- and wild type control 
mice at 6, 9, 10, 11 and 12weeks of age (n=6/ genotype). C) Organ weights of kidney and 
liver tissues normalised to body weight measured in 12week old Tst-/- and C57BL/6N wild 
























































3.3.6 H2S balance is compromised in Tst-/- mice 
3.3.6.1 Expression of mitochondrial H2S breakdown enzymes are not altered 
in Tst-/- mice 
In the heart and liver, quantitative real-time PCR showed that loss of Tst had no impact on 
the mRNA levels of the mitochondrial H2S breakdown enzymes, Sqrdl, Ethe1 or Suox. In the 
kidneys, PCR revealed a trend for reduced Sqrdl, Ethe1 and Suox mRNA levels mice (Figure 
3-8, Sqrdl P=0.13, Ethe1 P=0.1, Suox P=0.09). 
 
 
3.3.6.2 The rate of H2S breakdown is reduced in the heart and liver of Tst-/- 
mice 
Polarographic H2S electrode experiments revealed that the rate of H2S breakdown was 
significantly decreased in heart and liver homogenates from Tst-/- mice (Figure 3-9). In the 
heart and liver homogenates of Tst-/- mice, H2S breakdown was reduced by 20% and 50% 
respectively when compared to controls.  
 
 
3.3.6.3 Tst-/- mice have higher circulating H2S and thiosulfate levels and 
increased urinary concentration of thiosulfate 
Monobromobimane assays revealed that H2S levels were approximately 7-fold higher in the 
blood of Tst-/- mice compared to controls (μM; WT; 30.3 ± 1.3, Tst-/-; 227.1 ± 9.2) (Figure 
3-10). Thiosulfate levels were approximately 30-fold higher in the blood of Tst-/- mice 
compared to controls (μM; WT; 2.15 ± 0.2, Tst-/-; 66.3 ± 10.3) (Figure 3-10). Urinary 
thiosulfate levels are approximately 500-fold higher in the urine of Tst-/- mice compared to 
wild type controls (μM; WT; 4.99 ± 2.63, Tst-/-; 2374.49 ± 318.94) (Figure 3-10).  
 
 
3.3.6.2 H2S-sensitive Nrf2 downstream targets TRX1 and HO-1 are not 
altered in Tst-/- hearts  
Despite increased circulating levels of H2S, expression of the H2S-sensitive Nrf2 
downstream target proteins TRX1 and HO-1 are comparable in heart tissue from of Tst-/- and 

















































Figure 3-8 Expression of the mitochondrial H2S breakdown enzymes is not modified in 
Tst-/- mice  
Quantitative real time PCR analysis measuring mRNA levels of the mitochondrial H2S 
breakdown enzymes, Sqrdl, Ethe1 and Suox in heart (n=5/ genotype), liver (n=5/ genotype) 
and kidney (WT; n=7, Tst-/-; n=8) tissues from Tst-/- and C57BL/6N wild type mice. Data 
normalised to the housekeeping gene Cox4i1 and then normalised to level of wild type 
controls. Values are expressed as mean±SEM. Abbreviations; Sqrdl; sulfide quinone 








































































































Figure 3-9 Rate of H2S breakdown is reduced in heart and liver tissue of naïve Tst-/- 
mice 
Rate of H2S breakdown in normoxic fresh heart (A) and liver (B) homogenates of Tst-/- and 
C57BL/6N wild type mice. H2S signal was continuously measured following administration of 
20μM Na2S in a closed chamber (WT; n=4, Tst-/-; n=4-5) and corrected for protein. Values 



















































Figure 3-10 Circulating H2S and thiosulfate levels are markedly higher in whole blood 
from Tst-/-mice 
A) Representative monobromobimane peak for H2S and thiosulfate, measured by HPLC. B) 
H2S (n=4/ group) and (C) thiosulfate levels in blood (n=4/ group) of Tst-/- and C57BL/6N wild 
type mice. D) 24hour excreted urinary thiosulfate levels normalised to creatinine in Tst-/- and 
C57BL/6N wild type mice (WT; n=4, Tst-/-; n=5). Samples obtained from mice 4days 

































































































Figure 3-11 The H2S-sensitive Nrf2 downstream target proteins are not altered in Tst-/- 
hearts under basal conditions 
(A) Representative immunoblot and (B) densitometric analysis of TRX1 and HO-1 protein 
expression in hearts of naïve Tst-/- and C57BL/6N wild type mice. Data presented as relative 
intensity of protein expression when normalised to the internal control, β-actin and then 
normalised to level of C57BL/6N wild type controls (WT; n=4, Tst-/-; n=5). Values are 



































3.3.7 H2S synthetic enzyme expression is reduced in the hearts of Tst-/- 
mice 
Tst-/- mice have significantly lower mRNA (Figure 3-12) and protein (Figure 3-12, P=0.011) 
levels of the H2S synthetic enzyme CSE in their hearts.  However, while Mpst  (Figure 3-12) 
mRNA levels are lower in hearts from Tst-/- mice, western blots reveal that 3MST protein 
levels are comparable between groups  (Figure 3-12, P=0.2). Cardiac CBS expression was 
unaffected by loss of Tst (Figure 3-12). 
 
 
3.3.8 3MST is up-regulated in the liver mitochondria of Tst-/- mice  
Quantitative real-time PCR revealed that hepatic mRNA levels of the H2S synthetic enzymes 
Cse and Cbs were comparable to controls (Figure 3-13). Hepatic Mpst mRNA levels were 
significantly reduced in Tst-/- mice but western blotting revealed 3MST protein to be higher 
in mitochondria isolated from liver tissue (Figure 3-13).  
 
 
3.3.9 CSE is upregulated in the kidneys of Tst-/- mice 
Cbs mRNA levels tended to be lower in kidney tissue of Tst-/- mice (Figure 3-14, P=0.069) 
but western blots revealed that CBS protein tended to be higher in kidneys of Tst-/- mice 
compared to controls (Figure 3-14, P=0.09). Renal Cse mRNA levels were comparable 
between groups but CSE protein levels were higher in the kidneys of Tst-/- mice (Figure 3-
14). Mpst mRNA (Figure 3-14) was reduced in Tst-/- kidneys but protein levels were 




















































Figure 3-12 Cth/ CSE expression is reduced in the hearts of Tst-/- mice 
A) Quantitative real time PCR analysis measuring mRNA levels of the H2S synthetic 
enzymes Cbs, Cth and Mpst in heart tissue of Tst-/- and C57BL/6N wild type mice (WT; n=6, 
Tst-/-; n=8/ gene/ group). Data normalised to the housekeeping gene Tbp and then 
normalised to level of wild type controls. Representative immunoblots (B) and densitometric 
analysis (C) of H2S synthetic enzyme protein levels in heart tissue of Tst-/- and C57BL/6N 
wild type mice (WT; n=6, Tst-/-; n=5). Data presented as relative intensity of protein 
expression when normalised to the internal control, β-actin and then normalised to level of 























  CBS 
  3MST 
  β-actin 
   61kDa 
   33kDa 
   48kDa 











































































Figure 3-13 3MST protein expression is upregulated in hepatic mitochondria of Tst-/- 
mice 
A) Quantitative real time PCR analysis measuring mRNA levels of the H2S synthetic 
enzymes Cbs, Cth and Mpst in liver tissue of Tst-/- and C57BL/6N wild type mice (n=6-8/ 
gene/ group). Data normalised to the housekeeping gene Tbp and then normalised to level 
of wild type controls. Representative immunoblot (B) and densitometric analysis (C) of 3MST 
protein levels in isolated liver mitochondria of Tst-/- and C57BL/6N wild type mice (WT; n=6, 
Tst-/-; n=5). Data presented as relative intensity of protein expression when normalised to the 
mitochondrial internal control, COX IV and then normalised to level of C57BL/6N wild type 
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Figure 3-14 CSE expression is increased in Tst-/- kidneys 
A) Quantitative real time PCR analysis measuring mRNA levels of the H2S synthetic 
enzymes Cbs, Cth and Mpst in kidney tissue of Tst-/- and C57BL/6N wild type mice (n=8/ 
gene/ group). Data normalised to the housekeeping gene Tbp and then normalised to level 
of wild type controls. Representative immunoblots (B) and densitometric analysis (C) of H2S 
synthetic enzyme CBS, CSE and 3MST protein levels in kidney tissue of Tst-/- and 
C57BL/6N wild type mice (CBS/ 3MST; WT; n=6, Tst-/-; n=5, CSE; n=5/ group) when 
normalised to β-actin and then normalised to level of C57BL/6N wild type controls. Values 













































3.3.10 Tst-/- mice have altered eNOS expression in the heart 
Quantitative real-time PCR revealed that mRNA levels for Nos1, Nos2 and Nos3 were 
comparable in the hearts of Tst-/-mice and wild type littermates (Figure 3-17). Western blots 
performed on naïve hearts revealed that phosphorylation of the eNOS activation site, P-
eNOSSer1177 was comparable between groups but total eNOS was lower in Tst-/- hearts 
(Figure 3-16). A trend for reduced P-Vasp239 protein was present in Tst-/- hearts but failed to 

























Figure 3-15 mRNA levels of NOS isoforms are not altered in Tst-/- hearts 
 
Quantitative real time PCR analysis measuring mRNA levels of the nitric oxide isoforms, 
Nos1/ nNOS (WT; n=4, Tst-/-; n=6), Nos2/ iNOS (n=5/ group) and Nos3/ eNOS (WT; n=7, 
Tst-/-; n=8) in the heart of Tst-/- and C57BL/6N wild type mice. Data normalised to the 
housekeeping gene Tbp and then normalised to level of wild type controls. Values are 






































































Figure 3-16 Cardiac eNOS protein levels are lower in Tst-/- mice  
Representative immunoblot and densitometric analysis showing (A) phosphorylation of 
eNOS at the Serine1177 residue (P-eNOSSer1177), (B) total eNOS and (C) phosphorylation of 
Vasp at Serine239 residue (P-VaspSer239) in heart tissue of Tst-/- and C57BL/6N wild type 
mice (WT; n=5, Tst-/-; n=6). Data presented as relative intensity of protein expression when 
normalised to total eNOS (A), GAPDH (B) and total Vasp (C) and then normalised to level of 









































P-eNOSSer1177/ Total eNOS 
Total eNOS/ GAPDH 
D P-Vasp
































 Heart Liver Kidney 
Gene/ 
Protein 
mRNA Protein mRNA Protein mRNA Protein 
Cbs/ CBS N.D N.D N.D - N.D N.D 
Cth/ CSE Reduced Reduced N.D - N.D Increased 
Mpst/ 3MST Reduced N.D Reduced Increased Reduced N.D 
Nos1 N.D - - - - - 
Nos2 N.D - - - - - 
Nos3/ eNOS N.D Reduced - - - - 
P-
eNOSSer1177 
- N.D - - - - 
P-Vasp239 - Reduced - - - - 
TRX1 - N.D - - - - 
HO-1 - N.D - - - - 
Sqrdl N.D - N.D - N.D - 
Ethe1 N.D - N.D - N.D - 
Suox N.D - N.D - N.D - 
 
Table 3-1 Summary table of changes to mRNA and protein in heart, liver and kidney 
tissues in Tst-/- mice compared to wild type mice. 
Summary data detailing changes in mRNA and protein expression in naïve Tst-/- tissues 
compared to wild type controls. Changes labelled as ‘reduced’ or ‘Increased’ are significantly 
different to controls as shown in Figures 3-8 to Figures 3-16. Abbreviations; N.D; not 




3.3.11 Tst-/- mice have normal cardiac structure, function and mitochondrial 
respiration rates 
Haematoxylin & Eosin stained heart sections revealed no gross morphological alterations in 
the hearts of Tst-/- mice (Figure 3-17). Heart weight to body weight ratios are comparable 
between C57BL/6N and in Tst-/- mice (Figure 3-17).  
 
Ultrasound scanning showed that left ventricular size at end-systole and end-diastole were 
comparable between groups to controls at 6 and 10weeks of age (Table 3-2). Cardiac 
function, evaluated by ejection fraction and endocardial area change, was normal at 6 and 
10weeks of age (Table 3-2). Fractional shortening was reduced in Tst-/- hearts at 6weeks of 
age but was comparable to controls at 10weeks of age (Table 3-2). Doppler scanning 
revealed that isovolumetric contraction, relaxation and ejection times were comparable 
between groups at both timepoints (Table 3-3). The load-independent measure of cardiac 
function, myocardial performance index, was similar in Tst-/- and WT mice at 6 and 10weeks 
of age (Table 3-3). 
 
Basal mitochondrial respiration studies revealed that the O2 consumption rate during state-3 
respiration (Malate, succinate and ADP administration) was comparable in the mitochondria 


















Figure 3-17 Tst-/- mice have normal heart morphology and heart weight  
(A) Representative haematoxylin and eosin stained heart sections of Tst-/- and C57BL/6N 
wild type mice (WT; n=4, Tst-/-; n =5). Scale bar is 20μm. B) Heart weight normalised to body 
weight measured in 12week old Tst-/- and C57BL/6N littermates (WT; n=10, Tst-/-; n=9). 
Values are expressed as mean±SEM.  



























Table 3-2 Tst-/- mice have normal heart size and function at 6 & 10weeks of age  
2-dimensional long axis B-mode and short axis M-mode ultrasound scanning performed on 
anaesthetised naïve 6week and 10week old Tst-/- and C57BL/6N wild type mice (n=6/ group/ 
timepoint). Values are mean±SEM, analysed by 2-way ANOVA with Bonferroni post-hoc test,  
*p<0.05 WT vs. Tst-/- mice at 6weeks of age. Abbreviations; LVESD (mm2); left ventricular 
end systolic area, LVEDA (mm2); left ventricular end diastolic area, EF (%); ejection fraction, 




Table 3-3 Tst-/- mice have normal cardiac performance at 6 & 10weeks of age 
Doppler scanning performed on anaesthetised naïve 6 and 10wk old Tst-/- and C57BL/6N 
wild type mice, (n=6/ group/ timepoint). Values are mean±SEM, analysed by 2-way ANOVA. 
Abbreviations; IVCT (ms, milliseconds); isovolumetric contraction time, IVRT (ms, 
milliseconds); isovolumetric relaxation time, ET (ms, milliseconds); ejection time, MPI 









EF (%) FS (%) 
EAC 
(mm2) 
WT 6 12.3 ± 0.6 20.7 ± 0.9 58.5 ± 2.2 43.1 ± 2.4 8.6 ± 0.3 
  Tst -/- 6 11.6 ± 0.5 20.2 ± 0.7 62.3 ± 1 34.5 ± 1.6* 8.8 ± 0.4 
       
WT 10 13.9 ± 0.9 23 ± 0.3 58.9 ± 3.3 32.6 ± 1.5 9.3 ± 0.6 




IVCT (ms) IVRT (ms) ET (ms) MPI 
WT 6 11.5 ± 0.8 13.5 ± 0.9 39.5 ± 1.5 0.63 ± 0.03 
Tst -/- 6 13.4 ± 1.3 13.7 ± 0.4 41.3 ± 0.9 0.66 ± 0.03 
      
WT 10 10.7 ± 0.7 13.8 ± 0.8 38.5 ± 0.9 0.64 + 0.04 














































Figure 3-18 Tst-/- mice have normal cardiac mitochondrial respiratory rate  
A) Representative mitochondrial respiration trace of C57BL6 control mouse showing 
timepoints of substrate administration to achieve state 3 respiration; malate (M), succinate 
(S) and ADP. Blue line represents mitochondrial O2 consumption and red line denotes 
change of respiration with substrate administration. Black boxes represent the linear phase 
of O2 consumption (blue line) used for measurements. B) Absolute respiratory rate during 
State 3ADP respiration in isolated cardiac mitochondria when normalised to protein (WT; n=5, 
Tst-/-; n=6, two hearts pooled per n number). Values are expressed as mean±SEM. 
Abbreviations, ADP; adenosine diphosphate. 































The aim of the current study was to investigate the expression and localisation of TST within 
the murine heart and vasculature and to establish the role that TST plays in regulating H2S 
bioavailability in Tst deficient mice. 
 
TST and the H2S synthetic enzymes are expressed in the murine heart, liver and 
aorta 
The expression and localisation of the H2S synthetic enzymes in the murine heart and 
vasculature were assessed as a means to compare against Tst expression. Consistent with 
previous reports, the current study showed that the H2S synthetic enzymes, Cth (CSE), Cbs 
and Mpst were present in the murine heart. Cbs mRNA levels were low in the heart 
compared to liver supporting previous reports that CBS plays a lesser role in cardiac H2S 
production (Sen et al.,, 2008). Conversely, cardiac Cth and Mpst mRNA levels were both 
high in whole heart homogenates compared to liver tissue supporting previous findings 
(Geng et al., 2004b; Nagahara et al., 1998).  
Several studies have shown that CSE is expressed in both the vascular endothelium 
and smooth muscle (Fu et al., 2012a; Yang et al., 2008; Zhao et al., 2001) but the 
immunohistochemical staining presented here clearly suggests that CSE was present in aortic 
smooth muscle alone. CSE deficient mice produce less H2S and suffer from vascular 
dysfunction caused by impaired hyperpolarisation within the endothelium and impaired 
activation of the ATP-sensitive potassium activated-ATP channels in smooth muscle of 
small mesenteric arteries (Mustafa et al., 2011; Yang et al., 2008). Therefore, it seems likely 
our antibody simply failed to detect endothelial CSE and additional studies with alternate 
antibodies may be required. CBS expression in the cardiovascular system remains 
controversial with several groups suggesting it is weakly expressed (Sen et al., 2008; Zhao et 
al., 2001). CBS is involved in homocysteine breakdown, which is essential in the process of 
producing the H2S-synthetic enzyme substrate, L-cysteine. Silencing of CBS in human 
umbilical vein endothelial cells (HUVECs) with CBS shRNA reduces cellular proliferative 
potential and predisposes cells to premature senescence, which is exacerbated by 
administration of homocysteine (Albertini, 2012). CBS deficient mice develop 
hyperhomocysteinemia causing endothelial dysfunction, hypertension and vascular 
remodelling (Ovechkin et al., 2006). The present study demonstrates the presence of 
immunoreactive CBS in aortic endothelial cells and together with literature, indicates that 
CBS plays a broader role in vascular health than is currently acknowledged. 3MST 




(Shibuya et al., 2009), indicating it plays a role in vascular function but as no specific 3MST 
inhibitors are currently available, this remains to be elucidated. 
While TST was previously shown to be present in whole heart homogenate (Nagahara et al., 
1998), TST’s cellular localisation within the cardiovascular system was unclear. The current 
study showed that TST was present in whole heart, isolated cardiomyocytes, myocardial 
vascular smooth muscle cells and the aorta in a similar pattern to CSE. Furthermore, western 
blots and qRT-PCR showed that TST is expressed in whole aortic homogenates and in 
endothelial cells from aorta and intramuscular vessels of the hindlimb. These data confirm 
that TST is also expressed in vasculature outwith the heart and blood vessels, raising the 
possibility that TST plays a role in vascular function (discussed in Chapter 4). TST’s 
presence in the same tissues and cell types as the H2S-synthesising enzymes was not 
surprising given the toxic effects of H2S at high concentrations. As H2S can freely diffuse 
across cell membranes, mitochondrial bound TST is well situated to prevent endogenous or 
exogenous sources of H2S from inhibiting cytochrome c in the mitochondrial respiratory 
chain, which can be fatal. Immunohistochemical TST staining in aortic tissues was attempted 
but failed to show cellular specificity and due to time constraints, could not be properly 
optimised. Future studies should aim to optimise aortic TST immunohistochemical staining 
and perform immunofluorescent co-localisation staining with α-SMA and TST to elucidate if 
TST is present in aortic smooth muscle cells.  
 
TST knockout mice survive, but how? 
Upstream of TST, the sulfur dioxygenase ETHE1 participates in the H2S breakdown 
pathway to form sulfite from SQR persulfide groups (Kabil et al., 2014). Ethe1 knockout 
(Ethe1-/-) mice have retarded growth by post-natal day15 and impaired movement. These 
mice die at 5-6 weeks after birth due to sulfide toxicity (Tiranti et al., 2009). Elevated liver, 
brain and muscle tissue H2S levels in Ethe1
-/- mice lead to tissue cytochrome c inhibition and 
reduced mitochondrial complex IV activity (Tiranti et al., 2009). Surprisingly, Ethe1-/- mice 
have normal SQR and TST activities in all tissues despite cytochrome c inhibition, 
suggesting that ETHE1 plays a distinct yet vital role in the H2S breakdown pathway.  
TST has a putative role in the breakdown of H2S but as no selective pharmacological 
inhibitors or knockout mice have been reported to date, its importance in this process was 
unclear. To investigate this, we used a novel TST deficient mouse. Tst-/- mice showed 
complete loss of TST mRNA, protein and enzyme activity confirming that the knockout 
strategy was effective. Tst-/- mice all survived to adulthood (20 weeks) with no differences in 




development and that other pathways are likely modified to retain H2S within a non-toxic 
concentration range. However, Tst-/- mice have reduced H2S breakdown rates in the heart and 
liver confirming that TST is involved in H2S breakdown in these tissues. Impaired H2S 
breakdown is more pronounced in Tst-/- livers, explained by markedly higher TST expression 
in liver compared to the heart. H2S levels in the blood are also increased in Tst
-/-mice, yet 
these mice are viable and do not display the phenotypic characteristics seen in the Ethe1-/- 
mice. In vitro assays showed that the rate of H2S breakdown was impaired in heart and liver 
tissues but exogenous H2S was eventually catabolised. This may be because there is some 
redundancy in the system and other catabolic enzymes are able to take over H2S removal to 
some extent. TST has a high affinity for ETHE1-derived sulfite in the H2S breakdown 
pathway (Hildebrandt et al., 2008a) but SUOX can also utilise sulfite to produce sulfate in 
an oxygen dependent manner (Kabil et al., 2014). Expression of Sqrdl, Ethe1 and Suox 
mRNA levels were comparable in heart and liver tissues of Tst-/- and control mice. Although 
not statistically different, likely because of insufficient sample numbers, Suox mRNA levels 
tended to be higher in Tst-/- livers. As the liver preferentially converts sulfide to sulfate 
(Bartholomew et al., 1980), SUOX may play a vital role in mediating sulfite breakdown in 
Tst-/- mice. Western blotting assays were performed on heart, liver and kidney tissues to 
assess SQR, ETHE1 and SUOX protein levels with several antibodies but were unsuccessful. 
This area merits further investigation, including further optimisation of SUOX protein 
detection, and measurement of sulfite and sulfate levels to examine SUOX functional 
changes and the efficiency of its sulfite conversion.  
 
Circulating H2S levels in blood were found to be approximately 7-fold higher in Tst
-/- mice 
indicating that total body sulfide levels is elevated. Bacterial flora in the colon produce vast 
amounts of H2S, which is catabolised by efficient mitochondrial breakdown (Taniguchi et 
al., 2009). The liver is perfused with venous blood from the digestive tract via the portal vein 
and given its capacity to catabolise H2S, may act as a secondary barrier to limit colonic 
bacterial-derived H2S from entering the circulation (Szabó et al., 2014). TST is ubiquitously 
expressed in hepatocytes surrounding the portal vein and central vein of C57BL/6J mice 
(Appendix 1). Germ-free mice have markedly lower plasma H2S levels compared to controls 
(Shen et al., 2013) and so colonic bacterial-produced H2S is believed to contribute to plasma 
H2S levels (Szabó et al., 2014). Due to expression of the H2S synthetic enzymes in all 
tissues, colonic bacterial-produced H2S is not believed to act as a source of H2S to other 
tissues, confirmed by comparative tissue H2S levels the liver, heart and kidneys of germ free 




ulcerative colitis (UC). Mice with pharmacologically induced-UC have maintained CSE 
expression but reduced TST mRNA, protein and enzyme activity in the colon indicating that 
impaired H2S breakdown plays a vital role in UC (Taniguchi et al., 2009). Therefore, it is 
expected that loss of TST in the colon of Tst-/- mice results in inefficient H2S breakdown and 
subsequently, higher H2S levels in the blood in contact with the gut. Hepatic perfusion from 
the digestive tract into the liver of Tst-/- mice via the portal vein may result in higher H2S 
levels in the blood due to impaired hepatic H2S breakdown. To definitively understand the 
source of plasma H2S it will be important to measure tissue H2S levels in Tst
-/- mice, 
especially in the gut and liver.  
 
Measurement of tissue H2S in Tst
-/- mice 
H2S measurements were attempted in Tst
-/- mouse and control mouse tissues using a variety 
of methods with varying success including, (i) the methylene blue assay, (ii) polarographic 
electrode and (iii) monobromobimane analysis using HPLC. The widely used methylene 
blue assay relies upon incubating tissue samples with excess H2S synthetic enzyme substrate 
L-cysteine (10mM), trapping produced sulfide with zinc acetate and following incubations 
with coloured reagents dissolved in strong acids (1.2-7.2M HCl), methylene blue is formed 
and measured spectrophotometrically to infer H2S levels. There are several issues with this 
method, which have been previously reported including; (i) spectrophotometric interference 
of coloured substances, (ii) strong acidification treatments liberate stored sulfide giving false 
H2S values and (iii) lack of sensitivity to measure H2S concentrations in or below the μM 
range. In my hands, spectrophotometric optical density values obtained from the methylene 
blue method did not distinguish heat-treated (950C*5mins) negative control samples to 
regular samples confirming interference from coloured reagents. Following administration of 
Na2S (a H2S donor) standards, the assay failed to consistently detect sub-millimolar Na2S 
concentrations and as a result, this approach of H2S detection was abandoned.  
The H2S polarographic electrode is a more sensitive method where H2S can be 
measured in the nM range in real time. H2S production assays were employed using the same 
concentrations of the H2S synthetic enzyme substrates as the methylene blue assay in 
hypoxic conditions to avoid H2S breakdown by the oxygen dependent enzymes, ETHE1 and 
SUOX. Preliminary measurements revealed rapid H2S production in the presence of 10mM 
L-cysteine. Upon further investigation, it was observed that L-cysteine administration in 
Krebs buffer or deionised water alone released large amounts of H2S in normoxic and anoxic 
conditions in a concentration-dependent manner. Spontaneous decomposition of L-cysteine 




techniques (Furne et al., 2008). Based on Furne et. al. 2008 experiments, a second set of 
tissue H2S experiments were planned using a 10-fold lower L-cysteine concentration and 
tissue-free L-cysteine samples to correct for spontaneous decomposition in tissue-containing 
samples. Unfortunately, the H2S polarographic electrode broke before the study was 
conducted and despite considerable efforts, could not be fixed. Based on the requirement for 
L-cysteine substrate in both the methylene blue and the polarographic H2S assays, I would 
argue that these assays are an indirect measure of combined H2S synthetic enzyme activities 
and not actual H2S levels. The monobromobimane (MBB) HPLC assay, which is widely 
accepted as a sensitive stable technique to measure H2S, operates when MBB reacts with 
H2S to produce sulfide-dibimane and the reactants are then detected at established peaks 
using HPLC. Whilst this technique has been effective to measure whole blood H2S 
concentrations in Tst-/- mice, this approach has not yet been optimised for determining tissue 
H2S levels.  
Although it was not possible to assess absolute tissue H2S in the present study, it was 
possible to assess the expression of cellular targets of H2S as a surrogate marker. Cellular 
expression of nuclear receptor factor-E2-related factor (Nrf2) and its downstream targets 
thioredoxin (TRX1) and hemeoxygenase 1 (HO-1) are increased by H2S (Calvert et al., 
2009). Cardiac specific CSE overexpressing mice also have increased expression of Nrf2, 
TRX1 and HO-1 protein in heart, which is attributed to their increased H2S availability 
(Calvert et al., 2009). In the current study myocardial TRX1 and HO-1 protein levels were 
comparable between groups suggesting that cardiac H2S bioavailability is maintained.   
 
High H2S concentrations (>10μM) can decrease mitochondrial respiration via cytochrome c 
inhibition (Szabo et al., 2014). Administration of the H2S donor, Na2S to isolated cardiac 
mitochondria dose-dependently reduces mitochondrial oxygen consumption (Elrod et al., 
2007). Ethe1-/- mice have elevated plasma and tissue H2S levels and markedly impaired 
complex IV activity in isolated cardiac mitochondria (Tiranti et al., 2009). Given the hearts 
vast energy requirements, any disruption or inhibition of mitochondrial function would be 
detrimental. Mitochondria isolated from Tst-/- hearts show comparable oxygen consumption 
rates to controls, supporting the conclusion H2S does not accumulate to toxic levels in Tst
-/- 
hearts under basal conditions. Furthermore, Doppler ultrasound scanning confirms that 
cardiac size, function and performance were comparable between Tst-/- and WT control mice 
at 6 and 10weeks of age. This is consistent with data showing normal cardiac morphology 




phenotype facilitates the study of pathology in Tst-/- mice in myocardial infarction 
intervention studies, as outlined in the chapter 5.  
However, these data prompt the question of how Tst-/- mice maintain cardiac H2S 
levels when myocardial H2S breakdown is impaired and circulating H2S levels are increased. 
Evaluation of the myocardial H2S synthetic enzymes in Tst
-/- mice revealed reduction of 
Cse/CSE gene and protein levels, suggesting that a homeostatic negative feedback 
mechanism is triggered in the heart to limit H2S synthesis when breakdown is reduced. 
Reduced CSE-mediated H2S production could explain why cardiac TRX1 and HO-1 protein 
levels are comparable in Tst-/- and control mice. Activation of the negative feedback 
mechanism is likely triggered in Tst-/- hearts to enable the cardiac mitochondria and, 
subsequently, the whole heart to function normally. Reduced local CSE-mediated H2S 
generation likely influences eNOS expression in hearts of Tst-/- mice, an effect reported in 
other studies (King et al., 2014). 
Although mRNA levels of the NOS enzymes are unaltered by loss of TST, total 
eNOS protein was lower in Tst-/- hearts. NO activated protein kinase G mediates 
phosphorylation of the vasodilator-stimulated phosphoprotein (VASP) at the serine239 
residue (P-VaspSer239) (Defawe et al., 2010) and can be used as an indirect measure of NO 
availability. VaspSer239 tended to be lower in Tst-/- hearts, which is consistent with reduced 
cardiac total eNOS data indicating NO availability may also be lower in Tst-/- hearts. Indeed, 
CSE deficient mice have reduced eNOS activity and NO availability, and increase 
susceptibility to IRI (King et al., 2014). Whilst cardiac CSE downregulation appears to be a 
protective strategy under basal conditions, it may be detrimental in pathophysiological states. 
CSE and eNOS have been previously shown to be important mediators of the hearts response 
to MI (Elrod et al., 2006; 2007; King et al., 2014; Sumeray, 2000) and reduced basal 
expression of both enzymes in the heart may be detrimental for Tst-/- mice following MI. The 
response of Tst-/- mice to CAL will be discussed in Chapter 5. 
Dynamic regulation of tissue H2S synthetic enzymes have been shown in a variety of 
injury models including kidney nephropathy (Yamamoto et al., 2012), acute liver failure 
(Shirozu et al., 2014) and pressure overload-induced heart failure (Kondo et al., 2013), but 
the mechanism regulating their expression remains unclear. In the current study, the H2S 
synthetic enzymes respond differently in heart, liver and kidney tissues of Tst-/- mice 
indicating that H2S synthetic enzymes are likely to be regulated by integrated local and 
systemic H2S responsive pathways. In kidneys from Tst
-/- mice, CSE protein levels were 
higher and there was also a trend for increased CBS protein suggesting that renal H2S levels 




rates were not measured in Tst-/- kidneys, increased H2S production could detrimentally 
affect kidney function. This will be discussed further in Chapter 4.  
3MST is characterised as a H2S synthesising enzyme where it converts 3-
mercaptopyruvate or thiosulfate into H2S in concert with the endogenous reducing agent, 
thioredoxin (Mikami et al., 2011). In the current study, Mpst mRNA expression is 
approximately halved in heart, liver and kidney tissues of Tst-/- mice. As Mpst is in close 
proximity to Tst on chromosome 15 (within 1 kb), it is possible the TST knockout strategy 
with 5 and 3 homology arms inadvertently extended too far and affected the Mpst sequence. 
Sequencing of the entire Mpst gene in Tst-/- mice should be performed in the future to 
examine this. Despite reduced mRNA levels, 3MST protein levels were comparable between 
heart and kidney tissues and were elevated in liver mitochondria of Tst-/- mice. As the sample 
preparation for mitochondrial isolation does not separate cytosolic fractions cleanly, it is 
unclear if increased mitochondrial 3MST expression is due to its upregulation or due to 
enhanced compensatory translocation from the cytosol. Although 3MST is characterised as a 
H2S generating enzyme, it is possible it plays multiple roles depending on prevailing 
substrate and H2S levels. TST and 3MST are evolutionarily related and share considerable 
similarities of their sequence and 3-dimensional structure (Cipollone et al., 2007). Indeed, 
3MST has previously been implicated in cyanide detoxification and is capable of converting 
cyanide to thiocyanate, albeit at a much increased Km (Cipollone et al., 2007; Spallarossa et 
al., 2004). Nagahara and colleagues 2013, who developed the first 3MST knockout mouse 
for anxiety-based studies, accidentally created a 3MST-TST double knockout during initial 
knockout development. Interestingly, the double knockouts were embryonic lethal 
(Nagahara et al., 2013) supporting the vital functions of 3MST and TST and raising the 
intriguing possibility that 3MST may have the capacity to compensate for H2S detoxification 
with TST deficiency. Through collaboration, we acquired a novel 3MST inhibitor. Our aim 
was to perform the H2S breakdown assay in tissues pre-treated with the 3MST inhibitor but 
the H2S electrode broke before these studies were performed and should be tested in future 
with new H2S electrodes. 
 
Whilst Tst-/- hearts show negative feedback on CSE levels to limit H2S production, Tst
-/- 
kidney and liver tissues do not. It may be that H2S bioavailability is regulated through 
additional mechanisms in these tissues. H2S availability is regulated by mitochondrial 
breakdown and efficient sulfide storage in the cell in either acid-labile sulfide stores or as 
bound sulfane sulfur and can be released under certain conditions (Shen et al., 2012). Acid-




a variety of mitochondrial proteins and release H2S in acidic conditions (Ishigami et al., 
2009).  Alternatively, bound sulfane sulfur stores exist when sulfur covalently binds to 
another sulfur atom and can release H2S under reducing conditions (Kabil et al., 2014). 
Exogenous Na2S is absorbed in rat brain homogenates as bound sulfane sulfur within 
30minutes (Ishigami et al., 2009). Administration of the reducing agent, dithiothreitol (DTT) 
released 45% more H2S from Na2S pre-treated brain homogenates than non-treated control 
samples supporting this mechanism (Ishigami et al., 2009). Based on their redox sensitivity, 
such stores are believed to act as an emergency source of H2S under pathophysiological 
conditions but the action of release and the precise conditions in which they liberate H2S are 
poorly understood (Kolluru et al., 2013). Whilst it has long been considered an innocuous 
metabolite of TST, thiosulfate is now categorised as a bound sulfane sulfur compound that 
can rapidly release H2S under appropriate conditions (Mikami et al., 2011). In mouse liver 
tissues, co-administration of thiosulfate with the pharmacological or endogenous reducing 
agents, dithiothreitol (DTT) or dihydrolipoic acid (DHLA), respectively, releases H2S 
rapidly (Kolluru et al., 2013; Mikami et al., 2011; Olson et al., 2013). Furthermore, DHLA 
can dose-dependently relax pre-constricted mouse and rat aortas with IC50s of 30μM 
(mouse) and 70μM (rat) reported, indicating that liberated H2S stores can participate in 
biological functions (Olson et al., 2013). However, there is no evidence to support the notion 
that bound sulfane sulfur is used in lieu of free H2S for biological functions or H2S signalling 
events (Kabil et al., 2014). The current study shows that thiosulfate levels are markedly 
increased in in the blood and urine of Tst-/- mice. This surprising result contradicts previously 
held beliefs that TST produces thiosulfate in the H2S breakdown pathway (Hildebrandt et al., 
2008b). Studies performed on lugworm reported that the affinity of TST for thiosulfate was 
lower than that of sulfite but showed that TST can utilise thiosulfate as substrate nonetheless 
(Hildebrandt et al., 2008b). Although TST is involved in H2S breakdown as discussed 
previously, the accepted view that TST converts ETHE1-derived sulfite into thiosulfate 
within the H2S breakdown pathway clearly needs revision. Studies in bacteria suggest that 
thiosulfate is formed more efficiently by the SQR than by TST and may in fact be the source 
of its production (Jackson et al., 2012). Certainly this data would help explain why Ethe1-/- 
and Tst-/- mice also have such high thiosulfate levels. That such significant thiosulfate levels 
are present in urine suggests the body cannot efficiently catabolise sulfide to sulfate for 
excretion and may be a compensatory mechanism to rid the body of H2S. As selective 
inhibitors for SQR are not currently available, in-depth investigation to understand the role 




should test SQR enzyme activity to determine if it is raised in Tst-/- mice in response to 
higher circulating H2S levels. 
 
In conclusion, the current study shows that TST is expressed in the murine cardiovascular 
system as well as the kidney and liver where it contributes to regulation of H2S availability. 
The next chapter will investigate how changes in H2S availability impacts upon blood 






4 Tst knockout mice have altered endothelial function and 
kidney electrolyte-fluid homeostasis 
 
4.1 Introduction 
Blood pressure is regulated by small resistance arteries and arterioles that determine the 
peripheral resistance and in the kidney through electrolyte-fluid handling leading to changes 
in extracellular volume. Experiments in Chapter 3 have shown that TST is expressed within 
the kidney and the vascular smooth muscle of the myocardial vasculature as well as in dorsal 
aorta and in endothelial cells of the aorta and small intramuscular vessels of the hindlimb. In 
kidneys from Tst-/- mice expression of CSE protein was higher indicating that kidney H2S 
generation is likely to be elevated. H2S levels are markedly higher in the blood of Tst
-/- mice. 
Together these observations suggest that TST may have a role in controlling blood pressure 
through regulating the availability of H2S. Experiments in this chapter were therefore aimed 
at investigation of blood pressure regulating mechanisms in Tst-/- mice. 
 
Fluid homeostasis within the body is tightly regulated so that plasma osmolality and 
intravascular volume remain constant. Under physiological conditions, whole body water 
balance is regulated so that urinary excretion matches fluid intake and therefore, maintains 
plasma osmolality, blood volume and blood pressure. The renal nephron actively reabsorbs 
sodium and other electrolytes from the filtrate via several different sodium coupled 
exchangers and water reabsorption is dependent upon this process (Mullins et al., 2006; 
Wang et al., 2009), which is outlined in detail in section 1.1.5.3. The nephrons proximal 
convoluted tubule (PCT) reabsorbs ≈65% of the filtrates sodium and water content (Castrop 
et al., 2014). The H2S synthetic enzymes, CSE, CBS and 3MST are highly expressed in the 
kidney and have been localised to the PCT (Nagahara et al., 1998; Yamamoto et al., 2012). 
Administration of the H2S donor NaHS to the renal artery of rats increases urinary flow rate 
and excretion of sodium, highlighting a potential role of endogenous H2S in electrolyte-fluid 
homeostasis and blood pressure regulation (Xia et al., 2009). TST is also highly expressed in 
the murine kidney and has been localised to the PCT (Sylvester et al., 1990). TST expression 
and enzyme activity levels are comparable between kidney and liver tissues (Nagahara et al., 
1998) and as such, the kidney has classically been characterised as a cyanide detoxifying 
tissue given its exposure to cyanide in the blood (Cipollone et al., 2007). Previous findings 
in this thesis show that TST mediates H2S breakdown in heart and liver tissues and therefore, 




in the PCT. Tst-/- mice have increased CSE expression in the kidney and increased H2S in 
blood indicating that the kidney is exposed to higher concentrations of H2S. The experiments 
in this chapter are designed to investigate if loss of TST impacts upon kidney sodium-fluid 
handling and blood pressure regulation.  
 
Pharmacological H2S administration dose dependently reduces blood pressure (Yang et al., 
2008; Zhao et al., 2001). The ability of H2S to act as an endothelium derived hyperpolarising 
factor (EDHF), causing vasorelaxation, is thought to contribute to this blood pressure 
lowering effect (Hosoki et al., 1997; Mustafa et al., 2011; Yang et al., 2008; Zhao et al., 
2001). The cardiovascular specific H2S-synthetic enzyme, CSE is highly expressed in the 
endothelium and smooth muscle of the aorta (Fu, et al., 2012a; Shibuya et al., 2009; Yang et 
al., 2008). As described in chapter 3, TST is expressed in whole aorta and endothelial cells 
from aorta and small arteries of the hindlimb of wild type mice indicating that TST may play 
a role in regulating vascular function by controlling H2S availability. H2S plays a major role 
in relaxing small resistance arteries, which are largely eNOS and COX independent. Within 
small mesenteric arteries, H2S activates small and intermediate calcium activated potassium 
channels (SKCa and IKCa) in the endothelium and via diffusion into vascular smooth muscle, 
H2S also activates ATP-sensitive potassium channels (KATP). During cholinergic stimulation, 
calcium is released within endothelial cells and activates calmodulin, which then binds to 
and stimulates CSE to produce H2S (Mustafa et al., 2011; G Yang et al., 2008). Endothelial 
produced H2S activates SKCa and IKCa channels, permitting intracellular K+ efflux resulting 
in hyperpolarisation of endothelial cells and the whole vessel, causing relaxation (Mustafa et 
al., 2011). Inhibition of the H2S-sensitive SKCa and IKCa channels with apamin and 
charybdotoxin in isolated endothelial cells from mice attenuates acetylcholine-induced 
hyperpolarisation (Mustafa et al., 2011). Hyperpolarisation of the whole vessel and 
vasorelaxation is attenuated when the endothelium is removed confirming that endothelial 
produced H2S is vital in mediating mesenteric vasorelaxation (Mustafa et al., 2011; Yang et 
al., 2008). In contrast to small arteries, H2S plays a minor role in the relaxation of the aorta 
(Hosoki et al., 1997), which is largely eNOS and cyclooxygenase (COX) dependent. 
However, low doses of the nitric oxide (NO) donor sodium nitroprusside (10nM) enhance 
sensitivity to NaHS in isolated aortic rings (Hosoki et al., 1997), highlighting the importance 
of H2S-NO interactions in the vasculature. As Tst
-/- mice have increased circulating levels of 
H2S, it was hypothesised that vasodilatation would be increased and blood pressure reduced 
in Tst-/- mice. The potential for H2S-NO crosstalk was investigated by detection of eNOS 




availability (King et al., 2014). The present study aimed to investigate the influence of TST 
on the function of large conductance vessels (thoracic aorta), as well as smaller arteries 
(mesenteric) using myography. Furthermore, the vessel function experiments in this chapter 
were designed to investigate if (i) activation of the H2S-sensitive SKCa and IKCa channels is 
enhanced in small mesenteric arteries from Tst-/- mice and (ii) if augmented H2S-NO 








4.2.1 Blood pressure 
Blood pressure was measured in anaesthetised wild type and Tst-/- mice via the right carotid 
artery using an intravascular Millar catheter as described in section 2.2.1. Blood pressure 
was allowed to equilibrate for 30 minutes before basal blood pressure was measured.  
 
4.2.2 Metabolic cage water balance measurements 
Male wild type and Tst-/- mice were acclimatised to single housed metabolic cages for 6 days 
prior to data acquisition and fed a standard ground RM1 diet (0.25% salt content) and given 
free access to water. Daily measurements of body weight, water & food intake, urine & 
faecal output were recorded at the same time of day following the acclimatisation period as 
described in section 2.2.5. To minimise natural daily fluctuations, mean values of water 
intake, urine excretion and urinary sodium, potassium and chloride measurements were 
calculated over an 8-day period following acclimatisation. Water or electrolyte balances 
(excretion – intake) were calculated as cumulative balances. Metabolic cage sample 
collections were performed in collaboration with Matthew Gibbins.  
 
4.2.3 Urinary Electrolyte measurement  
Urinary sodium and potassium levels and plasma potassium levels were measured using the 
Roche 9180 Electrolyte analyser as described in section 2.2.6. Urinary electrolyte values 
were multiplied by total urinary weight in a 24hr period to calculate total electrolyte 
excretion. Values were calculated as mean excretions over an 8-day period following 
metabolic cage acclimatisation. Urinary calcium and phosphate measurements were 
performed by Forbes Howie in the Clinical Analysis Core Services at the University of 
Edinburgh using commercially available colorimetric assays as described in section 2.2.6.  
Values were calculated as mean calcium and phosphate excretions on two consecutive days 
following metabolic cage acclimatisation. Values were multiplied by total urinary weight in 
a 24hr period to calculate total electrolyte excretion. As urine samples were collected at the 
same day each day, values were not corrected for creatinine. 
 
4.2.4 Histology 
Tissue morphological analysis was assessed using haematoxylin and eosin (H&E) staining 




Kidney H&E sections were assessed by a rodent pathologist (James Baily) who was blinded 
to genotype to examine if any gross structural abnormalities existed. 
4.2.5 Western blotting 
Western blotting was performed using rabbit polyclonal antibodies as described in section 
2.5.6. Immunoblots analysing total eNOS and P-eNOSSer1177 protein levels in aortic tissues 
were carried out by Alessandra Borgognone in the University of Birmingham.  
 
4.2.6 Wire myography 
Vascular function was evaluated on isolated vessels using the Mulvany-Halpern myograph 
as described in section 2.3.7 Aorta and first order mesenteric arteries from Tst-/- and 
C57BL/6N wild type mice were isolated, placed onto stainless steel wires and passively 
stretched to their optimal resting tension in PSS filled myography baths as described in 
section 2.3.7. Vessel viability was assessed using high potassium solutions (KPSS) and 
noradrenaline (Aorta; KPSS alone; mesenteric arteries; KPSS and NA). Endothelium 
integrity was confirmed when pre-constricted vessels (70-80% of KPSS-mediated maximal 
constriction) relaxed by >70% of pre-constriction following the administration of 
acetylcholine (ACh, 1*10-5M). Vessels that relaxed by <70% following acetylcholine 
administration were not used for experimentation.  
Vessels were treated with increasing half-log increments (1x 10-9M – 3x 10-5M) of 
the α1-adrenergic receptor agonist phenylephrine (PE) to achieve cumulative drug dose 
response curves. Endothelium intact aortas and mesenteric arteries were preconstricted with 
PE to 80% of Emax (EC80) before cumulative additions of the endothelium dependent 
cholinergic receptor agonist, acetylcholine (ACh) or the endothelial independent nitric oxide 
donor sodium nitroprusside (SNP). To investigate the extent nitric oxide and cyclooxygenase 
play in aortic vasorelaxation, aortic rings were pre-incubated with and without inhibitors for 
nitric oxide (L-NAME, 100μM) and cyclooxygenase (Indomethacin, 10μM) prior to PE, 
ACh or SNP administration. To investigate the extent that small and intermediate calcium 
activated potassium channels (SKCa and IKCa respectively) play in vasorelaxation in small 
resistance arteries, mesenteric rings were incubated with and without Apamin (1μM) and 
Charybdotoxin (100nM) prior to ACh or SNP administration. Doses for all inhibitors were 
determined from the literature and previous experiments in the laboratory. Dose response 







All values are expressed as mean ± SEM. Comparisons of blood pressure and 24hour mean 
differences in water intake and excretion and electrolyte excretory data were assessed by 
unpaired student t-tests. Non-parametric cumulative water and urinary electrolyte balance 
data were compared using two-tailed Mann Whitney U tests. Comparisons of vessel 
myography are by 2-way ANOVA with Bonferroni post-hoc tests comparing between 
genotype and pharmacological agonist doses. EC50 and Emax values were calculated using 
non-linear regression analysis on Prism Graphpad 5.0. Unpaired students t-tests were 
performed when comparing EC50 and Emax values between treated and non-treated groups or 
within groups of treated versus non-treated mice of the same genotype. P values less than 






4.3 Results  
4.3.1 Tst-/- mice have normal blood pressure  
Intracarotid blood pressure measurements revealed that in comparison to WT mice, adult Tst-
/- mice have comparable systolic blood pressure (mmHg; WT; 96.2 ± 4.2, Tst-/-; 98.5 ± 5.8), 
diastolic blood pressure (mmHg; WT; 74.2 ± 4.5, Tst-/-; 67.6 ± 4.5) and mean arterial blood 
pressure (mmHg; WT; 81.5 ± 3.2, Tst-/-; 77.8 ± 4.3). 
 
 
4.3.2 Tst-/- mice are polydipsic and polyuric 
Metabolic cage studies showed that Tst-/- mice drank significantly more water and produced 
significantly more urine than age matched WT controls. Urine osmolality was lower in Tst-/- 
mice compared to WT controls. The polydipsia and associated polyuria observed in Tst-/- 
mice consequently led to maintained cumulative water balance (water intake-urine output) 
that was not significantly different to wild type control mice (P=0.28). Body weight was 
similar between groups at all time-points (Appendix 2).  
 
 
4.3.3 Tst-/- mice excrete significantly more sodium, potassium and chloride 
in their urine compared to control mice  
Tst-/- mice excreted significantly more sodium, potassium and chloride in their urine 
compared to control mice (Figure 4-3). Tst-/- mice ate significantly more food and therefore, 
ingested significantly higher doses of sodium, potassium and chloride from their diet 
compared to wild type control mice (Appendix 2). Tst-/- mice remain in positive electrolyte 
balance and have comparable cumulative sodium, potassium and chloride balances relative 
to WT controls (Figure 4-3).  
 
Urinary phosphate and calcium levels were measured to examine function within the 
proximal tubule and the thick ascending limb of Henle respectively. Urinary phosphate 
tended to be higher in Tst-/- mice (Table 4-1, P = 0.07). Urinary calcium excretion was 
comparable between groups (Table 4-1, P = 0.33). Haematoxylin & Eosin stained sections 








































Figure 4-1 Tst-/- mice are normotensive  
A) Systolic blood pressure, (B) diastolic blood pressure and (C) mean arterial blood pressure 
of anaesthetised adult Tst-/- and C57BL/6N wild type mice, measured by carotid cannulation 
































































































Figure 4-2 Tst-/- mice have higher water turnover than controls 
Mean 24 hour water intake (A), urine output (B), urine osmolality (C) and D) cumulative 
water balance (water intake – urine excretion) calculated over the 8 day post-acclimatisation 
period in Tst-/- and C57BL/6N wild type mice (WT; n=4, Tst-/-; n=5). Data are mean ± SEM. 
Statistical analysis was performed using student t-test (A-C) and Mann-Whitney U test (D). 













































































































Figure 4-3 Tst-/- mice excrete more sodium, potassium and chloride compared to 
controls but remain in positive electrolyte balance 
(A-C) Mean 24hour urinary sodium, potassium and chloride excretion in Tst-/- and C57BL/6N 
wild type mice. (D-F) Cumulative sodium, potassium and chloride balance (dietary intake - 
urinary excretion) over 8day post-acclimatisation period (WT; n=4,Tst-/-; n=5). Values were 
corrected for total urinary volume in a 24hr period. Data are mean ± SEM. Statistical analysis 
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Table 4-1 Urinary phosphate and calcium excretion are comparable between groups 
Mean 24hour urinary phosphate and chloride excretion from Tst-/- and C57BL/6N wild type 
mice over a 2day post-acclimatisation period. Values were corrected for total urinary volume 


























Figure 4-4 Tst-/- mice have normal kidney morphology 
Representative haematoxylin and eosin stained kidney tissue of Tst-/- and C57BL/6N wild 
type mice (WT, n=4, Tst-/-, n =5). Abbreviations, G (glomerulus), PCT (proximal convoluted 
tubule, DCT (distal convoluted tubule). Scale bar is 20μm. 
  
 WT Tst -/- 
n 4 5 
Phosphate  1.42 ± 0.28 2.48 ± 0.37 





4.3.4 Tst-/- mice have altered eNOS expression in aorta  
Western blots performed on aorta showed that protein levels of P-eNOSSer1177 were higher in 









































Figure 4-5 eNOS signalling is elevated in aorta of Tst-/- mice 
A) Representative immunoblot and densitometric analysis showing (B) phosphorylation of 
eNOS at the Serine1177 residue (P-eNOSSer1177) and (C) total eNOS in naïve aortic tissue 
(WT; n=5, Tst-/-; n=6). Data presented as relative intensity of protein expression when 
normalised to total eNOS (A) or GAPDH (B) and then normalised to level of C57BL/6N 
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4.3.5 Isolated vessels from WT and Tst-/- mice have similar responses to the 
α1-adrenergic agonist, PE 
 
Cumulative addition of phenylephrine (PE) to isolated endothelium intact aorta and 
mesenteric arteries from WT and Tst-/- mice caused dose-dependent contraction (Figure 4-6). 
The response of aorta and mesenteric arteries to PE was similar between groups at all 
concentrations (Figure 4-6, Table 4-2).  
 
4.3.6 Tst-/- vessels have mild endothelial dysfunction in small mesenteric 
arteries  
Vessel pre-constriction with PE to 80% of maximal constriction (EC80) was equivalent in 
aorta and mesenteric arteries from WT and Tst-/- mice for all interventions.  
 
Cumulative addition of ACh (Figure 4-7) or SNP (Figure 4-8) to isolated aortas and 
mesenteric arteries cause dose-dependent relaxation. The response to the endothelial 
dependent cholinergic receptor agonist ACh was comparable in aorta from WT and Tst-/- 
mice (Figure 4-7). There were no differences between groups for ACh EC50 or Emax (maximal 
relaxation) (Table 4-2). The responses to the endothelium independent, vascular smooth 
muscle cell relaxant agent, SNP were also comparable between groups (Figure 4-8, Table 4-
2). 
 
Mesenteric vessels from Tst-/- mice were less responsive to ACh than WT controls (Figure 
4-7) and there was a significant (P=0.015) increase in EC50 relative to WT (Table 4-2). The 
maximal relaxation induced by ACh was not different in mesenteric arteries of Tst-/- mice 
compared to WT controls (Table 4-2). The responses to SNP within mesenteric arteries were 
comparable between groups (Figure 4-8). EC50 and Emax of SNP in mesenteric arteries were 




































Figure 4-6 Contractile response to PE is normal in the vasculature of Tst-/- mice 
Cumulative concentration response to PE (1*10-9 – 3*10-5 M) in endothelial intact (A) aortic 
rings (n=6/ group) and (B) mesenteric artery rings (n=8/ group) isolated from C57BL/6N wild 
type and Tst-/- male mice. Vessel response to PE was expressed as percentage of maximal 
response to KPSS. Values are mean±SEM, analysed by 2-way ANOVA with Bonferroni post-
hoc test. Abbreviations; PE; phenylephrine 
  











































































































Figure 4-7 Tst-/- mice have mild endothelial dysfunction in small mesenteric arteries 
but not in aorta 
Cumulative concentration response to Ach (1*10-10 – 3*10-5 M) in endothelium intact (A) 
aortic rings (WT; n=5, Tst-/-; n=7) and (B) mesenteric rings (WT; n=7, Tst-/-; n=6) isolated 
from C57BL/6N wild type and Tst-/- male mice. Vessel response to ACh was expressed as 
percentage of vessel pre-constriction. Values are mean±SEM, analysed by 2-way ANOVA 
with Bonferroni post-hoc test. **p < 0.01, ***p < 0.001. Abbreviations; ACh; acetylcholine.  
































































































Figure 4-8 Relaxation response to nitric oxide donor, SNP is normal in the vasculature 
of Tst-/- mice 
Cumulative concentration response to SNP (1*10-10 – 3*10-5 M) in endothelium intact (A) 
aortic rings (WT; n=5, Tst-/-; n=6) and (B) mesenteric rings (WT; n=3, Tst-/-; n=6) isolated 
from C57BL/6N wild type and Tst-/- male mice. Vessel response to ACh was expressed as 
percentage of vessel pre-constriction. Values are mean±SEM, analysed by 2-way ANOVA 
with Bonferroni post-hoc test. Abbreviations; SNP; sodium nitroprusside  





























































































Table 4-2 Contractile and relaxant responses of WT and Tst-/- mice 
The EC50 (50% maximal constriction/ relaxation) and Emax (maximal constriction/ relaxation) were calculated for the contractile response to PE or 
relaxant response to ACh and SNP in endothelium intact aorta and mesenteric arteries isolated from C57BL/6N wild type and Tst-/- mice. Data are 
mean ± SEM. *p < 0.05; WT vs. Tst-/- in mesenteric arteries analysed by unpaired student t-test.   
 
 
 Aorta Mesentery 
  WT Tst -/- WT Tst -/- 
 n 6 6 8 8 
PE -logEC50 (M) 6.84 ± 0.20 6.51 ± 0.11 5.87 ± 0.12 5.96 ± 0.14 
 Emax (% KPSS) 134.92 ± 17.5 110.53 ± 14.7 90.36 ± 3.62 99.58 ± 5.08 
      
 n 5 7 7 6 
ACh -logEC50 (M) 6.91 ± 0.08 6.77 ± 0.08 7.5 ± 0.21 6.68 ± 0.21* 
 Emax  (% Relaxation) 80.05 ± 5.11 85.37 ± 2.05 85.01 ± 4.07 84.52 ± 3.53 
      
 n 5 6 3 6 
SNP -logEC50 (M) 7.91 ± 0.15 7.83 ± 0.19 8.12 ± 0.26 8.10 ± 0.26 




4.3.7 TST loss influences the basal release of NO and constrictor 
prostaglandins in the aorta 
In the presence of the nitric oxide and cyclooxygenase inhibitors, LNAME and 
indomethacin, the maximal response to PE was only significantly increased in aortas from 
Tst-/- mice (Table 4-3). However, the IC50 for PE was not significantly changed by L-NAME 
and indomethacin in aortas isolated from WT and Tst-/- mice (Figure 4-9, Table 4-3). 
 
 
4.3.8 NO and prostaglandins mediate endothelium dependent and 
independent vasodilatation in the aorta 
Incubation with L-NAME and indomethacin reduced endothelium dependent relaxation to 
Ach (Figure 4-10). Maximal relaxation was reduced in both groups to a similar extent 
(Figure 4-10, Table 4-3). IC50 was not different between groups when pre-treated with L-
NAME and Indomethacin (Table 4-3). In the presence of L-NAME and indomethacin, aortas 
from both WT and Tst-/- mice were both significantly more sensitive to the nitric oxide 
donor, SNP (Figure 4-10, Table 4-3). Maximal relaxation was not different within either 





































Figure 4-9 Nitric oxide and cyclooxygenase mediate the contractile response to PE in 
the aorta of WT and Tst-/- mice 
Cumulative concentration response to PE (1*10-9 – 3*10-5 M) in aortic rings pre-treated with 
LNAME (NO inhibitor) and indomethacin (cyclooxygenase inhibitor). Endothelium intact 
vessels were isolated from C57BL/6N wild type and Tst-/- mice (Non-treated; n=6/ group, 
Treated; WT; n=5, Tst-/-; n=6). Vessel response to PE was expressed as percentage of 
maximal response to KPSS. Values are mean±SEM, analysed by 2-way ANOVA with 
Bonferroni post-hoc test. *p < 0.05 WT vs. WT [+] LNAME/ INDO. $; p < 0.05, $$; p < 0.01, 
Tst-/- vs. Tst-/- [+] LNAME/ INDO. Abbreviations; PE; phenylephrine, LNAME; N(G)-nitro-L-
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Figure 4-10 Nitric oxide and cyclooxygenase independent vasorelaxation in aortas of 
WT and Tst-/- mice 
Cumulative concentration response to (A) ACh (Non-treated; WT; n=5, Tst-/-; n=7, Treated; 
WT; n=4/ group) and (B) SNP (Non-treated; WT; n=5, Tst-/-; n=6, Treated; n=5/ group) in 
aortic rings pre-treated with LNAME and indomethacin. Endothelium intact vessels were 
isolated from C57BL/6N wild type and Tst-/- mice. Vessel response to ACh and SNP were 
expressed as percentage of vessel pre-constriction. Values are mean±SEM, analysed by 2-
way ANOVA with Bonferroni post-hoc test. ***p < 0.001 WT vs. WT [+] LNAME/ INDO. $; p < 
0.05, $$; p < 0.01, $$$; p < 0.001 Tst-/- vs. Tst-/- [+] LNAME/ INDO 
WT
Tst-/- 
WT + LNAME/ INDO
Tst-/- + LNAME/ INDO
B 
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Table 4-3 Intra-group analyses of the contractile or relaxant response in the aortas of WT and Tst-/- mice pre-treated with or without L-
NAME and indomethacin 
The IC50 and Emax (maximal constriction/ relaxation) were calculated for the contractile response to PE or relaxant response to ACh and SNP in 
endothelium intact aorta isolated from wild type and Tst-/- mice pre-incubated with [+] or without [-] LNAME and indomethacin. Data are mean ± SEM 
analysed by 2way non-repeated measures ANOVA. *p<0.05, **p<0.01, ***p<0.001 when comparing within genotype of treated versus non-treated 
aortas. Abbreviations; LN; LNAME, INDO; indomethacin.  
  WT Tst -/- 
  [-] LN/ INDO [+] LN/ INDO [-] LN/ INDO [+] LN/ INDO 
 n 6 5 6 6 
PE -logIC50 (M) 6.84 ± 0.20 7.21 ± 0.13 6.51 ± 0.11 7.02 ± 0.16 
 Emax (% KPSS) 134.92 ± 17.5 191.78 ± 16.15 110.53 ± 14.7 189.43 ± 28.48* 
      
 n 5 4 7 4 
ACh -logIC50 (M) 6.91 ± 0.08 6.12 ± 0.69 6.77 ± 0.08 6.42 ± 0.39 
 Emax (% Relaxation) 80.05 ± 5.11 10.52 ± 4.77*** 85.37 ± 2.05 15.22 ± 6.16*** 
      
 n 5 5 6 5 
SNP -logIC50 (M) 7.91 ± 0.15 8.90 ± 0.13** 7.83 ± 0.19 8.68 ± 0.17** 




4.3.9 Small and intermediate calcium activated potassium channels do not 
regulate constriction in small mesenteric arteries from WT or Tst-/- 
mice  
The constrictor response to PE was unchanged in mesenteric arteries when pre-incubated 
with inhibitors of the small (SKCa) and intermediate calcium activated potassium channels 
































Figure 4-11 SKCa and IKCa channels do not mediate the contractile response to PE in 
the mesenteric arteries of WT and Tst-/- mice 
Cumulative concentration response to PE in mesenteric rings pre-treated with apamin (SKCa 
inhibitor) and charybdotoxin (IKCa inhibitor). Endothelium intact vessels were isolated from 
C57BL/6N wild type and Tst-/- mice (Non-treated; n=8/ group, Treated; WT; n=7, Tst-/-; n=5). 
Vessel response to PE was expressed as percentage of maximal response to KPSS. Values 
are mean±SEM, analysed by 2-way ANOVA. Abbreviations; CHx, Charybdotoxin, APA; 
Apamin. 
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4.3.10 Small and intermediate calcium activated potassium channels have an 
increased role in relaxation of small mesenteric arteries from Tst-/- 
mice 
Incubation with apamin and charybdotoxin revealed a difference in the contribution of small 
and intermediate potassium channels to ACh induced relaxation in small mesenteric arteries 
(Figure 4-12). The ACh IC50 was significantly increased by apamin and charybdotoxin in 
mesenteric arteries of Tst-/- mice compared to WT (Figure 4-12, Table 4-4). While the 
maximum response to ACh was reduced by apamin and charybdotoxin in mesenteric vessels 
from Tst-/- mice (Figure 4-12, Table 4-4, P=0.019), this was unaffected in mesenteric vessels 
from control mice (Appendix 5).  
 
In the presence of apamin and charybdotoxin there was evidence of a leftward shift of the 
SNP dose response curve in mesenteric vessels from Tst-/- mice compared to WT (Figure 
4-13). However, whist SNP IC50 values tended to be lower in treated Tst-/- compared to 
treated WT vessels, these were not statistically different in the small sample groups (n=3/ 




















































Figure 4-12 SKCa and IKCa channels mediate the relaxant response to ACh to a greater 
extent in Tst-/- mesenteric arteries  
A) Cumulative concentration response to ACh in endothelial intact mesenteric rings of wild 
type and Tst-/- mice when pre-treated with apamin (SKCa inhibitor) and charybdotoxin (IKCa 
inhibitor) (WT; n=5, Tst-/-; n=3). B) Comparative response to ACh in mesenteric vessels of 
Tst-/- mice when incubated with or without apamin and charybdotoxin (Non-treated; Tst-/-; 
n=6, Tst-/- [+] CHx/ APA; Tst-/-; n=3). Vessel response to ACh was expressed as percentage 
of vessel pre-constriction. Values are mean±SEM, analysed by 2-way ANOVA with 
Bonferroni post-hoc test. *p < 0.05, ***p<0.001.   




































   



































WT [+] CHx/ APA
Tst-/- [+] CHx/ APA
Tst-/-































Figure 4-13 SKCa and IKCa mediate the relaxant response to SNP to a greater extent in 
Tst-/- mice  
Cumulative concentration response to SNP in endothelial intact mesenteric rings of wild type 
and Tst-/- mice when pre-treated with apamin (SKCa inhibitor) and charybdotoxin (IKCa 
inhibitor) (n=3/ group). Vessel response to SNP was expressed as percentage of vessel pre-
constriction. Values are mean±SEM, analysed by 2-way ANOVA with Bonferroni post-hoc 
test. **p < 0.01
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Table 4-4 Intra-group analyses of the contractile or relaxant response in the mesenteric arteries of Tst-/- mice pre-treated with and without 
Apamin and Charybdotoxin  
The IC50 and Emax (maximal constriction/ relaxation) were calculated for the contractile response to PE or relaxant response to ACh in endothelium 
intact aorta isolated from WT and Tst-/- mice pre-incubated with [+] or without [-] apamin and charybdotoxin. Data are mean ± SEM analysed by 2way 
non-repeated measures ANOVA. *p<0.05 when comparing between genotypes of same treatment. $p<0.05 when comparing within genotype of treated 
versus non-treated vessels. Abbreviations; CHx, Charybdotoxin, APA; Apamin 
  WT Tst -/- 
   [-] CHx/ APA  [+] CHx/ APA  [-] CHx/ APA  [+] CHx/ APA 
 n 8 7 8 5 
PE  -logIC50 (M) 5.87 ± 0.12 6.01 ± 0.08 5.96 ± 0.14 6.13 ± 0.15 
 Emax (% KPSS) 90.36 ± 3.62 93.21 ± 3.65 99.58 ± 5.08 98.52 ± 1.99 
      
 n 7 5 6 3 
ACh  -logIC50 (M) 7.5 ± 0.21 7.3 ± 0.09 6.68 ± 0.21* 6.34 ± 0.44* 
 Emax (% Relaxation) 85.01 ± 4.07 78.09 ± 6.64 84.52 ± 3.53 64.58 ± 6.67$ 
      
 n 3 3 6 3 
SNP -logIC50 (M) 8.12 ± 0.26 7.92 ± 0.12 8.10 ± 0.26 8.62 ± 0.53 





The vasorelaxant and blood pressure lowering effects of H2S are well documented (Geng, 
Yang et al., 2004b; Yang et al., 2008; Zhao et al., 2001). Circulating H2S levels were found 
to be increased in Tst-/- mice (Chapter 3) and it was hypothesised that blood pressure would 
be reduced in these mice. Surprisingly this was not the case. However multiple alterations in 
the vascular and renal mechanisms regulating blood pressure have been identified in mice 
lacking TST, supporting a role for this pathway in the global control of blood pressure.  
 
Blood pressure is regulated in part by peripheral resistance but the primary mechanism for 
long-term blood pressure regulation is through regulation of electrolyte-fluid homeostasis by 
the kidney. The kidneys tightly regulate sodium reabsorption via several sodium exchangers 
along the nephron, thus determining the volume of water to be reabsorbed to maintain 
plasma osmolality. Whilst several studies have shown that H2S reduces blood pressure via 
vasorelaxation, few studies have investigated the role of electrolyte-fluid handling in the 
kidney.  
 
TST plays a role in electrolyte-fluid handling in the kidney  
The H2S synthesising enzymes, CSE, CBS and 3MST have all been localised to the proximal 
convoluted tubule (PCT), the site for the majority of electrolyte and fluid reabsorption within 
the nephron (Nagahara et al., 1998; Yamamoto et al., 2012). Acute administration of NaHS 
or the H2S synthetic enzyme substrate, L-cysteine to the left renal artery of rats dose 
dependently increased glomerular filtrate rate, urinary flow rate and urinary excretion of 
sodium and potassium but had no effect on urinary pH or mean arterial blood pressure (Xia 
et al., 2009). Administration of the CBS or CSE inhibitors, AOAA or PPG to the left renal 
artery dose dependently decreases electrolyte and fluid loss (Xia et al., 2009) showing that 
endogenous H2S plays a role in tubular electrolyte-fluid handling. Although mean arterial 
blood pressure was not affected by tubular sodium and water losses, these studies were 
performed acutely and it is likely compensatory regulatory channels were acutely activated 
to maintain normotension. TST is highly expressed in the kidneys (Sylvester et al., 1990) 
and has been localised to the renal PCT, but not the distal convoluted tubule (Sylvester et al., 
1990). In Tst-/- kidneys, protein levels of CSE and CBS are higher whilst mRNA levels of 
Sqr-dl, Ethe1 and Suox tend to be lower than in WT mice (see section 3.3.6.1). The rate of 
H2S breakdown is decreased by 50% in liver of Tst
-/- mice. Although H2S breakdown assays 
were not performed on kidney samples of Tst-/- mice, it is expected that the rate of H2S 




murine kidney and liver tissues (Nagahara et al., 1998). Furthermore, Tst-/- mice have 
increased levels of circulating H2S, and kidney CSE expression indicating local H2S 
generation was also increased (see section 3.3.6.3 and 3.3.10). Together these data suggest 
that Tst-/- kidneys are exposed to higher levels of circulating and endogenous H2S, which 
may not be efficiently catabolised. In the current study, metabolic cage experiments showed 
that Tst-/- mice are polydipsic, polyuric and excrete more sodium, potassium, chloride in their 
urine compared to wild type controls. The observed natriuretic and diuretic data are 
consistent with findings from Xia and colleagues (Xia et al., 2009) and indicates that TST 
contributes to regulation of tubular electrolyte fluid handling, likely via regulation of H2S 
availability in the PCT.  
 
The Na+/ K+-ATPase pump is present in the basolateral membranes of PCT, TALH and the 
distal convolute tubules (DCT) and is critical in producing the electrochemical gradient 
necessary for the active movement of electrolytes from the filtrate into the cell (as outlined 
in section 1.1.5.3)(Amirlak et al., 2000). Water reabsorption via AQP1 and 7 channels are 
dependent on this process. Inhibition of the Na+/ K+-ATPase with Ouabain or Bufalin, 
reduces Na+/ K+-ATPase activity and increases glomerular filtrate rate (GFR) and urinary 
sodium and potassium excretion in isolated perfused rat kidneys (Arnaud-Batista et al., 
2012; Cherniavsky-Lev et al., 2014). In vitro studies performed on isolated renal basolateral 
membranes from rats showed that NaHS dose dependently reduced Na+/ K+-ATPase activity 
with 19% inhibition observed with 1μM NaHS treatment (Xia et al., 2009). Inhibition of the 
Na+/ K+-ATPase activity with NaHS occurs via internalisation of the pump from the 
membrane to the cytosol (Ge et al., 2014). Indeed, reduced Na+/ K+-ATPase activity in the 
PCT would explain why sodium, phosphate, potassium, calcium and water excretion is 
higher in Tst-/- mice. Localisation of TST at the PCT (Sylvester et al., 1990) indicates that 
such inhibitory actions would be tightly regulated by H2S breakdown. However in Tst
-/-mice, 
high circulating H2S levels, locally elevated H2S production by CSE and reduced H2S 
breakdown in the kidney may inhibit Na+/ K+-ATPase activity in the PCT and impair 
reabsorption of electrolyte and water. Future studies should investigate Na+/ K+-ATPase 
activity in isolated basolateral membranes from Tst-/- kidneys. Additionally, microperfusion 
studies are required to confirm if sodium handling is impaired in the PCT of Tst-/- mice. As 
the Na+/ K+-ATPase pump is also present in the TALH and DCT, which are responsible for 
20-25% of NaCl reabsorption from filtrate (Mullins et al., 2006), it seems possible that 
increased H2S in filtrate of Tst
-/- mice may also reduce reabsorption at these regions of the 




malreabsorption in the PCT is not effectively compensated downstream. More in-depth 
examination of these regions using microperfusion techniques is warranted.  
 
Sodium and water losses decrease extracellular fluid volume, which acutely activate several 
neurohormonal systems to increase vascular tone and enhance reabsorption of sodium and 
water in the kidney (McKinley et al., 2004). The renin angiotensin aldosterone system 
(RAAS) is acutely activated and vasopressin released to reabsorb more sodium and water 
along the nephron (Mullins et al., 2006). However, the brain eventually corrects for sodium 
and water deficits by changes in behaviour, namely by increased ingestion of sodium (i.e. 
salt appetite) and the stimulation of thirst (McKinley et al., 2004). Osmoreceptors in the 
brain and neural inputs from cardiac baroreceptors detect small changes in plasma osmolality 
and hypovolemia respectively and are actively engaged with the central nervous system to 
maintain blood volume and osmolality through behaviour change (McKinley et al., 2004). 
Tst-/- mice compensate for electrolyte and water losses by increasing food intake (Appendix 
2) and water intake to remain in electrolyte and water balance indicating that their behaviour 
has been altered to offset losses in the kidney. Plasma renin concentrations were comparable 
between groups (Appendix 3) suggesting that sodium and water losses had occurred for 
extended periods of time. In a separate study performed by Clare McFadden in the Morton 
lab, Tst-/- mice also drank more water than wild type controls when singly housed in regular 
cages for an 8-day period, confirming the polydipsic phenotype (unpublished data, Appendix 
4). As the RM1 diet not only contains sodium but all necessary electrolytes required, 
increased appetite in Tst-/- mice restored sodium, potassium and chloride balance. Due to 
time restraints, neither aldosterone nor vasopressin have been measured in Tst-/- mice and 
should be performed in future. 
 
Tst-/- mice have altered eNOS expression in aorta   
Small resistance arteries play a significant role in the development of hypertension (Intengan 
et al., 2000). Impaired endothelium-dependent relaxation in small resistance arteries and 
arterioles reduces the lumen diameter leading to increased peripheral resistance and blood 
pressure (Intengan et al., 2000). The aorta is a large conductance artery and therefore makes 
little contribution to peripheral resistance or blood pressure maintenance. However, the 
isolated aorta provides a good model for characterisation of endothelial function, in 
particular where this is focused on nitric oxide (NO), as this gasotransmitter is an important 
mediator of aortic relaxation. In the present study, the aorta was selected to permit 




cyclooxygenase (COX) dependent, H2S has previously been shown to account for up to 25% 
of vasorelaxation in endothelium intact murine aorta (Hosoki et al., 1997).  
 
The current study showed that Tst-/- mice have increased P-eNOSSer1177 protein expression but 
no difference in total eNOS expression in naïve aortas compared to controls, suggesting 
increased bioavailability of NO. These data are reminiscent of those recently reported in the 
myocardium of CSE knockout (Cse-/-) mice that have reduced H2S availability. The 
myocardium of Cse-/- mice was reported to have reduced myocardial P-eNOSSer1177 but total 
eNOS protein comparable to wild type controls (King et al., 2014). This was accompanied 
by reduced levels of cardiac and plasma NO metabolites. Furthermore, administration of H2S 
donors to Cse-/- mice increased myocardial P-eNOSSer1177 and NO availability compared to 
vehicle treated mice but also had no effect on total eNOS protein expression (King et al., 
2014). These data indicate that eNOS activity (P-eNOSSer1177) rather than eNOS abundance 
per se is targeted by H2S to alter NO availability. However it remains unclear how H2S 
increases eNOS activity and NO availability and is an active area of research within the 
field. NO bioavailability was not directly measured in the present study but together the data 
would suggest that it would be increased in vessels from Tst-/- mice, secondary to increased 
H2S availability. H2S availability could be influenced by increased circulating H2S levels in 
Tst-/-mice, but also by locally reduced H2S breakdown in the endothelium. TST is expressed 
in whole aorta homogenates and in isolated CD31+ endothelial cells from aorta and small 
intramuscular vessels of the murine hind limb of C57BL/6J mice (Chapter 3). These data 
support a role for TST as an indirect regulator of eNOS activity via reduced H2S breakdown 
and helps explain why P-eNOSSer1177 is increased in aortas from Tst-/- mice. 
 
In functional myography studies, loss of TST had no direct impact upon PE-induced 
vasoconstriction, which was also found by Matt Gibbins in the Morton group (unpublished 
data). However, importantly, inhibition of nitric oxide synthase by L-NAME and 
indomethacin revealed a potentially increased contribution of NO and/or COX metabolites to 
regulation of contraction in arteries from Tst-/- mice. These data may indicate that NO 
availability is higher in Tst-/-aortas, consistent with increased P-eNOSSer1177 findings. Due to 
time constraints, the current study did not measure the H2S content or expression of H2S 
synthetic enzymes in Tst-/- aortas and as such, it is unknown what contribution these may 
have made to the observed outcomes. Further studies should assess H2S production and the 




The data presented here provide further evidence for significant tissue specific crosstalk 
between H2S and eNOS, which is likely influenced by TST-mediated H2S breakdown within 
the aortic endothelium. As previous reports have localised CSE in the endothelium of the 
aorta, it is likely that TST’s primary role in this cell type is to prevent locally produced H2S 
or circulating H2S from inhibiting mitochondrial respiration. Future studies should measure 
the rate of H2S breakdown in isolated aortic endothelial cells from Tst
-/- mice.  
 
Tst-/- mice have mild endothelial dysfunction in small mesenteric arteries  
Resistance in small arterioles plays a major role in blood pressure maintenance (Intengan et 
al., 2000). Relaxation of the mesenteric arteries involves H2S and is largely NO and COX 
independent (Mustafa et al., 2011). H2S is released in these arteries in response to 
mobilisation of intracellular Ca2+ by ACh, causing calmodulin activation and stimulation of 
Ca2+ -calmodulin sensitive CSE (Yang et al., 2008). ACh-induced H2S generation causes 
hyperpolarisation of endothelial cells by activating of small and intermediate calcium 
activated potassium channels (SKCa and IKCa) channels and also activates ATP-sensitive 
potassium (KATP) channels in vascular smooth muscle causing vasorelaxation in mesenteric 
arteries of mice (as outlined in section 1.1.5.5, Figure 1.7) (Mustafa et al., 2011; Paul et al., 
2012). Inhibition of SKCa and IKCa channels with apamin and charybdotoxin attenuates 
hyperpolarisation in isolated aortic endothelial cells of mice and partially reduces NaHS 
mediated vasorelaxation in isolated mesenteric arteries (Mustafa et al., 2011). In endothelial 
cells isolated from aorta of Cse-/- mice, ACh-mediated hyperpolarisation is abolished and is 
associated with reduced H2S-mediated activation of SKCa and IKCa channels in endothelium, 
contributing to their vascular dysfunction and hypertension (Mustafa et al., 2011). Studies 
with apamin and charybdotoxin in the present study reveal an enhanced contribution of the 
SKCa and IKCa channels to relaxation in small arteries from Tst
-/-mice, potentially caused by 
increased local H2S availability. TST is expressed in endothelial cells of small intramuscular 
vessels of the hindlimb suggesting that enhanced SKCa and IKCa channel activation in small 
mesenteric arteries of Tst-/-mice is indirectly caused by reduced H2S breakdown in the 
endothelium. However, maximal relaxation to ACh in these arteries was not enhanced and 
sensitivity was, if anything, reduced. Further compensatory mechanisms may therefore be 
engaged in these arteries and this merits further investigation.  
 
As H2S-induced SKCa and IKCa channel activation only constitutes 10-20% of total NaHS 
mediated vasorelaxation in rat mesenteric arteries (Mustafa et al., 2011), the answer likely 




vascular smooth muscle cells mediates ≈70% of NaHS- induced vasorelaxation in 
mesenteric arteries (Mustafa et al., 2011). Upon cholinergic stimulation, CSE-produced H2S 
diffuses to smooth muscle and activates KATP channels, permitting potassium entry into the 
cell causing smooth muscle relaxation and vasodilatation (as detailed in section 1.1.10, 
Figure 1.7). Administration of the KATP channel blocker glibenclamide attenuates NaHS-
mediated vasorelaxation (Mustafa et al., 2011; Zhao et al., 2001). Reduced H2S levels in 
Cse-/- mice prevents KATP channel opening and is thought to underlie the majority of their 
vascular dysfunction and hypertension (Mustafa et al., 2011). KATP channel inhibitor studies 
were attempted on wild type and Tst-/-mesenteric arteries in the present study. However, pre-
incubation with glibenclamide (dissolved in 0.1 and 0.01% DMSO in PSS) prevented stable 
PE pre-constrictions at EC80 and spontaneous relaxations meant that neither ACh nor SNP 
curves could not be performed. Unfortunately it was not possible to optimise this protocol 
within the time available for the resent study. However, as the maximal response to ACh is 
comparable between non-treated WT and Tst-/-mesenteric arteries, it is expected that KATP 
channels are not affected in this model.  
NO and COX mediate ≈10% of the maximal response to ACh in small mesenteric 
arteries. Whilst responses to SNP were comparable between non-treated WT and Tst-/-
mesenteric vessels, sensitivity to SNP was enhanced in Tst-/-vessels when pre-treated with 
apamin and charybdotoxin. These data may indicate an increase in the sensitivity of 
guanylate cyclase that could have resulted from a change in its activation by endogenous 
NO. These mechanisms and the role of H2S-NO crosstalk require further investigation. H2S 
has also been shown to activate Kv7 voltage activated potassium channels in arterial smooth 
muscle of rat aortic rings (Martelli et al., 2013). Whilst outside the scope of the current 
study, it is possible that these channels are responsible for the observed mild endothelial 
dysfunctional phenotype in Tst-/-mesenteric vessels and this should also be examined in the 
future. Additionally, its possible that the high circulating H2S concentrations found in Tst
-/- 
mice harms the endothelium and lack of TST in endothelium prevents efficient H2S removal. 
Electron microscopy should be performed on isolated small mesenteric arteries and 
resistance arterioles to investigate if the structure of the endothelium is damaged.  
 
Despite the severe endothelial dysfunction observed in mesenteric arteries of Cse-/- mice 
(<25% maximal response to methacholine), systolic blood pressure is only increased by 15-
20mmHg compared to controls. These data indicate that modulation of other regulatory 






The results presented here suggest that TST plays a relatively minor role in regulating 
vascular function, likely via modulation of H2S availability and cross talk with NO. In the 
aorta the contribution of NO appears to be enhanced in mice lacking TST, potentially 
through reduced H2S breakdown in the endothelium. In small mesenteric arteries, there is 
mild endothelial dysfunction and sensitivity to NO is enhanced through a mechanism that 
may involve activation of endothelial K+ channels, but this remains to be defined. These 
effects may be due to reduced H2S breakdown by TST in the endothelium, but could also be 
secondary to increased circulating H2S or to changes in local H2S production. Higher levels 
of H2S may cause direct cytotoxicity and endothelial damage. Meanwhile, increased water 
and electrolyte excretion in Tst-/- mice suggest that TST is involved in tubular function, 
especially within the PCT and possibly the TALH. TST may therefore be a potential future 
diuretic drug target but in depth ex vivo and in vivo studies are required to accurately localise 





5 Response of mice with global deletion of Tst to in vivo and 
ex vivo models of Myocardial Infarction 
 
5.1 Introduction  
Experiments in Chapter 3 have shown that TST is expressed in the smooth muscle of the 
cardiac vasculature and within cardiomyocytes. Global deletion of the Tst gene had no 
impact on basal cardiac function, structure or mitochondrial function under physiological 
conditions. In the Tst-/- mouse heart, H2S breakdown rates were reduced by approximately 
20% and circulating H2S levels were approximately 7-fold higher in Tst
-/- mice. In heart 
tissue, protein levels of the H2S-activated nuclear factor-E2-related factor (Nrf2) downstream 
targets, thioredoxin (TRX1) and heme oxygenase-1 (HO-1) were comparable between 
groups. Importantly, protein levels for the cardiac specific H2S-synthetic enzyme, 
cystathionine gamma lyase (CSE) were reduced in the Tst-/- heart, suggesting a homeostatic 
negative feedback mechanism to maintain myocardial H2S bioavailability at non-toxic levels. 
Total endothelial nitric oxide (eNOS) protein levels were reduced in the hearts of Tst-/- mice 
identifying a cross talk between H2S and nitric oxide (NO) signalling that has been observed 
by others (King et al., 2014). Experiments in chapter 4 showed that Tst-/- mice were 
normotensive despite altered sodium-fluid handling in the kidney and mild endothelial 
dysfunction in the small mesenteric arteries. Currently, little is known about the expression 
pattern of the Tst gene or its role in H2S bioavailability under pathophysiological conditions 
such as myocardial infarction (MI).  
 
Initial infarct size due to ischaemic injury and the subsequent infarct healing response are 
both integral determinants of cardiac functional outcome and the degree of cardiac 
remodelling after MI. Reperfusion therapies reduce infarct size and mortality rates from 
acute MI, but reperfusion itself causes irreversible injury to cardiomyocytes (Yellon et al., 
2007) so that cardiac dysfunction and subsequent heart failure are still evident when patients 
are followed up at 5 years post-MI (Velagaleti et al., 2008). The pathogenesis of permanent 
ligation and reperfusion injury are well characterised and covered in section 1.1.6.1. 
 
Although H2S donor therapy is effective in reducing infarct size following permanent 
coronary artery ligation (CAL) (Zhang et al., 2014; Zhu et al., 2006), the majority of 
research investigates the cardioprotective effects of H2S using IRI models of MI. Due to the 
different aetiologies of injury and healing caused by CAL and IRI, many facets of the 




pharmacological H2S donors at the time of reperfusion can reduce infarct size and improve 
ejection fraction in mice when assessed at 3 days after IRI (Elrod et al., 2007). The 
cardioprotective profile of H2S in IRI models operates via several mechanisms including; 
preserved mitochondrial function (Elrod et al., 2007), stimulation of anti-oxidant and anti-
apoptotic gene transcription (Calvert et al., 2009) and reduced leukocyte infiltration (Elrod et 
al., 2007). Administration of the H2S donor Na2S to mice increases expression of the 
antioxidant transcription factor, nuclear receptor factor-E2-related factor (Nrf2) and its 
downstream targets, thioredoxin (Trx1) and heme-oxygenase 1 (HO-1) (Calvert et al.,, 2009) 
by 24hours. This response alleviates damage associated with reperfusion-induced oxidant 
stress generation. Although single-dose administration of H2S can reduce injury acutely 
when given shortly before and/ or at the time of reperfusion (Elrod et al., 2007; Johansen et 
al., 2006), single doses fail to protect against cardiac dysfunction and ventricular 
remodelling by 4 weeks after IRI (Calvert et al., 2010). However, H2S donor treatment 
administered at reperfusion and then daily for 7 days after IRI increases Nrf2 expression by 
7 days and improves cardiac outcome by 4 weeks after IRI (Calvert et al., 2010) suggesting 
that early and sustained delivery of H2S during the first week after injury is essential for 
long-term protection. Mice with cardiomyocyte-specific overexpression of the H2S synthetic 
enzyme CSE (αMHC-CGL-Tg) produce more H2S and have increased basal expression of 
the H2S-sensitive Nrf2, Trx1 and HO-1 in the heart (Calvert et al., 2009). At 72 hours post 
IRI, αMHC-CGL-Tg mice have reduced infarct size (Elrod et al., 2007) and by 4 weeks after 
IRI have improved cardiac outcomes compared to wild type controls (Calvert et al., 2010). 
However, by 7 days after CAL, 30% of αMHC-CGL-Tg mice die and by 4 weeks post-CAL, 
cardiac function is not improved compared to controls (Calvert et al., 2010) indicating that 
the effects of H2S in different MI models are more complex than previously thought. 
Therefore, investigation of when and to what extent the heart regulates CSE and other H2S 
metabolic enzymes in the infarcted myocardium within 7 days after CAL is warranted.  
 
Leukocyte infiltration is considered harmful in acute IRI but is vital in the process of healing 
in mouse models of permanent ligation. The stages of leukocyte infiltration are well defined 
and highlighted in section 1.1.6.4. Infarct healing after injury is orchestrated by infiltrating 
neutrophils, monocyte subsets (Ly6Chigh and Ly6Clow) and the macrophages derived from 
them which all respond to different chemokine signals released from the injured myocardium 
during the early and late healing phases (Nahrendorf et al., 2010). Leukocytes remove dead 
cardiomyocytes and initiate the process that results in formation of a collagen rich scar to 




recruitment is vital for myocardial repair (Dewald et al., 2005), excessive early neutrophil 
and Ly6Chigh monocyte recruitment can destabilise the repair process and lead to cardiac 
rupture (Frangogiannis, 2012). 
H2S has anti-inflammatory actions. H2S treatment reduces leukocyte infiltration and pro-
inflammatory cytokine expression following IRI (Elrod et al., 2007) but it is unclear if this 
effect is secondary to reduced myocardial damage. Intravital microscopy experiments 
showed that H2S dose-dependently inhibited aspirin-induced leukocyte adherence in 
mesenteric venules of rats in a KATP channel-dependent manner (Sivarajah et al., 2006). 
Furthermore, in models of inflammation such as carrageenan-induced paw oedema or air 
pouch inflammation, H2S treatment reduced leukocyte infiltration and oedema, which was 
abrogated in rats pre-treated with the CSE or KATP channel inhibitors, β-cyano-l-alanine 
(BCA) and glibenclamide respectively (Sivarajah et al., 2006). These data suggested that 
vascular CSE mediated H2S production reduced leukocyte adhesion via KATP channel 
activation (Zanardo et al., 2006). As leukocyte recruitment is an essential element of infarct 
healing following CAL, it seems unlikely the heart would endogenously produce H2S during 
the infarct-healing phase, which would otherwise limit leukocyte infiltration and hamper 
necrotic tissue removal and stable scar formation.  
 
The experiments in this chapter were designed to investigate the regulation of TST and the 
H2S synthetic enzymes CSE and 3-mercaptopyruvate sulfurtransferase (3MST) following 
permanent coronary artery ligation. Using in vivo and ex vivo MI models, this chapter aimed 
to establish TSTs role in the response of the heart to ischaemia and how it regulates infarct 








5.2 Methods  
5.2.1 In vivo coronary artery ligation 
Male C57BL/6N wild type or Tst-/- mice aged 18-20 weeks were used for in vivo myocardial 
infarction experiments. Mice underwent permanent coronary artery ligation (CAL) for 
induction of myocardial infarction, with un-operated mice serving as baseline controls as 
described in section 2.2.3. Surgery was conducted by Dr Katie Mylonas and by Xiaofeng 
Zhao. Mice were checked daily following CAL surgery and any deaths recorded. Post-mortem 
analysis was carried out on dead mice to establish the cause of death. Cardiac rupture was 
identified as cause of death when the chest cavity was filled with blood.  
 
Study one 
Heart tissue was collected from naïve adult male C57BL/6J mice or from C57BL/6J mice at 
1 day, 2 days or 7 days after CAL surgery for analysis of gene expression by qRT-PCR and 
protein expression by western blotting. Infarct and infarct border zone tissue was dissected 
from the left ventricular free wall below the ligature for RNA extraction and for protein 
extraction as detailed in section 2.5.1 and 2.5.4 respectively. Taqman probes for H2S 
metabolic enzymes were used to assess changes in gene expression at the timepoints 
indicated above. For full details of Taqman probes, please refer to Table 1-4, section 2.5.3.  
For western blotting experiments, an equal amount of myocardial infarct and border 
zone protein was loaded into SDS gels for electrophoresis, transferred onto nitrocellulose 
membranes and incubated with antibodies for CSE and 3MST. For full details of the 
procedure, please refer to section 2.5.6. 
 
Study two 
Tst-/- mice and wild type littermates underwent CAL surgery. Cardiac size and function were 
evaluated in surviving mice by echocardiography 7 days after coronary artery ligation surgery 
as described in section 2.2.2. Adrian Thomson performed echocardiography scanning. Cardiac 
dimensional and functional measurements were analysed in a single blinded fashion. 
Following echocardiography, mice were anaesthetised and perfusion fixed with formalin as 
described in section 2.4.2. Perfusions were carried out by Dr Katie Mylonas and by Xiaofeng 
Zhao. The hearts were dissected, fixed for 24hours in 10% formalin and processed for 
histology. Infarct scar characteristics and collagen deposition were assessed in heart sections 
stained with Massons Trichrome and Picrosirius Red. Staining was performed by Deborah 




collagen deposition was carried out on Stereologer Analyser 3 using CapturePro5 software. 
Further details are discussed in section 2.4.8.  
 
Study three 
Blood was withdrawn (30μl blood: 30μl 3.2% citrate) from the tail vein in conscious 
Tst-/- and wild type control mice at 2 days post MI to measure leukocyte mobilisation of 
monocytes and neutrophils, using flow cytometry. Blood samples were incubated with 
antibodies against CD11b, Ly6C and Ly6G at 1:50 dilution and the red blood cells lysed as 
described in section 2.5.8. Cells were incubated with counting beads (50,000 beads/ μl) 
immediately before samples were run in the LSR Fortessa. Samples were run until 5000 
counting bead events were detected. The gating strategy to identify circulating leukocyte 
populations is detailed in Figure 2-6, section 2.5.8.1.  
Immediately following blood withdrawal, wild type and Tst-/- mice were put under terminal 
anaesthesia, perfused with PBS and the hearts were removed to investigate leukocyte 
recruitment by flow cytometry. Dr. Katie Mylonas performed the perfusions. All left 
ventricular free wall tissue below ligature was dissected, placed in collagenase disassociation 
solution and cells dissociated as detailed in section 2.5.8.2. Cells were incubated with 
antibodies; CD45, CD11b, Ly6G, Ly6C at 1:50 dilution. Cells were incubated with DAPI 
(1:1000 dilution) and counting beads (50,000 beads/ μl) immediately before samples were 
run in the LSR Fortessa. Samples were run until 30,000 counting bead events were detected. 
The gating strategy to identify infiltrated leukocyte populations is detailed in Figure 2-7, 
section 2.5.8.2.  
 
Study four 
Heart tissue was collected from wild type and Tst-/- mice at 4hours and 2 days after CAL 
surgery for analysis of gene expression by qRT-PCR and protein expression by western 
blotting. Mice were perfused with PBS by Dr. Katie Mylonas and all the left ventricular free 
wall below the ligature was dissected and cut into 2 pieces – one half was used for RNA 
extraction and the other for protein extraction as described in section 2.5.1 and 2.5.4 
respectively. Taqman probes for inflammatory chemoattractant and adhesion molecules were 
used to assess changes in gene expression at 2 days post-CAL. For full details of Taqman 
probes, please refer to Table 2-4, section 2.5.3.  
For western blotting experiments, equal amounts of infarcted cardiac protein was 




incubated with antibodies for CSE, 3MST, TRX1 and HO-1. For full details of the 
procedure, please refer to section 2.5.6. 
 
5.2.2 Ex vivo ischaemia and reperfusion in buffer perfused heart 
Hearts were quickly isolated from male wild type or Tst-/- mice aged 12-13 weeks for ex vivo 
perfusion in Langendorff mode as detailed in section 2.3.1. Ischaemia was induced for 30 
minutes followed by 2hours reperfusion. Upon completion of the ex vivo IRI protocol, the 
ligature was re-tied and Evans blue solution (1% w/v in 0.9% saline) was perfused into the 
heart to identify the area at risk and the heart washed in 0.9% saline to remove excess Evans 
Blue stain. All myocardium above the ligature was discarded and the hearts then frozen at -
200C for subsequent analysis of infarct size by 2, 3, 5-triphenyltetrazolium chloride staining 
as detailed in section 2.3.2. These experiments were conducted in collaboration with Emma 
Batchen. 
 
5.2.3 In vitro mitochondrial ischaemia reperfusion injury 
Mitochondria were isolated from two pooled hearts of wild type or Tst -/- male mice aged 14-
16 weeks as described in section 2.3.5. Mitochondria were placed into a closed chambered 
Oroboros oxygraph and exposed to excess substrate and ADP to stimulate maximal 
respiration as detailed in section 2.3.6. Basal O2 respiratory rate was calculated during the 
linear phase of O2 consumption. Ischaemia was considered initiated when mitochondria 
consumed all O2 within the chamber. Following a 20 minute ischaemic period, the chamber 
was opened to ambient O2 to simulate reperfusion injury. Upon stable O2 equilibrium within 
the chamber, the chamber was re-sealed and ischaemic respiratory recovery rate calculated 
as post ischaemic respiratory rate as percentage of pre-ischaemic respiratory rate.  
 
5.2.4 Statistical Analysis 
All values presented are as mean±SEM. Analysis of survival was performed using a Chi 
squared test. Unless otherwise stated, comparisons are by unpaired two-tailed Student t-test.  
1-way ANOVA followed by post-hoc analysis using Tukeys Multiple Comparison test was 
performed on PCR results for the H2S metabolic genes at various timepoints during the 








5.3 Results  
 
5.3.1 H2S metabolic enzyme mRNA level is dynamically regulated in the 
early infarct healing phase 
Quantitative real-time PCR analysis revealed that Cth mRNA was downregulated in infarct 
border zone of C57BL/6J hearts by day 1 (Figure 5-1) and day 2 post-CAL (Figure 5-1) 
compared to naïve controls but recovered to baseline levels by day 7 (Figure 5-1). Mpst 
mRNA expression was also downregulated in C57BL/6J hearts by day 1 and day 2 post-
CAL (Figure 5-1) but remained significantly lower by day 7 (Figure 5-1). Western blots 
performed on separate myocardial infarct tissue samples confirm that cardiac CSE and 
3MST protein are significantly lower by day 2 post-CAL (Figure 5-2). In comparison, Sqrdl, 
Ethe1, Tst and Suox mRNA are markedly upregulated in C57BL/6J hearts (TST upregulated 
≈12-fold) by day 2 post-CAL (Figure 5-1) and returned to baseline levels by day 7. No 
differences were observed in cardiac expression of housekeeping genes at any timepoint 














































Figure 5-1 Cardiac mRNA expression of H2S metabolic enzymes is regulated during 
early infarct healing phase to limit H2S bioavailability 
A) Quantitative real time PCR analysis measuring mRNA levels of H2S synthetic enzymes, 
Cth and Mpst (A) and H2S breakdown enzymes, Sqrdl, Ethe1, Tst and Suox (B) in naïve 
C57BL/6J hearts and in myocardial infarct and infarct border zone tissue of C57BL/6J mice 
at 1, 2 and 7 days after coronary artery ligation (CAL) surgery (n=4/ timepoint). All data are 
normalised to the housekeeping genes; Tbp (A) or Cox4i1 (B) and then normalised to 
expression level of naïve controls. Values are expressed as mean±SEM. *p < 0.05, **p < 
0.01, ***P < 0.001 vs. naïve by 1way ANOVA with Tukeys post hoc test. Abbreviations; D1, 
D2, D7 post-CAL; day 1, day 2 or day 7 post coronary artery ligation, Cth; cystathionine 
gamma lyase, Mpst; 3-mercaptopyruvate sulfurtransferase, Sqrdl; sulfide quinone 
oxidoreductase, Ethe1; sulfur dioxygenase, Tst; thiosulfate sulfurtransferase, Suox; sulfide 
















































































































































































































































Figure 5-2 Protein levels of H2S synthetic enzymes are reduced by 2days post-CAL 
Representative immunoblots and densitometric analysis of CSE (A-B) and 3MST (C-D) 
protein levels in naïve and day 2 post-CAL myocardial infarct and infarct border zone tissue 
of C57BL/6N mouse hearts (Naive; n=5, 2day CAL; n=4). Data presented as relative 
intensity of protein expression when normalised to the internal control, β-actin and then 

































































5.3.2 Tst-/- mice have increased mortality and worsened cardiac outcomes 
at 7 days post-CAL  
At 7 days post-CAL, mortality rates were significantly higher in Tst-/- compared to 
C57BL/6N mice (Figure 5-3). Survival rate was 87.5% in C57BL/6N wild type mice and 
50% in Tst-/- mice, and in both groups, death was due to cardiac rupture, evidenced at post-
mortem investigation by blood in the chest cavity. At 7 days after CAL, heart rate was 
comparable between groups (Figure 5-3). LVESA and LVEDA were higher in both groups 
at 7 days post-CAL compared to baseline measurements (Figure 5-3, P < 0.01). Tst-/- mice 
had increased LVESA and LVEDA compared to C57BL/6N wild type mice at 7 days post-
CAL (Figure 5-3). CAL surgery decreased fractional area change (FAC) in both groups 
compared to baseline (Figure 5-3, P < 0.01) whilst fractional shortening (FS) was only 
decreased in the Tst-/- group compared to baseline measurements (Figure 5-3, P < 0.001). By 
7 days after CAL, FAC and FS were reduced in Tst-/- compared to control mice (Figure 5-3). 
 
 
5.3.2.1 Myocardial chemokine and adhesion molecule gene expression is 
normal in Tst-/- mice 
Quantitative real-time PCR analysis revealed that mRNA levels for the monocyte 
chemoattractant protein MCP-1/ Ccl2 and the MCP-1 receptor, Ccr2 tended to be lower in 
infarcted hearts of Tst-/- mice at 2 days post-CAL but were not statistically different (Figure 
5-4). Levels of mRNA for the adhesion molecules Icam1 and Vcam were comparable 






















































Figure 5-3 Loss of TST is detrimental to cardiac outcome by 7 days after CAL surgery 
A) Survival rates following coronary artery ligation, analysed by Chi2 test (n=8/ group). Two-
dimensional B-mode and M-mode ultrasound images and paw electrode signals were 
analysed for (B) heart rate (bpm), (C) LVESA (mm2), (D) LVEDA (mm2), (E) FAC (mm2) and 
(F) FS (%), (WT; n=6, Tst-/-; n=4). Values are expressed as mean±SEM. *p<0.05 WT 7 days 
CAL vs. Tst-/- 7 days CAL by unpaired student t-test. Abbreviations; BPM; beats per minute, 
LVESA; left ventricular-(LV) end systolic area, LVEDA; LV end diastolic area, FAC; fractional 
area change, FS; fractional shortening.   








































































































































Figure 5-4 mRNA levels of chemokine and adhesion molecules is normal in infarcted 
hearts of Tst-/- mice at 2 days post-CAL 
Quantitative real time PCR analysis measuring mRNA levels of the chemokine MCP-1/ Ccl2 
(A), the MCP-1 receptor Ccr2 (B) and adhesion molecules, Icam1 (C) and Vcam D) in 
myocardial infarct and infarct border zone tissue of Tst-/- and C57BL/6N control mice at 2 
days after coronary artery ligation (CAL) surgery (WT; n=4, Tst-/-; n=5). All data are 
normalised to the housekeeping gene Tbp and then normalised to expression level of wild 
type controls. Values are expressed as mean±SEM. Abbreviations; MCP-1/ Ccl2; monocyte 
chemoattractant protein 1, Ccr2; chemokine receptor 2, Icam1; intracellular adhesion 

































































5.3.3 Increased rupture incidence is not due to excessive leukocyte 
recruitment into the damaged heart 
 
At 2 days post-CAL, flow cytometry showed that leukocyte mobilisation in the blood is 
comparable between Tst-/- and C57BL/6N mice (Figure 5-5). Circulating numbers of 
neutrophils, Ly6Chigh and Ly6Clow monocytes were similar in the blood at 2 days post-CAL 
(Figure 5-5). In CAL-operated Tst-/- and wild type littermates, numbers of recruited 
neutrophils, Ly6Chigh and Ly6Clow monocytes to the heart were comparable between groups 




















































Figure 5-5 Loss of TST has no impact on leukocyte mobilisation or recruitment into 
the damaged heart at 2 days post-CAL  
Flow cytometric analysis detailing the numbers of circulating blood A) neutrophils (CD11bhigh/ 
Ly6Ghigh/ Ly6Cintermediate) B) Ly6Chigh monocytes (CD11bhigh/ Ly6Glow/ Ly6Chigh) and C) Ly6Clow 
monocytes (CD11bhigh/ Ly6Glow/ Ly6Clow) in whole blood of Tst-/- and C57BL/6N control mice 
at 2 days following CAL surgery, WT; n=11, Tst-/-; n=9. Flow cytometric analysis of the 
number of D) infiltrated live neutrophils (DAPIlow/ CD45high/ CD11bhigh/ Ly6Ghigh/ 
Ly6Cintermediate), E) Ly6Chigh monocytes (DAPIlow/ CD45high/ CD11bhigh/ Ly6Glow/ Ly6Chigh) and 
F) Ly6Clow monocytes (DAPIlow/ CD45high/ CD11bhigh/ Ly6Glow/ Ly6Clow) in digested hearts of 













































































































































































5.3.4 Macrophage recruitment is similar in surviving mice at 7 days post-
CAL 
At 7 days after surgery, macrophage infiltration, assessed by Mac 2 immunostaining was 
comparable between wild type and Tst-/- mice by day 7 (Figure 5-6). Mac 2 immunostaining 
was observed in the infarct and border zones but not the remote myocardium.  
 
5.3.5 Surviving Tst-/- mice form stable scars and have similar scar areas to 
controls by 7 days post-CAL  
Collagen deposition, assessed by Picrosirius Red staining was comparable between 
C57BL/6N wild type and Tst-/- mice (Figure 5-7). Scar area, evaluated by Massons 
Trichrome staining was similar between groups at 7 days after CAL (Figure 5-7). Infarct 































Figure 5-6 Macrophage staining in the myocardial infarct area is similar between 
groups at 7 days post-CAL 
Representative tiled 7day post-CAL heart section immunostained with anti-Mac2 antibody 
(A). Quantification of Mac2 macrophage staining as percentage of LV (B) in wild type and 


























































































Figure 5-7 Histological analysis reveals similar collagen deposition and fibrosis 
between groups by 7 days after MI 
Representative tiled images of sections stained with Picrosirius Red (A) for collagen 
deposition and Massons Trichrome (B) to stain infarct fibrosis. C) Collagen deposition and, 
D) scar formation as percentage of left ventricle were evaluated from Picrosirius Red and 
Massons Trichrome stained sections. E) Scar thickness was averaged from three points 
across the scar, evaluated from Massons Trichrome stained sections. F) Scar length 
expressed as percentage of the left ventricle in Massons Trichrome stained sections (WT; 





































































5.3.6 Loss of TST leads to dysregulation of H2S synthetic enzyme 
expression at 48hours after CAL 
Cardiac protein expression of the H2S synthetic enzymes, CSE and 3MST were assessed by 
western blotting at 4hrs and 48hrs after CAL. At 4hrs post-CAL, cardiac CSE and 3MST 
protein levels were comparable between wild type and Tst-/- hearts (Figure 5-8). In 
comparison, by 48hrs post-CAL, CSE and 3MST protein levels were significantly 


























Figure 5-8 H2S synthetic enzymes are comparable between groups at 4hours after 
CAL 
Representative immunoblot and densitometric analysis of CSE (A-B) and 3MST (C-D) 
protein levels in myocardial infarct and infarct border zone tissue of Tst-/- and C57BL/6N wild 
type mice at 4hours post-CAL. Data presented as relative intensity of protein expression 
when normalised to the internal control, β-actin and then normalised to level of C57BL/6N 


















































































Figure 5-9 Loss of TST alters the protein expression of H2S synthetic enzymes at 
48hours post-CAL surgery 
Representative immunoblot and densitometric analysis of cardiac CSE (A-B) and cardiac 
3MST (C-D) protein levels in myocardial infarct and infarct border zone tissue of Tst-/- and 
C57BL/6N wild type at 48hours post-CAL. Data presented as relative intensity of protein 
expression when normalised to the internal control, β-actin and then normalised to level of 

















































5.3.7 Nrf2 downstream anti-oxidant proteins are increased in Tst-/- mice at 
48hrs after MI 
Cardiac protein expression of the nuclear receptor factor 2 (Nrf2) regulated downstream anti-
oxidant proteins, thioredoxin (Trx1) and heme-oxygenase-1 (HO-1), were assessed by 
western blotting at 4hrs and 48hrs after CAL. At 4hours after CAL, Trx1 protein appeared to 
be downregulated in Tst-/- hearts compared to controls, but did not reach statistical 
significance (Figure 5-10, P=0.08). By 48hrs post-CAL, Trx1 and HO-1 protein levels were 
significantly upregulated by approximately 10-fold and 40-fold respectively in Tst-/- hearts 
































Figure 5-10 Nrf2 downstream targets TRX1 and HO-1 are higher by 48hours post-CAL  
(A-B) Representative immunoblot and densitometric analysis of TRX1 protein levels in 
myocardial infarct and infarct border zone tissue of Tst-/- and C57BL/6N wild type at 4hours 
post-CAL. (C-D) Representative immunoblot and densitometric analysis of Trx1 and HO-1 
protein levels in myocardial infarct and infarct border zone tissue of Tst-/- and C57BL/6N wild 
type at 48hours post-CAL. Data presented as relative intensity of protein expression when 
normalised to the internal control, β-actin and then normalised to level of C57BL/6N wild type 
controls (WT; n=4, Tst-/-; n=5). Values are expressed as mean±SEM. *p < 0.05. 

















































5.3.8 Tst-/- cardiomyocytes are more susceptible to ex vivo ischaemia 
reperfusion injury 
The area at risk (AAR) was comparable between groups (Figure 5-11, WT; 29.4 ± 6.0, Tst-/-; 
31.8 ± 6.9) indicating that ligature placement around the coronary artery was consistent 
between groups. Infarct size as percentage of AAR was significantly higher in the Tst-/- 
group compared to C57BL/6N wild type controls (WT; 64.6 ± 5.9 vs. Tst-/-; 88.2 ± 2.3, 



























Figure 5-11 Infarct size is significantly increased following ex vivo model of ischaemia 
reperfusion injury 
A) TTC stained area at risk (AAR) expressed as a percentage of the left ventricle. B) TTC 
stained infarct size as a percentage of area at risk. WT; n=5, Tst-/-; n=4. Values are 













































5.3.9 Myocardial mitochondrial respiration is diminished but comparable 
between groups following in vitro ischaemia reperfusion injury 
In vitro ischaemia reperfusion injury (IRI) reduces cardiac mitochondrial oxygen 
consumption when compared to baseline readings (Figure 5-12). Mitochondrial respiratory 
recovery rate was similar between groups following in vitro IRI (Figure 5-12, WT; 70.9% ± 






















Figure 5-12 Isolated Tst-/- cardiac mitochondria show similar response to in vitro 
ischaemia reperfusion insult when compared to controls 
A) Representative mitochondrial respiration trace showing timepoints of substrate 
administration to achieve state 3 respiration; malate (M), succinate (S) and ADP. Figure 
details the onset of ischaemia (ISCH), reperfusion (REP) and when the chamber was closed 
to atmosphere (C). Blue lines represents mitochondrial O2 consumption and red line denotes 
change of respiration with substrate administration or O2 depletion/ reintroduction 
(ischaemia/ reperfusion). Black boxes represent the linear phase of O2 consumption (blue 
line) used for measurements. B) Oxygen consumption rate before and after ischaemia 
reperfusion injury (IRI) when normalised to protein. C) Oxygen consumption rate following 
IRI expressed as a percentage of pre-ischaemic respiration of same genotype and 
normalised to protein. WT; n=5, Tst-/-; n=6, two hearts pooled per n number. Values are 

















































































The aims of the current study were (i) to evaluate how myocardial H2S metabolic enzymes 
respond following coronary artery ligation (CAL) and (ii) to establish whether TST plays a 
role in regulating the response to ischaemia and/or infarct healing. This study showed that 
the heart actively regulates H2S metabolic enzymes during the early and late infarct-healing 
phases and that loss of TST leads to dysregulation of this process. Loss of TST is detrimental 
to the heart, causing increased susceptibility to acute ischaemia and reperfusion injury, 
increased risk of cardiac rupture and enhanced detrimental structural and functional 
remodelling in survivors.  
 
 
Dynamic Regulation of H2S metabolic enzymes 
Considerable cellular damage and cell death occurs in the minutes to hours following the 
onset of ischaemia. The early infarct-healing phase recruits neutrophils and pro-
inflammatory monocyte/macrophages to the site of injury in the hours-days following MI to 
remove dead cardiomyocytes and cellular debris (Frangogiannis, 2012). Anti-inflammatory 
pro-repair monocyte/ macrophages dominate the cellular milieu from day 3-4 post MI 
onwards and initiate angiogenesis within infarcted tissue and form stable scar tissue. H2S 
administration has been repeatedly shown to promote protection in models of acute 
myocardial ischaemia reperfusion injury (IRI) (Elrod et al., 2007; Johansen et al., 2006) and 
myocardial infarction (MI) induced by coronary artery ligation (CAL) (Zhu et al., 2006). 
However, little is known of the extent to which endogenous H2S synthetic and breakdown 
enzymes are regulated in the myocardium following injury.  
 
In the current study, myocardial mRNA levels for the H2S synthetic enzymes, Cth and Mpst 
were reduced during the early infarct healing phase at day 1 and 2 post-CAL, 
correspondingly protein levels were reduced at day 2 post-CAL compared to unoperated 
controls. Conversely, at 2 days post-CAL, myocardial mRNA levels for the H2S breakdown 
enzymes Tst, Sqrdl, Ethe1, Suox levels were all markedly upregulated when compared to 
unoperated controls. Unfortunately insufficient tissue was collected to permit confirmation 
of protein levels in infarcted tissue. H2S donors limit leukocyte recruitment to the heart 
following IRI or CAL (Elrod et al., 2007; Zhang et al., 2014). At 24hours post-CAL, cardiac 
H2S levels were reported to fall as increased numbers of CD11b+/ Gr-1+ monocytes were 
mobilised into the blood from the spleen and recruited into the infarcted hearts of mice 




2006) in agreement with the present findings. The data presented here and in the literature 
infers that during the early infarct-healing phase, the emphasis is on removal of H2S, rather 
than production and this may help to ensure that inflammatory cells can infiltrate into the 
damaged tissue. TST is expressed in cardiomyocytes, myocardial vascular smooth muscle 
and in endothelial cells of aorta and intramuscular vessels (see sections 3.3.2 - 3.3.4) in a 
similar pattern to CSE, which may contribute to observed changes in expression. It is unclear 
if early pro-inflammatory leukocytes express TST, which may explain the timing of 
increased mRNA expression and should be investigated in future studies. 
 
By 7 days post-CAL, during the second phase of infarct healing, mRNA levels of Cth and 
the H2S breakdown enzymes are normalised relative to unoperated mice, although mRNA 
levels of the minor cardiovascular relevant H2S generating enzyme Mpst remain reduced. 
This is a period of active angiogenesis in the healing myocardium (McSweeney et al., 2010). 
H2S donors have been reported to stimulate angiogenesis following MI via upregulation of 
vascular endothelial growth factor (VEGF) (Qipshidze et al., 2012). In the current study, 
insufficient tissue was available to determine protein levels of the H2S metabolic enzymes or 
cardiac H2S levels at 7 days post-CAL so it was not possible to determine to what extent this 
was regulated during this phase of infarct healing. Together these data demonstrate the 
dynamic nature of H2S metabolism in the infarcted heart during infarct healing phase and 
support a greater importance of TST and the other mitochondrial H2S breakdown enzymes. 
 
Myocardial rupture, infarct healing and structural/functional remodelling  
Cardiac rupture is a fatal complication following MI, which typically occurs at the infarct 
border zone (Gao et al., 2005). In C57BL/6 mice, cardiac rupture peaks at days 3-5 post-
CAL due to ventricular wall thinning and reduced ventricular tensile strength (Gao et al., 
2005). According to the VALIANT trial, 8% of patient deaths within the first 30 days after 
MI were due to cardiac rupture (Shamshad et al., 2010), with rupture incidence peaking 
between 5-10 days following MI. In the current study, the frequency of cardiac rupture is 
approximately 40% higher in Tst-/- mice compared to controls by 5 days post-CAL. 
Surviving Tst-/- mice have greater cardiac dysfunction and dilatation at 7 days post-CAL 
compared to controls. Cardiac function and remodelling following CAL are determined by 
the initial infarct size as well as by the quality of infarct healing. The evidence for changes in 
TST expression, together with detrimental outcomes in Tst-/- mice indicates that TST may 




rupture including, (i) infarct size, (ii) dysregulated leukocyte infiltration and (iii) 
haemodynamic status (Gao et al., 2012). 
 
(i) Infarct size 
Initial infarct size is a key factor determining functional outcome and the extent of 
ventricular remodelling following injury. In C57BL/6J mice, cardiac rupture frequency 
markedly increases when infarct size exceeds 30% of the left ventricle (LV) corresponding 
to reduced ventricular tensile strength (Gao et al., 2005). Early infarct size was not directly 
assessed in the present study in mice with permanent ligation. However, the observation that 
infarct size was increased in isolated perfused hearts from Tst-/- mice subjected to ischaemia 
and reperfusion, without any increase in the area at risk, suggests that the myocardium is 
more susceptible to injury in the absence of TST. 
 
Robust production of H2S from CSE is likely to be important in protection of the heart 
during the first minutes and hours after induction of ischaemia. Indeed, pharmacological 
inhibition of the H2S synthesising enzyme CSE with PAG, administered to rats for 7 days 
prior to CAL, leads to increased infarct size and mortality compared to vehicle treated 
controls (Zhu et al., 2006). Previous findings in this thesis (Chapter 3) show that expression 
of CSE is reduced in Tst-/- hearts under basal conditions (see section 3.3.8), perhaps as a 
result of a homeostatic negative feedback loop to limit H2S production and avoid 
cytotoxicity. Thus reduced initial H2S availability might account for increased injury in Tst
-/- 
mice. In support of this hypothesis, protein levels of the H2S-sensitive Nrf2 downstream 
target TRX1 show a downward trend at 4hours post-CAL in Tst-/- compared to WT hearts. 
Nitric oxide availability is another critical determinant of ischaemic injury (Scherrer-Crosbie 
et al., 2001). Indeed protection of the heart by H2S donors may be dependent upon NO. H2S 
donor administration leads to phosphorylation of the eNOS activation site, phospho-
eNOSS1177. This is associated with increased myocardial NO availability and reduced IRI-
induced damage in CSE-deficient mice (King et al., 2014). Furthermore H2S donor treatment 
has no effect on infarct size when administered to eNOS deficient mice or mice with mutated 
phospho-eNOSS1177, confirming a role for eNOS in H2S-mediated cardioprotection (King et 
al., 2014). It is therefore important to note that hearts from Tst-/- mice also have reduced 
expression of eNOS protein (see section 3.3.11). CSE deficient mice have reduced cardiac 
H2S and NO availability and increased infarct size compared to controls (King et al., 2014), 
highlighting the importance of H2S-NO crosstalk in mediating injury. eNOS derived NO is 




Crosbie et al., 2001). In comparison with the current study, mortality rates of eNOS deficient 
mice is approximately 40% higher than controls by 7 days post-CAL, whilst surviving eNOS 
deficient mice have reduced fractional shortening and greater left ventricular dilatation by 28 
days post-CAL (Scherrer-Crosbie et al., 2001). Therefore, it is likely that homeostatic 
feedback loops between H2S breakdown and synthetic enzymes in the heart also influence 
myocardial H2S-NO crosstalk and predisposes Tst
-/- mice to increased injury, dysfunction, 
dilatation and rupture. eNOS protein expression and NO levels were not measured following 
CAL. It will be important to assess these and the expression of nNOS and iNOS, as both are 
alternative sources of NO in the injured myocardium. Due to mechanical failure of the H2S 
electrode cardiac H2S levels could not be directly measured in post-CAL hearts, this should 
also be addressed in future experiments.  
 
Mitochondrial respiration  
At low concentrations (0.1-1μM), H2S can stimulate mitochondrial respiration by acting as 
an electron donor at complex 2 in the electron transport chain to produce ATP (Modis et al., 
2013b; Szabo et al., 2014). However, higher concentrations of H2S (3-30μM) can acutely 
inhibit mitochondrial bioenergetics (Modis et al., 2013b) at cytochrome c in the respiratory 
chain.  
Under basal conditions, Tst-/- mice have impaired H2S breakdown in the heart and 
likely reduce cardiac CSE expression as a compensation to avoid H2S-mediated cytochrome 
c inhibition. Previous findings show that respiratory rate is normal in mitochondria isolated 
from naive Tst-/- hearts (see section 3.3.12). In the current study, in vitro IRI studies 
performed on isolated cardiac mitochondria from naïve Tst-/- and control mice showed 
comparable respiratory recovery rates following injury. However, interpretation of these 
studies is limited by the removal of the cytosolic fraction, which contains the H2S synthetic 
enzymes. Under in vivo hypoxic and in vitro calcium overload conditions (which occurs in 
myocardial IRI), CBS and CSE can translocate from the cytosol to the mitochondria in 
hepatocytes and mesenteric smooth muscle cells respectively, increasing H2S production, 
mitochondrial respiration and ATP production (Fu et al., 2012a; Teng et al., 2013). 
However, it is currently unclear if H2S enzyme translocation occurs in cardiac mitochondria 
following IRI or CAL-induced ischaemia. At 2 days post-CAL, protein expression of CSE, 
3MST, TRX1 and HO-1 was increased in Tst-/- hearts, consistent with higher H2S levels. If 
confirmed, increased myocardial H2S levels the absence of TST at 2 days post-CAL could 
feasibly inhibit mitochondrial respiration and contribute to increased injury in Tst-/- mice. 




(ii) Early infarct healing and leukocyte recruitment 
Although H2S reduces infarct size and mortality at 24-48hours post-CAL (Zhang et al., 
2014; Zhu et al., 2006), no studies (to the authors knowledge) have yet investigated if 
regular administration of H2S during the infarct-healing phase following CAL improves 
cardiac outcome. Cardiac specific CSE overexpressing mice (αMHC-CGL-Tg), produce 
more H2S and have increased Nrf2 activation leading to greater protection from myocardial 
IRI (Calvert et al., 2010; Elrod et al., 2007). However, by 7 days after CAL, αMHC-CGL-
Tg mice had a 30% mortality rate and by 4 weeks post-CAL, showed no improvement in 
cardiac function compared to controls (Calvert et al., 2010). Although the authors failed to 
acknowledge the cause of death in the αMHC-CGL-Tg group, mortalities began from day 2 
post-CAL, at a similar time to when we observe suppression of myocardial CSE expression 
in C57BL/6J mice. In the current study, protein levels of CSE and 3MST were significantly 
higher in Tst-/- hearts at day 2 post-CAL, 1 day prior to the onset of cardiac rupture in these 
mice. As mentioned previously, increased protein levels of CSE, 3MST, TRX1 and HO-1 in 
Tst-/- hearts at day 2 post-CAL are consistent with higher H2S availability. Together these 
data infer that in models of CAL, raised cardiac CSE expression may be detrimental, leading 
to greater susceptibility to rupture and cardiac dysfunction in surviving mice, possibly due to 
elevated H2S levels. Future studies should aim to administer CSE inhibitor compounds at 
day 2 post-CAL to Tst-/- mice to determine if CSE is involved in mitigating cardiac injury.  
 
Ischaemia initiated by CAL elicits an intense inflammatory response mediated by activation 
of Toll-like receptors and the complement cascade (Ghigo 2014). Although essential for 
infarct repair, exaggerated or prolonged early neutrophil and Ly6Chigh monocyte recruitment 
can impair the healing process leading to adverse remodelling and increased risk of rupture 
(Frangogiannis, 2012). Suppression of inflammatory cell recruitment is also detrimental to 
wound healing and leads to exaggerated cardiac remodelling (Frangogiannis, 2012). Several 
studies have demonstrated the anti-inflammatory effects of H2S donors in models of 
inflammation and MI (Zanardo et al., 2006). In cultured RAW264.7 macrophages, the H2S 
donor, GYY4137 dose dependently inhibited lipopolysaccharide induced-NF-kB activation 
and expression of the pro-inflammatory cytokines, TNF-α and IL-1β (Whiteman, 2010). 
Administration of the H2S donor, NaHS immediately before and 1hour following CAL 
suppresses myocardial leukocyte infiltration and expression of the inflammatory cytokines 
TNF-α and IL-1β at 24hours post-CAL (Zhang et al., 2014). Although the Zhang 2014 study 
confirmed previous findings that H2S limits inflammation following injury, it did not assess 




The current study used day 2 post-CAL as a key time-point to investigate whether alteration 
of leukocyte recruitment was responsible for detrimental wound healing in Tst-/-mice because 
(i) Tst mRNA levels were markedly elevated in C57BL/6J mice at day 2 post-CAL (ii) CSE 
and 3MST protein expression is higher in Tst-/- hearts at day 2 post-CAL, and (iii) cardiac 
rupture incidence began at day 3 post-CAL permitting investigation prior to animal 
mortalities. 
However, careful analysis using flow cytometry failed to detect any alteration in either the 
numbers of neutrophils and Ly6Chigh monocytes detected in the blood after MI, or in those 
present in the infarcted left ventricle. Analysis of mRNA levels of myocardial MCP-1/ Ccl2, 
the MCP-1 receptor Ccr2 and the adhesion molecule Icam1 and Vcam also failed to reveal 
any modification in inflammatory signalling in hearts from Tst-/- mice. Alteration of the 
initial inflammatory response to infarction may not therefore account for increased cardiac 
rupture in these mice.  
 
In the second infarct-healing phase that follows MI an orchestrated response is initiated by 
several different cell types to suppress pro-inflammatory signalling and promote repair 
(Frangogiannis, 2012). Defective resolution of post-infarction leukocyte response may lead 
to adverse cardiac remodelling and cardiac rupture (Frangogiannis, 2012; Ghigo et al., 
2014). From day 3-4 post-MI the monocyte/macrophage population becomes a more 
predominantly anti-inflammatory, pro-repair phenotype (Ly6Clow), under the influence of 
chemokines e.g. IL-4 and IL-13, generated in the healing myocardium by other cells, 
including fibroblasts and T cells. Promotion of these pro-repair monocytes/macrophages 
leads to increased angiogenesis, reduced infarct expansion and improved retention of cardiac 
function (McSweeney et al., 2010). Growth factors including TGF-β that stimulate fibroblast 
to myofibroblast differentiation are necessary for collagen synthesis and deposition during 
scar formation (Gao et al., 2012). Scar formation at the site of cardiomyocyte loss increases 
the tensile strength of the heart and is vital in preventing rupture (Gao et al., 2012). 
Administration of H2S-donors to human atrial fibroblasts in vitro markedly reduces TGF-β 
induced proliferation and differentiation into myofibroblasts, evident by reduced α-SMA 
mRNA levels and α-SMA immunoreactivity (Sheng et al., 2013). In the current study, 
comparable numbers of Ly6Clow monocytes were detected in the blood and in digested hearts 
at 2 days post-CAL. However, it would be of interest to determine the extent to which the 
pro-repair process is initiated and sustained in Tst-/- heart. Studies carried out here do not 
support any reduction of macrophage content, or collagen deposition in mice surviving to 7 




infarcted hearts of surviving mice at day 4-5 post-CAL to confirm that rupture is not caused 
by delayed removal of necrotic tissue and impaired collagen scar tensile strength when 
rupture incidence peaks. Additionally, pro-resolution inhibitory factors at day 4-5 post-CAL 
should be measured to identify if defective inflammatory resolution is the cause of the 
adverse cardiac remodelling and/or rupture.  
 
(iii) Haemodynamic status 
Heart rate and blood pressure are known risk factors influencing cardiac rupture following 
MI, which act as a force to facilitate wall tearing (Gao et al., 2012). MI-induced 
cardiomyocyte loss and the replacement with stiff scar tissue alters ventricular contractility 
and stroke volume resulting in temporarily reduced blood pressure (Sutton et al., 2000). To 
compensate, numerous neurohormonal factors are quickly activated such as the sympathetic 
adrenergic system, the renin angiotensin-aldosterone system (RAAS) and the release of 
endothelin, which increase heart rate, contractility of non-infarcted myocardium, 
vasoconstriction and fluid and sodium retention to temporarily maintain cardiac output and 
blood pressure (Sutton et al., 2000). Telemetry observations indicate that cardiac rupture is 
preceded by marked increases in heart rate and blood pressure, typically when the mice are 
most physically active (Gao et al., 2005; van den Borne et al., 2008). 
 
Although the current study did not measure heart rate prior to cardiac rupture at days 3-5 
post MI, heart rate was comparable in anaesthetised Tst-/- and control mice at baseline and at 
7 days after CAL. However, as heart rate is depressed with inhaled isoflurane to ensure clear 
echocardiographic image acquisition, the anaesthesia may mask the real values and so heart 
rate cannot be ruled out as a possible cause of cardiac rupture in these mice.  
 
As outlined previously, TST is present in myocardial vascular smooth muscle and 
endothelial cells from large and small conductance arteries (see section 3.3.3 and 3.3.4). 
Under basal conditions, Tst-/- mice have mild endothelial dysfunction in small mesenteric 
arteries (see section 4.3.6), but remain normotensive, possibly via altered renal sodium 
handling (see section 4.3.3). However, it is unknown if Tst-/- mice maintain blood pressure 
regulation following MI. Blood pressure assessment was attempted in anaesthetised mice at 
day 2 post-CAL but insufficient numbers were carried out to permit statistical analysis and 
should be performed with larger sample groups in the future. However, given murine cardiac 




be performed to monitor heart rate and blood pressure in conscious mice during the initial 7 





6 General Discussion 
Numerous studies have characterised the ability of H2S to dilate blood vessels, reduce blood 
pressure and protect the heart from MI-induced injury. It is recognised that local H2S 
bioavailability is mediated by its enzymatic production and breakdown within the cell. 
However little is known of what impact H2S breakdown has on net H2S availability or 
indeed, how it regulates vascular function, blood pressure or the response to MI. The data 
described in this thesis tested the hypothesis that TST was present in the murine heart and 
vasculature and is actively involved in regulating local H2S availability by efficient 
breakdown. Furthermore, it was hypothesised that TST loss would lead to increased H2S 
availability and ultimately, would reduce blood pressure via increased vasodilatation and 
reduce injury following MI.  
 
TST expression has been reported in several tissues throughout the body where it is thought 
to be involved in cyanide and H2S breakdown (Nagahara et al., 1998). Data in this thesis 
showed that TST is expressed in heart, liver, aorta and kidney tissues and in endothelial cells 
from aorta and small intramuscular vessels of the hindlimb (Chapter 3). Mice deficient for 
TST had significantly higher H2S levels in the blood and a reduced rate of H2S breakdown in 
the heart and liver. Together, these data supported our original hypothesis that TST is present 
in the heart where it regulates H2S breakdown (Chapter 3). These data showcase the first 
viable mouse model of altered H2S breakdown that do not present with associated H2S-
mediated cytotoxic complications observed in Ethe1-/- mice (Tiranti et al., 2009).  
 
TST utilises thiosulfate created at the SQR 
Data in this thesis showed that Tst-/- mice had significantly higher levels of thiosulfate in 
plasma and urine, suggesting that contrary to previous conclusions (Hildebrandt et al., 
2008b), TST primarily utilises thiosulfate rather than producing it. A revision of the H2S 
breakdown pathway has recently been proposed and this provides insight into why 
thiosulfate levels are higher in Tst-/- mice. Jackson and colleagues show that the SQR 
produces thiosulfate using the ETHE1-derived sulfite as SQR-borne persulfide acceptor 
(Jackson et al., 2012). In vitro studies performed using purified recombinant human SQR 
expressed in E.coli showed that breakdown of H2S by SQR using sulfite as the persulfide 
acceptor is a rapid and efficient reaction at physiological pH, resulting in thiosulfate 
formation (Jackson et al., 2012). Moreover, Jackson and colleagues argue that thiosulfate 




formation by rat or bovine TST (Jackson et al., 2012). In this model SQR oxidises H2S to 
persulfide, which is transferred to the acceptor sulfite, forming thiosulfate (Figure 6-1). TST 
then transfers sulfur from SQR-derived thiosulfate to gluthathione (GSH) forming 
gluthathione disulphide (GSSH) and simultaneously regenerates sulfite for the SQR reaction. 
GSSH provides substrate for ETHE1, producing sulfite that can be further converted to 
sulfate by SO and excreted or ETHE1-derived sulfite can be recycled to aid thiosulfate 
creation by the SQR. To date, evidence supporting this model had been lacking in 
mammalian models but higher thiosulfate levels observed in Tst-/- mice supports it. Loss of 
TST would appear to disrupt the efficiency of this pathway, increasing the accumulation of 
thiosulfate and reducing the rate of H2S breakdown, as shown in heart and liver tissues. It is 
unclear what tissues are directly responsible for increased circulating thiosulfate and H2S 
levels in Tst-/- mice but it seems likely that the colon and liver should play a major role. TST 
is highly expressed in the colon (Taniguchi et al., 2009) to aid in the removal of bacterial-
derived H2S and therefore it is expected that loss of TST impairs H2S breakdown and leads 
to increased concentrations of H2S and thiosulfate in the blood. The hepatic portal vein 
receives venous blood from the digestive tract and accounts for approximately 75% of 
hepatic blood flow. TST is highly expressed in liver (Nagahara et al., 1998) and as such, the 
liver is believed to act as a secondary barrier preventing colonic bacterial-derived H2S from 
entering the systemic circulation via the central vein (Szabo et al., 2014). The rate of H2S 
breakdown is reduced by 50% in livers of Tst-/- mice indicating that the hepatic H2S 
breakdown barrier is impaired and likely contributes to increased levels of H2S and 
thiosulfate in the blood. However, although the rate of H2S breakdown is reduced in heart 
and liver tissues from Tst-/- mice, H2S is eventually catabolised, albeit at a slower rate 
indicating the system has compensated for TST loss. Sqrdl expression was not statistically 
different in heart, liver and kidney tissues of Tst-/- mice whilst higher thiosulfate levels in 
blood indicates that tissue SQR function is not impaired and indeed, may be enhanced to 
effectively catabolise high circulating H2S when in contact with body tissues. Western 
blotting was attempted to measure SQR protein abundance but was unsuccessful on several 
occasions, warranting further investigation. Significantly higher concentrations of thiosulfate 
in urine of Tst-/- mice suggest that without TST, the body cannot adequately breakdown 
thiosulfate for sulfite and sulfate generation and subsequently, excretes it as waste. The 
Morton group is in the process of optimising assays to measure sulfite and sulfate levels as 
surrogate markers of ETHE1 and SO enzyme activity respectively, but these experiments 




pathway in Tst-/- mice is warranted to understand how the pathway is adapted in the absence 




















Figure 6-1 The Jackson mitochondrial H2S oxidation pathway  
H2S is oxidised by the SQR forming thiosulfate, using sulfite as the SQR-persulfide acceptor. 
TST transfers sulfur from thiosulfate to glutathione, forming glutathione disulfide (GSSH) and 
further oxidised by ETHE1 to sulfite. ETHE1 derived sulfite can be recycled and used by the 
SQR or further oxidised to sulfate by sulfite oxidase and excreted. Diagram modified from 
(Kabil, Vitvitsky, & Banerjee, 2014). 
 
 
Loss of TST activates a homeostatic negative feedback mechanism in the heart but 
not in kidney 
TST is co-expressed in the same tissues as the H2S synthetic enzymes, indicating that locally 
generated H2S is tightly regulated by local breakdown within the mitochondria. Loss of TST 
alters the expression of CSE in heart and kidney tissues suggesting that TST may play an 
indirect role in its regulation. However, opposing effects were observed; CSE expression is 
reduced in the heart but increased in the kidney suggesting that alternate mechanisms are 
activated in these tissues. 
 
Reduced CSE expression in hearts of Tst-/- mice supports the hypothesis that a homeostatic 
feedback mechanism exists in the murine heart. This is likely a protective mechanism to 
limit local H2S generation and avoid H2S-mediated cytotoxicity, supported by findings that 
cardiac structure and function is normal in Tst-/- mice compared to controls. Although, it 




the cell detects high levels of circulating H2S and subsequently suppresses CSE production. 
Additionally, it’s possible that intracellular signalling occurs between the cells sulfur storage 
pools and cytosolic bound CSE in heart, which regulates H2S synthesis depending on 
whether sulfur pools are full or not. At 6 weeks following transaortic constriction (TAC) 
surgery, bound sulfane sulfur stores are reduced in the murine heart and correspond with 
increased myocardial CSE expression (Kondo 2013). Administration of the H2S donor, 
SG1002 increases myocardial bound sulfane sulfur stores and normalises CSE expression to 
sham levels, supporting this hypothesis. Thiosulfate is recognised as bound sulfane sulfur 
present in the cells sulfur storage pools, which can be converted to H2S under reducing 
conditions. The exogenous and endogenous reducing agents dithiothreitol (DTT), 
dihydrolipoic acid (DHLA) and thioredoxin (Trx1) rapidly generate H2S from thiosulfate, 
which can exert biological effects such as vasodilatation in isolated aortas of mice or rats 
(Kolluru et al., 2013; Mikami et al., 2011; Olson et al., 2013; Shen et al., 2012). Therefore, 
high thiosulfate levels may be partly responsible for reduced CSE expression in Tst-/- hearts. 
Little is understood of how CSE or sulfur stores are regulated and are both active areas of 
research within the H2S field. Future studies should measure cardiac CSE expression and 
enzyme activity following acute administration of the DTT, DHLA or Trx1 to determine if 
liberation of stored sulfane sulfur coincides with modified CSE expression or activity. It is 
possible that H2S generation in the heart is more tightly regulated than other tissues studied 
to ensure that cardiac output is maintained to permit whole body perfusion.  
 
It remains unclear why this negative feedback mechanism is not activated in the kidney of 
Tst-/- mice, especially given its exposure to high levels of H2S in the blood/ filtrate. However, 
increased CSE expression in kidneys may not be caused by a dysfunctional feedback 
mechanism but perhaps a secondary effect to vascular dysfunction in small resistance 
arteries, which will be discussed in detail below. Unfortunately, due to issues with a batch of 
internal control antibodies, it is unknown if CSE protein levels are altered in the liver of Tst-/- 







TST and blood pressure regulation 
The ability of H2S to relax blood vessels has long been considered the mechanism 
underlying its blood pressure lowering effects (Yang et al., 2008; Zhao et al., 2001). CSE is 
expressed in the vascular endothelium and smooth muscle and CSE deficient mice present 
with marked endothelial dysfunction in small mesenteric arteries and hypertension. Work in 
this thesis showed that TST is also expressed in endothelium of aorta and intramuscular 
vessels of the hindlimb (Chapter 3) suggesting that it may play a role in vascular function in 
small resistance vessels via regulation of H2S availability. We hypothesised that loss of TST 
would increase H2S availability and increase vasodilatation in small mesenteric arteries, 
lowering blood pressure. Myography experiments showed that Tst-/- mice have mild 
endothelial dysfunction of small mesenteric vessels (Chapter 4), contradicting this 
hypothesis. It remains unclear why Tst-/- mice have endothelial dysfunction but may be 
caused by endothelial damage induced by high H2S levels in blood, warranting further 
investigation. Similar dysfunction in resistance vessels of Tst-/- mice would contribute to 
increased peripheral resistance and could increase blood pressure. Currently, it is unknown if 
Tst-/- mice have increased peripheral vascular resistance and this should be assessed 
alongside myography studies performed on smaller resistance arteries.  
 
Increased sodium and water excretion in Tst-/- mice may be due to a pressure natriuresis (PN) 
response initiated by the kidney to maintain normotension. The PN response directly inhibits 
sodium reabsorption in the proximal convoluted tubule (PCT) by a cascade of paracrine and 
biophysical events, which increases excretion of sodium and water in urine, lowering 
extracellular fluid volume and normalising blood pressure (as detailed in background section 
1.1.5.1) (Ivy et al., 2014; McDonough et al., 2003). Paracrine signalling is believed to be 
involved in the PN response by internalising sodium transporters such as the NHE3 and the 
Na+/ K+-ATPase pump from the membrane to the cytosol, resulting in reduced activity and 
sodium reabsorption (McDonough et al., 2003), but this mechanism is not well understood. 
The Na+/ K+-ATPase pump is present in the PCT, thick ascending limb of Henle (TALH) 
and the distal convoluted tubule (DCT) and is critical in producing the electrochemical 
gradient necessary for the movement of electrolytes and water from the filtrate into the cell 
via sodium cotransporters. Interestingly, NaHS has been reported to inhibit Na+/ K+-ATPase 
activity in renal basolateral membranes of rats due to internalisation, resulting in increased 
excretion of sodium, potassium and water (Ge et al., 2014; Xia et al., 2009). Considering 
that CSE, CBS and 3MST are localised in the PCT (Nagahara et al., 1998; Yamamoto et al., 




acute PN response by inhibiting the Na+/ K+-ATPase pump and resultantly, impairing 
sodium reabsorption. TST is also expressed in the PCT (Sylvester et al., 1990) and may 
indirectly regulate such a PN response by moderating H2S bioavailability. Work presented in 
this thesis shows that CSE protein is increased whilst CBS protein tends to be higher in 
kidneys of Tst-/- mice suggesting that local H2S generation is enhanced, and may be 
responsible for electrolyte malreabsorption. A strong trend for increased urinary phosphate 
excretion in Tst-/- mice suggests that the Na+-Pi cotransporter is impaired and indicates that 
the PCT is the source of sodium and water losses in Tst-/- mice. The Na+-Pi cotransporter is 
heavily reliant on the electrochemical gradient produced by the Na+/ K+-ATPase pump for 
sodium and phosphate reabsorption and serves as a surrogate marker of PCT function. This 
may be caused by a PN response initiated by CSE and CBS-mediated H2S production. 
Inhibitor studies should be performed in the future to investigate if the CSE and CBS 
inhibitors, DL-propargylglycine (PAG) and aminooxyacetic acid (AOAA) can normalise 
electrolyte and water losses in Tst-/- mice. Unfortunately, small group numbers fail to provide 
statistical power for phosphate measurements and numbers should be increased in the future. 
 
However, it cannot be ruled out that the natriuretic and diuretic phenotype in Tst-/- mice is 
simply due to the combined effects of high circulating H2S levels, increased local H2S 
production and reduced H2S breakdown in the kidney causing direct inhibition of the Na+/ 
K+-ATPase in the PCT (Figure 6-2). As the Na+/ K+-ATPase is also present in the TALH and 
DCT, it is possible that increased H2S in filtrate may also inhibit Na+/ K+-ATPase at these 
regions of the nephron by diffusing through apical membranes (Figure 6-2). This may 
explain why sodium losses were not compensated downstream of the PCT in Tst-/- mice, 
particularly in the TALH where 20-25% of total NaCl reabsorption from filtrate occurs by 
NKCC2 action. Although H2S breakdown assays were not performed on kidney tissues, TST 
expression and enzyme activity in the kidney and liver are comparable (Nagahara et al., 
1998) and suggests that kidney H2S breakdown is also markedly impaired and should be 
confirmed in future studies.  
 
More in-depth investigation using specific experimental models of PN is warranted to 
elucidate if H2S acts as a paracrine-signalling molecule in the PN response. The PN response 
can be experimentally replicated by surgically ligating the mesenteric and celiac arteries of 
mice causing incremental increases in MABP. Cannulation of the ureter allows collection of 
urine to measure urinary excretion of sodium and water during arterial pressure ramps (Ivy et 




normal blood pressure (Ivy et al., 2014). Using this experimental model, future studies 
should measure (i) the enzyme activities of TST and the H2S synthetic enzymes (ii) H2S 
levels (iii) Na+/ K+-ATPase activity and (iv) sodium and water excretion in control mice 
during pressure ramps to determine if H2S is involved in PN-induced sodium 
malreabsorption in the kidney to maintain normotension. Ideally, this should be performed 
using TST inhibitors, as high circulating H2S levels in Tst
-/- mice cannot be controlled for. 
Unfortunately there are currently no commercially available selective TST inhibitors. 
Attempts were made by the Scott Webster drug discovery group, (QMRI, University of 
Edinburgh) to synthesise several in-house TST inhibitors but tests performed by the Morton 

































Figure 6-2 Model of increased electrolyte excretion in Tst-/- mice 
TST prevents locally synthesised and circulating H2S from internalising the Na+/ K+-ATPase 
in the proximal convoluted tubule (top left panel) and the thick ascending limb of Henle 
(bottom left panel). Loss of TST in the PCT of Tst-/- mice increases internalisation of the Na+/ 
K+-ATPase by CSE-mediated H2S production (top right panel) and high circulating H2S levels 




TST is critical in regulating the heart's response to injury 
The work in this thesis establishes that the mitochondrial bound TST is expressed in the 
cardiomyocytes and vasculature of the heart. We hypothesised that reduced H2S breakdown 
in Tst-/- hearts would increase H2S availability and protect the heart from MI. However, 
contrary to our hypothesis, Tst-/- mice are significantly more susceptible to injury. The 
precise mechanism causing this effect is unclear but it is likely that multiple factors 
occurring locally (as discussed in detail in chapter 5) and systemically are involved. 
Langendorff studies showed that cardiomyocytes are more susceptible to injury in the 
absence of TST, evident by increased infarct size following IRI. This is likely caused by 
reduced CSE expression that protects the heart from excessive H2S generation under basal 
conditions but may predispose the heart to enhanced injury following MI. Reduced CSE-
mediated H2S generation is likely responsible for lowered eNOS expression under basal 
conditions and together, likely impair the hearts ability to acutely release H2S and NO 
following injury, leading to increased damage. Reduced H2S-NO crosstalk has been reported 
in CSE deficient mice, increasing their vulnerability to MI (King et al., 2014). Future 
Langendorff studies should administer H2S or NO donors during ischaemia to rescue Tst
-/- 
hearts from IRI-induced injury.  
 
Thiosulfate can be recycled to form H2S by 3MST and the endogenous reducing agent, Trx1 
(Mikami et al., 2011) and has been hypothesised to act as an emergency sulfide source 
during ischaemia to stimulate ATP production via electron donation at complex 2 by the 
SQR (Olson, 2012). Increased myocardial expression of 3MST and Trx1 at 2days post CAL 
could generate toxic high concentrations of H2S from high circulating thiosulfate levels, 
leading to inhibition of mitochondrial respiration in Tst-/- hearts, prompting cardiac 
dysfunction (Disatnik et al., 2013; Neubauer, 2007). I hypothesise that TSTs utilisation of 
thiosulfate limits its conversion to H2S by 3MST and Trx1 and this may explain why TST 
expression is markedly upregulated in control hearts at 2days post CAL. Under basal 
conditions, myocardial 3MST and Trx1 expression are comparable between groups 
suggesting that circulating thiosulfate would not be converted to H2S when oxygen supply is 
sufficient to drive mitochondrial ATP production. This is supported by in vitro and in vivo 
findings showing comparable cardiac mitochondrial respiration and cardiac function 
between Tst-/- and WT mice. Future studies should measure thiosulfate and H2S levels in the 
blood and heart tissue at 2days post CAL in Tst-/- mice to see if falling thiosulfate levels 




experiments should be performed on Tst-/- and control hearts collected at 2day post CAL to 
determine if H2S-mediated dysfunction is responsible for poorer post MI outcome. 
 
Following MI-induced cardiomyocyte loss, activation of the renin angiotensin-aldosterone 
system (RAAS) and release of endothelin increase vasoconstriction and retention of sodium 
and water to temporarily maintain cardiac output and blood pressure (Sutton et al., 2000). 
Loss of TST causes mild vascular dysfunction in small mesenteric arteries (Chapter 4) but 
blood pressure is not affected under basal conditions. However, it is possible that a 
combination of sympathetic stimulation, endothelin release and RAAS stimulation following 
MI may cause excessive vasoconstriction in small arteries and increase fluid and sodium 
retention in Tst-/- mice leading to cardiac rupture and cardiac dilatation in surviving mice. As 
outlined in chapter 5, blood pressure measurements were attempted on mice 1 day prior to 
the onset of rupture, but insufficient numbers were tested to permit statistical analysis. 
However, MI-induced cardiac rupture typically occurs at night when mice are most active 
and therefore, blood pressure measurements performed on unconscious mice during the day 
may not be the best approach. Therefore telemetry and metabolic cage studies should be 
performed in unison to monitor blood pressure and fluid retention in conscious mice during 
the initial 7 days after MI to elucidate if neurohormonal stimulated haemodynamic 
alterations contribute to increased cardiac rupture risk in Tst-/- mice.  
 
Although the H2S field has been preoccupied with CSE transgenic models and 
pharmacological H2S donors to ensure protection from IRI, little consideration has been 
afforded to what impact such treatments may place upon the mitochondrial H2S breakdown 
enzymes. Here, we show that TST is critical in mediating the hearts response to injury in IRI 
and permanent ligation models (Chapter 5). TST is increased during the early healing phase 
and loss of TST increases the rate of rupture. To date, 11 polymorphisms in the TST gene 
have been identified in healthy humans (Billaut-Laden et al., 2012) and mice suffering from 
inflammatory bowel disease (IBD) have reduced TST expression and activity in the colon 
(Taniguchi et al., 2009). It is unknown if TST activity is reduced in the colon of IBD patients 
or if TST activity is impaired in their hearts, which may predispose them to enhanced injury 
following unreperfused MI. Cardiac specific CSE overexpressing mice (αMHC-CGL-Tg+) 
have increased H2S availability in the heart but fail to preserve cardiac function by 4weeks 
following permanent ligation and this may be due to an impaired infarct healing response 
(Calvert et al., 2010). From the data presented in this thesis (Chapter 5), control hearts 




enzymes during the early healing phase. Early stage clinical trials using the H2S donor 
SG1002 on heart failure patients are underway and should these drugs be administered to 
patients who did not receive reperfusion therapy, it is possible that SG1002 may 
inadvertently cause harm, especially if given regularly during the early infarct-healing phase.  
 
Concluding remarks and future directions 
Global loss of TST modifies several organ systems simultaneously confirming the 
ubiquitous expression of TST and highlighting its role in the vasculature and in the heart’s 
response to MI. However, Tst-/- mice have increased H2S levels in blood, altering tissue H2S 
synthetic enzyme expression and making tissue effects difficult to interpret. Although 
Langendorff studies show that TST plays a critical role in the heart’s response to injury in 
isolation from other systems and circulating levels of H2S and thiosulfate, a more specific 
transgenic mouse model is warranted to understand the mechanism causing the cardiac 
rupture and poorer post MI outcomes in Tst-/- mice. Future studies require tissue specific 
TST knockout models and inducible transgenic mice to fully elucidate the role of TST in 
these organ systems and its role following injury. This data shows that TST is beneficial for 
vascular health and is critical following MI. As such, future studies may attempt to stimulate 
TST during the early infarct-healing phase following unreperfused MI to reduce cardiac 
rupture and improve cardiac outcome. Furthermore, these data may accelerate the 
development of TST inhibitors for use as loop diuretics in the kidney or as treatments in 
haemorrhagic shock patients to reduce vasodilatation but obviously, further work as detailed 
above needs to be completed to understand the actions involved in these processes. 
Moreover, these data will further the understanding of the H2S breakdown pathway in the 
mitochondria and provide the H2S field with an alternative mouse model to investigate the 
complexity of H2S biology following permanent ligation. It is becoming clearer that H2S 
may not be a wonder molecule in all injury models and the data outlined here supports that 
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Appendix 1 Immunohistochemical localisation of TST 




Sections photographed using an Olympus light microscope camera. Sections illustrate 
negative control stained sections (top row) and positive DAB staining (brown) in hepatic 
portal tracts (left column), and hepatic central veins (right columns). Abreviations; PV (portal 
vein), HA (hepatic artery), BD (bile duct), H (hepatocytes). Scale bar, 50μm. 
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Figure 2: Gene expression & protein analysis of H2S synthesising & degradative enzymes in the murine liver. (A) Real-
time PCR data identifies that all H2S modulating enzymes are present at high levels in 10wk old male C57BL/6J control mouse 
liver assessed via cycle threshold; cT values (high gene expression <30cycles), n=4. (B) H2S synthesising enzyme expression is 
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Figure 4: Gene expression & protein analysis of H2S synthesising & degradative enzymes in the murine heart. (A) Real-time 
PCR data identifies that all H2S modulating enzymes are present in 10wk old male C57BL/6J control mouse heart but at moderate-
low levels assessed via cycle threshold (cT) values (moderate gene expression <35cycles, low gene expression >35cycles). CSE, 
MPST & TST are moderately expressed in the mouse heart while CBS is weakly expressed, n=4. (B) H2S synthesising & degradative 
enzyme expression is confirmed in the heart with western blots from the same mouse heart tissue samples, n=4.   
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Appendix 2 Tst-/- ingest more sodium, potassium and 




























Mean body weight (A) and mean food take (B) over 8day post-acclimatisation period (WT; 
n=4,Tst-/-; n=5). (C-E) Mean 24hour sodium, potassium and chloride intake over 8day post-
acclimatisation period (WT; n=4,Tst-/-; n=5). Electrolyte intake [food intake (g) x (g) of Na+, K+ 
or Ca2+ in RM1 diet]. Data are mean ± SEM. Statistical analysis was performed using 
unpaired student t-test *p < 0.05 
















E) Chloride Intake 






























Appendix 3 Plasma renin concentrations are not 


















Radioimmunoassay detecting plasma renin concentration in plasma from 12week old WT 
and Tst-/- mice (n=4/ group). Data are mean ± SEM. [Assay performed by Dr. Chris Kenyon 



























Appendix 4 Independent observations of polydipsic 

















Average daily water intake Tst-/- and C57BL/6N wild type littermates in single housed regular 




Average Weekly Water Intake
(Control  Animals)































Appendix 5 Contribution of SKCa and IKCa channels to 
the relaxant response to ACh in isolated mesenteric 
































Cumulative concentration response to ACh in endothelial intact mesenteric rings of wild type 
mice when pre-treated with or without apamin (SKCa inhibitor) and charybdotoxin (IKCa 
inhibitor) (Non-treated; WT; n=7, WT [+] CHx/ APA; Tst-/-; n=5). Vessel response to ACh was 
expressed as percentage of vessel pre-constriction. Values are mean±SEM, analysed by 2-
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